===== DISCHARGE NOTE =====
note_id=14047385-DS-16 | hadm_id=20809359

 
Name:  ___     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Dapsone / methotrexate
 
Attending: ___.
 
Chief Complaint:
scheduled admission for chemotherapy
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Mr ___ is a ___ yr old male with hx of HIV on HAART, CAD w/ 
hx
STEMI ___ s/p PCI, HTN as well as CNS lymphoma dx ___ after
presenting with balance disturbance and blurry/double vision. He
underwent craniotomy and brain biopsy c/w CNS lymphoma and was
started on induction methotrexate starting ___.  Per patient
has had marked improvement in vision soon after ___ cycle and
balance also significantly improved.  He has been walking up to 
3
miles, no falls, only occasionally has to steady himself. States
he has intermittent double vision in R lower corner of vision,
for instance describes he might see "two hands", now occurs only
if stressed or sleep deprived.  His last opthal eval did not 
show
evidence of lymphoma on eye exam and he was given techniques for
trying to focus his eyes. Last MRI brain ___ showed ongoing
resolution of R cerebellar enhancement.

He is here today for next high-dose MTX, this is second since
spacing out to every 2-months. States he gets some nausea with
MTX otherwise tolerates well. No recent fever/chills, HA, neck
pain, numbness, weakness, cough, SOB, ab pain, N/V/D. Is eating
well.
Of note he was seen in ED ___ with episode of chest pain. 
Given
cardiac hx he had EKG, serial trops that were negative and CTA
chest that did not show PE.  He does report that pain comes on
after eating esp if laying down soon after as he often eats and
then goes to bed.  Some burning quality also some epigastric
pain, none for few days. Chest pain is not exertional, he is
walking as above and not limited by dyspnea. No further
intervention was recommended but he has not yet followed up with
cardiology.
 
Past Medical History:
His neurological problem began at the end of ___ when
he experienced imbalance and blurry vision.  Initially, his gait
imbalance was intermittent, mostly occuring after eating and
lasting for a couple of hours.  However, it progressed to a
constant fashion.  He also developed blurry vision and he had to
close one eye in order to see clearly.  On ___, his
imbalance was severe enough that his brother, ___, took him to ___.  He had a head
CT that showed a mass at the brainstem.  He was referred to see
Dr. ___ on ___ who admitted him to the
Neurosurgery Service.  A gadolinium-enhanced head MRI on 
___
showed a homogeneously enhancing mass at the lateral recess on
the right side of the fourth ventricle.  He then underwent a
stereotaxic biopsy of the mass by Dr. ___ on
___.  After biopsy he remains neurologically stable.  He
then started high-dose methotrexate on ___.

(1) stereotaxic biopsy of the mass by Dr. ___ on
___,
(2) an echocardiogram that was performed on ___ showing
apical hypokinesis but his ejection fraction remained at 55%,
(3) started high-dose methotrexate on ___ and had 5
induction cycles so far,
(4) started re-induction high-dose methtorexate on ___ and
had 3 cycles,
(5) started maintenance high-dose methotrexate on ___ at
monthly interval and had 4 cycles, and
(6) started every 2-month maintenance high-dose methotrexate on
___ and had 1 cycle.

PAST MEDICAL HISTORY:
He has coronary artery disease, myocardial infarction, HIV
disease, pancreatitis, hypertension, hypercholesterolemia and
gastric ulcer.  He also had right-sided ophthalmic shingles as
well as shingles in V3 distribution in ___.  He does not have
diabetes or COPD.

He is HIV positive from heterosexual contact.  He was on HAART
therapy from ___ to ___, and subsequently stopped from ___ to
___, and then resumed in ___.  His viral load is undetectable
when it was last checked at ___ in
___.  He sees Dr. ___ and ___ there.  He is on Truvada and 
Kaletra.

His cardiac history is significant for a myocardial infarction
with inferior ST elevation that occurred in ___.  
He
subsequently received a cardiac stent in the large obtuse
marginal branch.  He also had a chronically occluded LAD
collateralized from the right coronary artery.  An exercise
stress test in ___ showed a fixed moderate myocardial
perfusion defect in the anteroapical wall with no evidence of
reversible ischemia and echocardiogram.  His ejection fraction
was 55% with severe apical hypokinesis.  He had a repeat
echocardiogram on ___ that showed apical hypokinesis but 
his
ejection fraction remained at 55%.
 
Social History:
___
Family History:
His parents are alive; his mother has
pre-diabetes while his father has glaucoma and prostate cancer. 
He has 6 brothers, one of the, has kidney problem.  He has 3
daughters and they are all healthy.
 
Physical Exam:
VITAL SIGNS: afebrile, OVSS
I/O 3L/5L, weight down 1lb
HEENT:  MMM, no OP lesions, 
Neck: supple, no JV
Lymph: no cervical, supraclavicular, axillary or inguinal
adenopathy
CV:  RR, NL S1S2 no S3S4 or MRG
PULM:  CTAB
ABD:  BS+, soft, NTND, no masses or hepatosplenomegaly
EXT:  warm well perfused, no edema
SKIN:  No rashes or skin breakdown
NEURO:  alert and oriented x 4, ___, EOMI, no nystagmus, face
symmetric, no tongue deviation, full hand grip, shoulder shrug
and bicep flexion, full toe dorsiflexion and hip flexion against
resistance bilateral, sensation intact to light touch, no 
clonus,
no dysmetria with FTN/HTS testing, visual fields intact to
confrontation, gait normal and able to tandem walk in a straight
line, Romberg negative 
 
Pertinent Results:
DAY OF DISCHARGE:

Source: ___
___  AGap=14
3.9321.1

Ca: 9.0 Mg: 2.4 P: 3.6
ALT: 58 AP: 71 Tbili: 0.5 Alb:
AST: 39

mthotrx: 0.14

wbc 5.0hgb 14.3plt 194
 
Brief Hospital Course:
Mr ___ is a ___ yr old male with hx HIV on HAART, hx CAD w/
STEMI s/p PCI on plavix as well as CNS lymphoma now in remission
on HD-MTX.

(1) CNS Lymphoma:  Presented with imbalance and double vision,
symptoms now much improved. In ongoing remission w/ resolution 
of
R cerebellar enhancement. 
- here now for cycle 6 maintenance high-dose methotrexate 
(8g/m2)
now given at 2-month interval, dose completed 0400 ___
-  was continued on hydration and urine alkalinization with 
sodium bicarb to
maintain urine pH >8
- started leucovorin rescue 24 hrs after MTX dose completed.
- pt will continue oral leucovorin and sodium bicarb for 24 hrs 
on discharge as MTX level 0.14 and continues to clear

2) Hx HIV - Pt on HAART therapy thru ___ 
___. Last CD4 here 157 ___.   Viral load undetectable as 
of ___ per Dr ___.  Cont truvada and 
lopinavir-ritonavir. Is on prophy bactrim

(3) Hx Herpes Zoster Eruption at Left S1-2 Dermatomes:  He is on 
prophylactic acyclovir.

(4) Coronary Artery Disease:  hx STEMI s/p PCI to large obtuse 
marginal.Currently no active cardiac symptoms. maintained on ASA 
and plavix.  Did have recent nonexertional chest pain most c/w 
GERD. Most recent EF 55% ___. 
- cont metoprolol, plavix and statin, held ASA w/ MTX and 
resumed on discharge
- he has cardiology f/u in ___ GERD - changed PPI to rantidine w/ MTX,add tums or maalox prn
acute symptoms

6) Hx HTN - holding lisinopril while on MTX, BP was stable
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acyclovir 800 mg PO BID 
2. Atorvastatin 80 mg PO DAILY 
3. Clopidogrel 75 mg PO DAILY 
4. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
5. Lisinopril 5 mg PO DAILY 
6. Lopinavir-Ritonavir 2 TAB PO BID 
7. Metoprolol Succinate XL 25 mg PO DAILY 
8. Pantoprazole 40 mg PO Q24H 
9. LOPERamide 2 mg PO QID:PRN diarrhea 
10. Aspirin 81 mg PO DAILY 
11. Fish Oil (Omega 3) 1000 mg PO DAILY 
12. Sulfameth/Trimethoprim DS 1 TAB PO 3X/WEEK (___) 

 
Discharge Medications:
1. Acyclovir 800 mg PO BID 
2. Atorvastatin 80 mg PO DAILY 
3. Clopidogrel 75 mg PO DAILY 
4. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
5. Fish Oil (Omega 3) 1000 mg PO DAILY 
6. LOPERamide 2 mg PO QID:PRN diarrhea 
7. Lopinavir-Ritonavir 2 TAB PO BID 
8. Metoprolol Succinate XL 25 mg PO DAILY 
9. Sulfameth/Trimethoprim DS 1 TAB PO 3X/WEEK (___) 
10. Leucovorin Calcium 40 mg PO Q6H 
take 4 doses (for one day) 
RX *leucovorin calcium 10 mg 4 tablet(s) by mouth every 6 hours 
Disp #*16 Tablet Refills:*0
11. Sodium Bicarbonate 1300 mg PO Q6H 
take every 6 hours for 4 doses (for one day) 
RX *sodium bicarbonate 650 mg 2 tablet(s) by mouth every 6 hours 
Disp #*8 Tablet Refills:*0
12. Aspirin 81 mg PO DAILY 
13. Lisinopril 5 mg PO DAILY 
14. Pantoprazole 40 mg PO Q24H 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
CNS lymphoma

 
Discharge Condition:
Condition - stable
Mental status - alert and oriented
Ambulatory status - independent

 
Discharge Instructions:
Mr ___ it was a pleasure caring for you during your stay at 
___.  You were admitted for your next cycle of high dose 
methotrexate which you tolerated well. Your methotrexate level 
was 0.14 so you will take oral leucovorin and sodium bicarbonate 
while the methotrexate continues to clear over the next day
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=14047385-DS-3 | hadm_id=21063209

 
Name:  ___     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: NEUROLOGY
 
Allergies: 
Dapsone
 
Attending: ___.
 
Chief Complaint:
Rash
 
Major Surgical or Invasive Procedure:
None during this hospitalization
 
History of Present Illness:
___ is a ___ man with past medical history 
of HIV and recently diagnosed high-grade CNS B-Cell lymphoma, 
status post high-dose MTX and dexamethasone who presents with a 
___ rash. The rash began on ___ on just superior to 
his anus. He knew this rash was there because he could feel the 
rash with his hand. The rash then began to become more 
pronounced on ___ and became itchy with spread to his anus. 
He described his anus, in ___, as "agitated". Then, on 
___, the rash became larger and harder. He does not know if 
there was any drainage. He denies using any new products - 
lotions, detergents, etc. recently. He states that he has had 
these bisters ___ times in the past ___ years and has had 
acyclovir for them. He also states that he has had zoster 
before. His rash now feels like what he has experienced in the 
past. In terms of his sexual history, he used to have sex with 
men and women but now only with women. His last new partner was 
in ___ and ___ has not had sex since then. Of note, pt gets 
his care at ___ but frequently travels to ___ 
___.
 
Past Medical History:
CAD s/p BMS (___)
HIV on HAART (VL undetectable)
h/o pancreatitis ___ HIV medication
HTN
HLD
Gastric ulcer

 
Social History:
___
Family History:
It is notable for father and brother with prostate cancer, 
several paternal aunts with breast cancer and maternal uncles 
with diabetes.
 
Physical Exam:
======================
Admission Examination
======================
Vital Signs: Temperature 98.5 F, blood pressure 118/72, heart 
rate 66, respiration 16, and oxygen saturation 99% in room air
General: well-appearing, pleasant, no distress
HEENT: well-healing scalp incision right occipital area, no 
tenderness, clear oral pharynx, no vesicular lesions, anicteric 
sclerae
Neck: no adenopathy
Cardiovascular: RRR, normal S1, S2, no murmurs
Lungs: lungs clear bilaterally
Abdomen: soft, non-tender, non-distended, no organomegaly
Perineum: crops of flesh-colored papules near anus; also clear 
vesicular lesions in gluteal fold, left > right, with small skin 
tear between anus and scrotum, no surrounding erythema
Skin: tiny erythematous pustules near hair follicles of chest, 
near right ear
Extremities: 2+ radial and DP pulses, no edema

Neurological Examination: His Karnofsky Performance Score is 70. 
He is awake, alert, and oriented times 3.  His language is 
fluent with good comprehension, naming, and repetition (he 
speaks ___.  Recent recall is intact.  Cranial Nerve 
Examination: His pupils are equal and reactive to light, 4 mm to 
2 mm
bilaterally.  Extraocular movements are full; there is no 
nystagmus.  Visual fields are full to confrontation.  His face 
is symmetric.  Facial sensation is intact bilaterally.  His 
hearing is intact bilaterally.  His tongue is midline.  Palate 
goes up in the midline.  Sternocleidomastoids and upper 
trapezius are strong.  Motor Examination:  He does not have a 
drift.  His
muscle strengths are ___ at all muscle groups.  His muscle tone 
is normal.  His reflexes are 2- bilaterally.  His ankle jerks 
are absent.  His toes are down going.  Sensory examination is 
intact to touch and proprioception.  Coordination examination 
does not reveal dysmetria.  His gait is steady.  He has 
difficulty performing tandem gait.  He has a Romberg.

========================
Discharge Examination
========================
Vital Signs: Temperature 98.1 F, heart rate 62, blood pressure 
114/73, and oxygen saturation 100% in room air
General: NAD
HEENT: NCAT, EOMI, PERRLA
Neck: no JVD, no LAD
Cardiovascular: RRR
Lungs: CTAB
Abdomen: +BS, soft, NT/ND
Genitourinary: multiple fluid filled perianal vesicles and 
superior lesions that are larger in gluteal fold, some have 
opened and dried, 2 ___ ulcers with clean bases
Extremities: warm, +2 ___ pulses, warm

Neurological Examination: His ___ Performance Score is 70. 
He is awake, alert, and oriented times 3.  His language is 
fluent with good comprehension (he speaks ___.  Recent 
recall is intact.  Cranial Nerve Examination:  His pupils are 
equal and reactive to light, 4 mm to 2 mm bilaterally.  
Extraocular
movements are full; there is no nystagmus.  Visual fields are 
full to confrontation.  His face is symmetric.  Facial sensation 
is intact bilaterally.  His hearing is intact bilaterally.  His 
tongue is midline.  Palate goes up in the midline. 
Sternocleidomastoids and upper trapezius are strong.  Motor 
Examination:  He does not have a drift.  His muscle strengths 
are
___ at all muscle groups.  His muscle tone is normal.  His 
reflexes are 2- bilaterally.  His ankle jerks are absent.  His 
toes are down going.  Sensory examination is intact to touch and 
proprioception.  Coordination examination does not reveal 
dysmetria.  His gait is steady.  He has a Romberg.
 
Pertinent Results:
======================
admission
======================

___ 07:15PM BLOOD WBC-11.8*# RBC-5.53 Hgb-17.0 Hct-49.8 
MCV-90 MCH-30.8 MCHC-34.2 RDW-12.5 Plt ___
___ 07:15PM BLOOD Neuts-90.9* Lymphs-5.0* Monos-3.2 Eos-0.3 
Baso-0.7
___ 07:15PM BLOOD Glucose-176* UreaN-26* Creat-0.9 Na-130* 
K-5.0 Cl-94* HCO3-23 AnGap-18

=======================
discharge
=======================

___ 06:50AM BLOOD WBC-7.2 RBC-4.90 Hgb-15.0 Hct-44.8 MCV-91 
MCH-30.5 MCHC-33.4 RDW-12.4 Plt Ct-86*
___ 06:50AM BLOOD Glucose-168* UreaN-19 Creat-0.6 Na-129* 
K-4.6 Cl-94* HCO3-23 AnGap-17
___ 06:50AM BLOOD Calcium-8.6 Phos-3.7 Mg-2.0

=======================
pertinent
=======================

___ 08:14PM BLOOD Lactate-3.9*
___ 12:26AM BLOOD Lactate-4.7*
___ 03:37AM BLOOD Lactate-3.6*
___ 09:50AM BLOOD Lactate-3.6*
___ 05:47PM BLOOD Lactate-3.9*
___ 09:50AM BLOOD ___ pH-7.46* Comment-GREEN TOP 
___ 05:47PM BLOOD ___ pH-7.44
___ 09:40AM BLOOD Osmolal-272*

=====================
micro
=====================
___ 9:31 am 
      Direct Antigen Test for Herpes Simplex Virus Types 1 & 2
      LOWER BUTTOCK VESICLES. 

                            **FINAL REPORT ___

   Direct Antigen Test for Herpes Simplex Virus Types 1 & 2 
(Final
      ___: 
      Reported to and read back by ___ ___ ___ 1150AM. 

      POSITIVE FOR HERPES SIMPLEX TYPE 2 (HSV2). 
         Viral antigen identified by immunofluorescence.

___ 8:50 pm URINE      SOURCE: ___. 

                            **FINAL REPORT ___

   URINE CULTURE (Final ___: 
      ESCHERICHIA COLI.    10,000-100,000 ORGANISMS/ML.. 
         PRESUMPTIVE IDENTIFICATION. 

                              SENSITIVITIES: MIC expressed in 
MCG/ML
                      
_________________________________________________________
                             ESCHERICHIA COLI
                             |   
AMPICILLIN------------  =>32 R
AMPICILLIN/SULBACTAM--     4 S
CEFAZOLIN-------------  =>64 R
CEFEPIME--------------   <=1 S
CEFTAZIDIME-----------     4 S
CEFTRIAXONE-----------    32 R
CIPROFLOXACIN---------   =>4 R
GENTAMICIN------------   <=1 S
MEROPENEM-------------<=0.25 S
NITROFURANTOIN--------  <=16 S
PIPERACILLIN/TAZO-----   <=4 S
TOBRAMYCIN------------   <=1 S
TRIMETHOPRIM/SULFA----   <=1 S 
 
Brief Hospital Course:
___ is a ___ man with past medicla history 
of high-grade CNS lymphoma, HIV presents with painful anal rash.

1. HSV Infection: Direct antigen from scrapings of base of 
ulcers returned as positive for HSV. No evidence of disseminated 
HSV infection. Pt reports he has had multiple infections with 
HSV in the past ___ years that have been treated with acyclovir. 
He was started on acyclovir with improvement in his symptoms and 
rash. He will complete a treatment course of acyclovir followed 
by continuing acyclovir at a prophylactic dose for continued 
suppression. 

2. Hyperlactatemia: Unknown etiology, did not respond to fluid 
resuscitation. Likely type 2 lactic acidosis due to NRTIs, less 
likely CNS lymphoma. Lack of evidence of hypoperfusion and 
sepsis argues against type I lactic acidosis. Per ___ 
attending, HAART unlikely to be culprit as pt has been 
stabilized on this regimen for awhile but unknown if lactate had 
ever been checked. Will have this followed up as an outpatient. 

3. Asymptomatic Bacteriuria: Urine culture grew e coli. Treated 
with three days of antibiotics. 

4. CNS Lymphoma: He is status post high-dose MTX, continues on 
dexamethasone; no evidence of meningitis. He will follow up with 
Dr. ___ continuing chemotherapy. 

5. Hyponatremia: He appears euvolemic. Serum osmolality low, 
urine sodium inappropriately high. This is most likely c/w 
SIADH. Most likely related to underlying intracranial disease.

6. Thrombocytopenia: It is possibly due to MTX. no other new 
medications. Stable but low. 

7. HIV: He is well controlled, CD 4 count 245, suppressed viral 
load. HAART re-started. 

8. CAD: s/p remote PCI with BMS, stable, cont ASA, BB, ACEi

9. GERD: PPI

========================
transitional issues
========================
* Follow up Dr. ___ ___ for discussion about when 
chemotherapy will continue
* Continue acyclovir at prophylactic dose after completing 
treatment for HSV
 
Medications on Admission:
The Preadmission Medication list may be inaccurate and requires 
futher investigation.
1. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
2. Lisinopril 5 mg PO DAILY 
3. Lopinavir-Ritonavir 2 TAB PO BID 
4. Metoprolol Succinate XL 25 mg PO DAILY 
5. Omeprazole 40 mg PO DAILY 
6. Pravastatin 40 mg PO DAILY 
7. Dexamethasone 4 mg PO Q12H 
8. Aspirin 81 mg PO DAILY 
9. Fish Oil (Omega 3) 1000 mg PO DAILY
 
Discharge Medications:
1. Aspirin 81 mg PO DAILY 
2. Dexamethasone 4 mg PO DAILY 
RX *dexamethasone 4 mg 1 tablet(s) by mouth daily Disp #*30 
Tablet Refills:*0
3. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
4. Fish Oil (Omega 3) 1000 mg PO DAILY 
5. Lisinopril 5 mg PO DAILY 
6. Lopinavir-Ritonavir 2 TAB PO BID 
7. Metoprolol Succinate XL 25 mg PO DAILY 
8. Omeprazole 40 mg PO DAILY 
9. Pravastatin 40 mg PO DAILY 
10. Acyclovir 800 mg PO Q8H until ___ 
RX *acyclovir 800 mg 1 tablet(s) by mouth every eight hours Disp 
#*21 Capsule Refills:*0
11. Docusate Sodium 100 mg PO BID prn constipation 
RX *docusate sodium [Colace] 100 mg 1 capsule(s) by mouth twice 
a day Disp #*30 Capsule Refills:*0
12. Senna 1 TAB PO BID prn constipation 
RX *sennosides [senna] 8.6 mg 1 capsule by mouth twice a day 
Disp #*30 Capsule Refills:*0
13. Acyclovir 200 mg PO DAILY starting ___ onwards 
RX *acyclovir 200 mg 1 capsule(s) by mouth daily Disp #*30 
Capsule Refills:*0
14. Outpatient Lab Work
please check chem 10, lactate on ___ at ___ and review 
results with Dr ___ (Phone: ___, Fax: 
___ 
 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY:
1. anal herpes simplex
2. urinary tract infection, complicated
3. hyponatremia
4. hyperlactic acidosis

SECONDARY
5. HIV
6. CNS lymphoma
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Dear Mr. ___, 

It was a pleasure taking care of you at the ___ 
___. You came into the hospital because of 
a painful rash that you had. We took a sample of the rash and we 
confirmed that it is herpes simplex virus 2 (hSV 2). You were 
given a medication called acyclovir that helps treat your 
infection. Please continue to take the treatment dose of 
acyclovir, 800mg every 8 hours for 7 days (ie until ___. 
After that you will need to continue taking a prevention dose 
daily (200mg once a day) until you complete your chemotherapy.
You are being discharged on a bowel regimen to keep the stools 
soft to prevent pain while the HSV2 is healing. Please apply 
vaseline to the area daily to prevent dryness. 

 As you know, this is a recurrent infection. For your safety, 
and the safety of your sexual partners, you should always use 
protection as herpes is transmissible during sexual encounters.

We also reduced the dose of your dexamethasone to 4mg once a 
day. 
Please discuss on your appt with Dr ___ you should continue 
taking this medication. 

You will see Dr ___ on ___, and he will decide based 
on how the herpes is healing, whether you can have your 
chemotherapy on ___

Thank you for choosing ___.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=14047385-DS-22 | hadm_id=21716702

 
Name:  ___     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Dapsone / methotrexate
 
Attending: ___.
 
Chief Complaint:
Scheduled chemotherapy high dose methotrexate
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ PMH of HIV, CNS Lymphoma, Multinodular goiter causing
dysphagia (s/p total thyroidectomy) presented for last of his
yearly methotrexate infusions 

Of note patient had last MRI in ___ without e/o disease
recurrence so presents for last yearly MTX infusion then will be
followed with observation alone. 

Patient is ___ speaking so bilingual nurse assisted for
translation. 

Pt reports that he is in his USOH without any neurologic
concerns/symptoms. He stated that he is eating, drinking,
voiding, stooling without difficulty. Noted that he has normal
energy levels. Reported that he is slightly anxious during
admissions, and is hopeful that he will not have to stay in the
hospital too long  
 
REVIEW OF SYSTEMS:  
A complete 10-point review of systems was performed and was
negative unless otherwise noted in the HPI. 
 
Past Medical History:
- HIV on HAART (viral load undetectable)
- CAD
- HTN
- MI s/p stent placement x 3 (___)
- CNS lymphoma (dx ___, on chemotherapy, no neuro deficits)

 
Social History:
___
Family History:
His parents are alive; his mother has pre-diabetes while his 
father has glaucoma and prostate cancer.  He has 6 brothers.  He 
has 3 daughters and they are all healthy.  
 
Physical Exam:
ADMISSION PHYSICAL EXAM:  
Vitals: 24 HR Data (last updated ___ @ 1137)
    Temp: 98.5 (Tm 98.5), BP: 115/80, HR: 76, RR: 18, O2 sat:
97%, O2 delivery: RA, Wt: 199.8 lb/90.63 kg   
GENERAL: Sitting in bed, appears comfortable, no acute distress,
pleasant, calm
EYES: He was equally round reactive to light, anicteric sclera
HEENT: Oropharynx clear, moist mucous membranes
NECK: Supple, normal range of motion
LUNGS: Clear to auscultation bilaterally no wheezes rales or
rhonchi, no increased work of breathing 
CV: regular rate and rhythm, no murmurs rubs or gallops, normal
distal perfusion
ABD: Soft, nondistended, normoactive BS, nontender 
GENITOURINARY:
no Foley or suprapubic tenderness
EXT: No deformity, normal muscle bulk, normal strength 5 out of 
5
all extremities
SKIN: Warm dry, no rash 
NEURO: Alert and oriented x3, fluent speech, cranial nerves
intact without focal deficits, strength intact in bilateral
upper/lower extremities, sensation preserved grossly in all
extremities.
ACCESS: Peripheral IV

DISCHARGE EXAM:
119 / 72 66 16 98 RA  
GENERAL: Standing in room, no distress, pleasant. 
EYES: Round reactive to light, anicteric sclera
HEENT: Oropharynx clear, moist mucous membranes
NECK: Supple, normal range of motion
LUNGS: Clear to auscultation bilaterally no wheezes rales or
rhonchi, no increased work of breathing 
CV: regular rate and rhythm, no murmurs rubs or gallops, normal
distal perfusion
ABD: Soft, nondistended, normoactive BS, nontender
GENITOURINARY: no Foley or suprapubic tenderness
EXT: No deformity, normal muscle bulk, normal strength 5 out of 
5
all extremities
SKIN: Warm dry, no rash 
NEURO: Alert and oriented x3, fluent speech, cranial nerves
intact without focal deficits, strength intact in bilateral
upper/lower extremities, sensation preserved grossly in all
extremities.
 
Pertinent Results:
ADMISSION LABS:
___ 12:30PM BLOOD WBC-4.2 RBC-4.79 Hgb-14.7 Hct-44.4 MCV-93 
MCH-30.7 MCHC-33.1 RDW-12.7 RDWSD-43.5 Plt ___
___ 12:30PM BLOOD Neuts-55.8 ___ Monos-8.9 Eos-2.2 
Baso-0.7 Im ___ AbsNeut-2.32 AbsLymp-1.34 AbsMono-0.37 
AbsEos-0.09 AbsBaso-0.03
___ 12:30PM BLOOD ___ PTT-32.9 ___
___ 12:30PM BLOOD Glucose-96 UreaN-13 Creat-1.3* Na-140 
K-4.2 Cl-107 HCO3-23 AnGap-10
___ 12:30PM BLOOD ALT-31 AST-25 AlkPhos-64 TotBili-0.3
___ 12:30PM BLOOD Calcium-9.2 Phos-3.0 Mg-2.0

LFT trend:
___ 12:30PM BLOOD ALT-31 AST-25 AlkPhos-64 TotBili-0.3
___ 05:48AM BLOOD ALT-26 AST-20 AlkPhos-59 TotBili-0.2
___ 09:00AM BLOOD ALT-175* AST-116* AlkPhos-71 TotBili-0.4
___ 09:00AM BLOOD ALT-203* AST-133* AlkPhos-60 TotBili-0.3
___ 09:00AM BLOOD ALT-281* AST-164* AlkPhos-69 TotBili-0.6
___ 03:08PM BLOOD ALT-319* AST-192* AlkPhos-71 TotBili-0.5
___ 05:45AM BLOOD ALT-405* AST-248* AlkPhos-68 TotBili-0.7
___ 06:00AM BLOOD ALT-332* AST-139* AlkPhos-67 TotBili-0.4

MTX trend:
___ 09:00AM BLOOD mthotrx-1.8*
___ 09:00AM BLOOD mthotrx-0.53*
___ 09:00AM BLOOD mthotrx-0.11
___ 03:08PM BLOOD mthotrx-0.09
___ 05:45AM BLOOD mthotrx-0.05
___ 06:00AM BLOOD mthotrx-<0.04

OTHER DISCHARGE LABS:
___ 06:00AM BLOOD WBC-3.1* RBC-4.74 Hgb-14.9 Hct-44.7 
MCV-94 MCH-31.4 MCHC-33.3 RDW-12.2 RDWSD-42.7 Plt ___
___ 06:00AM BLOOD Neuts-63.7 ___ Monos-2.9* Eos-1.9 
Baso-0.3 Im ___ AbsNeut-2.00 AbsLymp-0.97* AbsMono-0.09* 
AbsEos-0.06 AbsBaso-0.01
___ 06:00AM BLOOD ___ PTT-30.2 ___
___ 06:00AM BLOOD Glucose-91 UreaN-8 Creat-1.3* Na-139 
K-4.2 Cl-98 HCO3-32 AnGap-9*
___ 06:00AM BLOOD Calcium-8.9 Phos-3.3 Mg-2.___ PMH of HIV, CNS Lymphoma, Multinodular goiter causing 
dysphagia (s/p total thyroidectomy) presented for last of his 
yearly methotrexate infusions course c/b transaminitis

#CNS Lymphoma
#Transaminitis ___ liver injury from methotrexate infusion
Last MRI in ___ without e/o disease recurrence so presented 
for yearly MTX infusion. Dosing was complicated by transaminitis 
which was improving but not resolved by time of discharge. 
Patient was instructed to schedule an appt and repeat lab draw 
for LFTs with his PCP ___ 1 week to ensure that they have 
normalized. Pt is to f/u with Dr ___ in ___ year. 

#CAD: 
Takes single agent ASA at home. Given interference with MTX, ASA 
replaced with Plavix during stay

#HTN
Continued on lisinopril/metoprolol during stay

#HLD
Statin held during stay and on discharge in view of 
transaminitis. Patient is to continue to withhold dosing until 
his LFTs are re-checked by his primary care doctor.

#HIV
Reportedly well controlled, continued on stribild

#Headache/Migraine
Right sided above eye. Occurred on ___, unresponsive to 
multiple agents, CTH negative for acute issues, eventually 
resolved with fioricet.

Transitional Issues:
1. Patient was instructed to schedule an appt and repeat lab 
draw for LFTs with his PCP ___ 1 week to ensure that they have 
normalized. 
2.Patient is to continue to withhold pravastatin dosing until 
his LFTs are re-checked by his primary care doctor
3.Pt is to f/u with Dr ___ in ___ year

I personally spent 26 minutes preparing discharge paperwork, 
educating patient/family, answering questions, and coordinating 
care with outpatient providers
 
___ on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY 
2. Lisinopril 5 mg PO DAILY 
3. Metoprolol Succinate XL 25 mg PO DAILY 
4. Pravastatin 80 mg PO QPM 
5. Stribild 1 tab Other DAILY 
6. Levothyroxine Sodium 150 mcg PO DAILY 

 
Discharge Medications:
1.  Aspirin 81 mg PO DAILY  
2.  Levothyroxine Sodium 150 mcg PO DAILY  
3.  Lisinopril 5 mg PO DAILY  
4.  Metoprolol Succinate XL 25 mg PO DAILY  
5.  Stribild 1 tab Other DAILY  
6. HELD- Pravastatin 80 mg PO QPM  This medication was held. Do 
not restart Pravastatin until you have your liver tests 
re-checked by your primary care doctor in 1 weeks time

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
CNS Lymphoma
HD MTX infusion
HIV
Transaminitis

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Mr ___,

It was a pleasure taking care of you while you were hospitalized 
at ___. As you know, you were admitted for your annual 
methotrexate infusion which you tolerated well. You should get 
your liver tests checked in 1 week by your primary care doctor 
to ensure that they have normalized. 

Dr ___ will call you with followup appointment details 
for next year. 
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=14047385-DS-17 | hadm_id=22092543

 
Name:  ___     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Dapsone / methotrexate
 
Attending: ___.
 
Chief Complaint:
admit for MTX
 
Major Surgical or Invasive Procedure:
NONE

 
History of Present Illness:
___ w/ HIV on HAART, CAD s/p STEMI
___ s/p PCI, and CNS lymphoma dx ___ presents for third 
cycle
of 2-monthly HD MTX. 

The patient previously undwerwent craniotomy and brain biopsy 
c/w
CNS lymphoma and was started on induction methotrexate starting
___. His last opthal eval did not show evidence of lymphoma
on eye exam and he was given techniques for trying to focus his
eyes. Last MRI brain ___ which showed no evidence of
recurrence.

He is here today for third high-dose MTX since spacing out to
every 2-months. He has been doing well since recent admission.
Only reports some occasional frontal headaches from sinus
congestion. No fevers, chill, naisea, vomitting, diarrhea,
constipatin, angina, dyspnea or any other symptom. 

REVIEW OF SYSTEMS: +ve per HPI. 

 
Past Medical History:
PAST ONCOLOGIC HISTORY (updated): His neurological problem began
at the end of ___ when he experienced imbalance and
blurry vision.  Initially, his gait imbalance was intermittent,
mostly occuring after eating and lasting for a couple of hours. 
However, it progressed to a constant fashion.  He also developed
blurry vision and he had to close one eye in order to see
clearly.  On ___, his imbalance was severe enough that his
brother, ___, took him to ___.  He had a head CT that showed a mass at the brainstem. 

He was referred to see Dr. ___ on ___ who
admitted him to the Neurosurgery Service.  A gadolinium-enhanced
head MRI on ___ showed a homogeneously enhancing mass at 
the
lateral recess on the right side of the fourth ventricle.  He
then underwent a stereotaxic biopsy of the mass by Dr. ___ on ___.  After biopsy he remains neurologically
stable.  He then started high-dose methotrexate on ___.
(1) stereotaxic biopsy of the mass by Dr. ___ on
___
(2) an echocardiogram that was performed on ___ showing
apical hypokinesis but his ejection fraction remained at 55%
(3) started high-dose methotrexate on ___ and had 5
induction cycles so far
(4) started re-induction high-dose methtorexate on ___ and
had 3 cycles
(5) started maintenance high-dose methotrexate on ___ at
monthly interval and had 4 cycles
(6) started every 2-month maintenance high-dose methotrexate on
___ and had 1 cycle.
(7) got second  every 2-month maintenance high-dose methotrexate
on 
___

PAST CARDIAC HISTORY:
His cardiac history is significant for a myocardial infarction
with inferior ST elevation that occurred in ___. He
subsequently received a cardiac stent in the large obtuse
marginal branch.  He also had a chronically occluded LAD
collateralized from the right coronary artery.  An exercise
stress test in ___ showed a fixed moderate myocardial
perfusion defect in the anteroapical wall with no evidence of
reversible ischemia and echocardiogram.  His ejection fraction
was 55% with severe apical hypokinesis.  He had a repeat
echocardiogram on ___ that showed apical hypokinesis but 
his
ejection fraction remained at 55%.
 
HIV HISTORY (updated):
He is HIV positive from heterosexual contact.  He was on HAART
therapy from ___ to ___, and subsequently stopped from ___ to
___, and then resumed in ___.  His viral load is undetectable
when it was last checked at ___ in
___.  He sees Dr. ___ and ___ there.  He was on Truvada and 
Kaletra
but changed to stribild in ___.

 
Social History:
___
Family History:
His parents are alive; his mother has
pre-diabetes while his father has glaucoma and prostate cancer. 
He has 6 brothers, one of the, has kidney problem.  He has 3
daughters and they are all healthy.
 
Physical Exam:
ADMISSION PHYSICAL EXAM:
General:  NAD
VITAL SIGNS: 98.6 104/68 78 16 99 ra ___
HEENT:  MMM, no OP lesions, no cervical, supraclavicular, or
axillary adenopathy, no thyromegaly
CV:  RR, NL S1S2 no S3S4 MRG, port in palce, looks non-infected
PULM:  CTAB
ABD:  BS+, soft, NTND, no masses or hepatosplenomegaly
LIMBS:  No edema, clubbing, tremors, or asterixis; no inguinal
adenopathy
SKIN:  No rashes or skin breakdown
NEURO:  Cranial nerves II-XII are within normal limits excluding
visual acuity which was not assessed, no nystagmus; strength is
___ of the proximal and distal upper and lower extremities

DISCHARGE EXAM:
General:  NAD
VITAL SIGNS:  97.6  106/64  53  18  94%RA
HEENT:  MMM, no OP lesions, no cervical, supraclavicular, or
axillary adenopathy, no thyromegaly
CV:  RR, NL S1S2 no S3S4 MRG
PULM:  CTAB
ABD:  BS+, soft, NTND, no masses or hepatosplenomegaly
LIMBS:  No edema, clubbing, tremors, or asterixis; no inguinal
adenopathy
SKIN:  No rashes or skin breakdown
NEURO:  ___ strength throughout, PERRLA, EOMI

 
Pertinent Results:
___ 11:43AM BLOOD WBC-4.1 RBC-4.50* Hgb-14.2 Hct-39.7* 
MCV-88 MCH-31.6 MCHC-35.7* RDW-13.2 Plt ___
___ 05:59AM BLOOD WBC-7.3 RBC-4.37* Hgb-13.8* Hct-37.7* 
MCV-86 MCH-31.5 MCHC-36.4* RDW-12.8 Plt ___
___ 05:59AM BLOOD Neuts-82.6* Lymphs-14.8* Monos-1.8* 
Eos-0.6 Baso-0.1
___ 11:43AM BLOOD Glucose-118* UreaN-15 Creat-1.0 Na-137 
K-3.6 Cl-103 HCO3-24 AnGap-14
___ 05:59AM BLOOD Glucose-118* UreaN-10 Creat-0.9 Na-140 
K-3.5 Cl-101 HCO3-32 AnGap-11
___ 11:43AM BLOOD ALT-25 AST-21 LD(LDH)-134 AlkPhos-68 
TotBili-0.5
___ 05:59AM BLOOD ALT-148* AST-45* LD(LDH)-155 AlkPhos-65 
TotBili-0.4
___ 05:59AM BLOOD Calcium-8.4 Phos-3.8 Mg-2.2
___ 06:12AM BLOOD mthotrx-0.96
___ 05:59AM BLOOD mthotrx-0.12
___ 06:10PM BLOOD mthotrx-LESS THAN 
 
Brief Hospital Course:
ASSESSMENT AND PLAN:Mr ___ is a ___ yr old male with hx HIV 
on HAART, hx CAD w/ STEMI s/p PCI on plavix as well as CNS 
lymphoma now in remission on HD-MTX.

# CNS Lymphoma:  Presented with imbalance and double vision, 
symptoms now much improved. In ongoing remission w/ resolution 
of R cerebellar enhancement. Started cycle 7 maintenance 
high-dose methotrexate (8g/m2) now given at 2-month interval on 
___. contd hydration and urine alkalinization with sodium 
bicarb to
maintain urine pH >8. Increased bicarb rate from 150/hr to 
200/hr per patient request as not tolerating tabs too well. 
monitored I/O, fluid status, Cr closely. Started leucovorin 
rescue 24 hrs after MTX dose completed. DCd ___ when MTX <0.05 
or tomorrow AM.

# Hx HIV - Pt on HAART therapy thru ___ 
___. Taken off bactrim. Contd stribild

# Hx Herpes Zoster Eruption at Left S1-2 Dermatomes: stable, 
continued prophylactic acyclovir

# Coronary Artery Disease:  hx STEMI s/p PCI to large obtuse 
marginal. Currently no active cardiac symptoms. maintained on 
ASA and plavix.  Did have recent nonexertional chest pain most 
c/w GERD. Most recent EF 55% ___ but had some regional and 
apical HK. contd metoprolol, plavix but hold statin. Held ASA w/ 
MTX and resumed on discharge

# GERD - stable, rarely uses ppi - continued PPI in house

# Hx HTN - stable held lisinopril on MTX resumed on DC
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acyclovir 800 mg PO BID 
2. Atorvastatin 80 mg PO DAILY 
3. Clopidogrel 75 mg PO DAILY 
4. Fish Oil (Omega 3) 1000 mg PO DAILY 
5. LOPERamide 2 mg PO QID:PRN diarrhea 
6. Metoprolol Succinate XL 25 mg PO DAILY 
7. Aspirin 81 mg PO DAILY 
8. Lisinopril 5 mg PO DAILY 
9. Pantoprazole 40 mg PO Q24H 
10. Stribild (elvitegr-cobicist-emtric-tenof) ___ mg 
oral qd 

 
Discharge Medications:
1. Acyclovir 800 mg PO BID 
2. Clopidogrel 75 mg PO DAILY 
3. Metoprolol Succinate XL 25 mg PO DAILY 
4. Stribild (elvitegr-cobicist-emtric-tenof) ___ mg 
oral qd 
5. Aspirin 81 mg PO DAILY 
6. Atorvastatin 80 mg PO DAILY 
7. Fish Oil (Omega 3) 1000 mg PO DAILY 
8. Lisinopril 5 mg PO DAILY 
9. Pantoprazole 40 mg PO Q24H 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
CNS Lymphoma
HIV
Coronary artery disease

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
You were admitted to for chemotherapy which you tolerated 
without complications.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=14047385-DS-15 | hadm_id=22116730

 
Name:  ___     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: NEUROLOGY
 
Allergies: 
Dapsone / methotrexate
 
Attending: ___.
 
Chief Complaint:
High-Dose Methotrexate
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
___ is a ___ man with HIV and CNS lymphoma 
receiving MTX (last cycle ___ s/p Portacath insertion 
___ by ___ and recent NSTEMI while admitted for methotrexate 
therapy presents for maintenance HD-MTX for his lymphoma.  Since 
his last admission, ___ denies any changes in symptoms and is 
doing well.  ___ recently returned from a trip to ___. ___ 
no changes in his neurologic symptoms since his last 
chemotherapy visit.  ___ claims stable double vision, occasional 
dizziness with sudden turns, but denies weakness of 
numbness/tingling.  ___ has occasional headaches which resolve 
spontaneously.

On arrival to the floor, patient reports ___ is feeling well and 
would like to start his chemotherapy.
 
Past Medical History:
PAST ONCOLOGIC HISTORY:
-- ___  - stereotaxic biopsy of the mass by Dr. ___  
-- ___  - started high-dose methotrexate  
-- ___  - C2D1 HD-MTX
-- ___  - C3D1 HD-MTX
-- ___  - C4D1 HD-MTX
-- ___  - C5D1 HD-MTX
-- ___  - C6D1 HD-MTX
-- ___  - C7D1 HD-MTX
-- ___  - C8D1 HD-MTX
-- ___  - C9D1 HD-MTX
-- ___  - C10D1 HD-MTX
-- ___  - C11D1 HD-MTX
 
PAST MEDICAL HISTORY:
-coronary artery disease s/p PCI in ___ and ___
-NSTEMI ___
-HIV
-pancreatitis (possibly from dapsone)
-hypertension,
-hypercholesterolemia
-gastric ulcer
-h/o right-sided ophthalmic shingles as well as shingles in V3
distribution in ___.  
 
Social History:
___
Family History:
Mother - diabetes
Father - glaucoma, prostate cancer
 
Physical Exam:
Admission Physical Examination
VITAL SIGNS: Reviewed. Stable. Afebrile.
GENERAL: NAD.  
HEENT: AT/NC, EOMI, PERRLA, anicteric sclera, pink conjunctiva, 
patent nares, MMM, good dentition, non-tender supple neck, no 
LAD, JVP is at the base of clavicle at 30-degrees, non-tender 
thyroid
CARDIAC: RRR, S1/S2, no murmurs
CHEST: Powerport in place, non-tender, not-erythemtous or warm
LUNGS: Clear, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles  
ABDOMEN: obese, non-distended, +BS, tender to deep palpation in 
the epigastrum, no rebound/guarding
EXTREMITIES: moving all extremities well, no cyanosis, clubbing 
or edema, no obvious deformities  
PULSES: 2+ DP pulses bilaterally  
NEUROLOGICAL EXAMINATION: CN II-XII intact. ___ strength in 
upper and lower extremities, sensation intact in upper and lower 
extremities, coordination normal, negative romberg, gait normal, 
no dysdiadochokinesis 
SKIN: warm and well perfused, no excoriations or lesions, no 
rashes 

Discharge Physical Examination
VITAL SIGNS: Temperature 98.3 F, blood pressure 110/62, pulse 
56, respiration 18 and oxygen saturation 98% on room air
GENERAL: NAD.  
HEENT: AT/NC, EOMI, PERRLA, anicteric sclera, pink conjunctiva, 
patent nares, MMM, good dentition, non-tender supple neck, no 
LAD, JVP is at the base of clavicle at 30-degrees, non-tender 
thyroid
CARDIAC: RRR, S1/S2, no murmurs
CHEST: Powerport in place, non-tender, not-erythemtous or warm
LUNGS: Clear, no wheezes, rales, rhonchi, breathing comfortably 
without use of accessory muscles  
ABDOMEN: obese, non-distended, +BS, not tender to palpation, no 
rebound/guarding
EXTREMITIES: moving all extremities well, no cyanosis, clubbing 
or edema, no obvious deformities  
PULSES: 2+ DP pulses bilaterally  
NEUROLOGICAL EXAMINATION: CN II-XII intact. ___ strength in 
upper and lower extremities, sensation intact in upper and lower 
extremities, gait normalSKIN: warm and well perfused, no 
excoriations or lesions, no rashes.
 
Pertinent Results:
Admit Labs
___ 01:15PM BLOOD WBC-6.1 RBC-4.18* Hgb-12.3* Hct-38.3* 
MCV-92 MCH-29.4 MCHC-32.1 RDW-14.0 Plt ___
___ 01:15PM BLOOD ___ PTT-29.3 ___
___ 01:15PM BLOOD Glucose-136* UreaN-13 Creat-0.9 Na-140 
K-3.6 Cl-104 HCO3-26 AnGap-14
___ 01:15PM BLOOD ALT-15 AST-17 AlkPhos-78 TotBili-0.6
___ 01:15PM BLOOD Calcium-8.5 Phos-3.9 Mg-1.9

Pertinent Labs
___ 06:15PM BLOOD mthotrx-1.5
___ 06:08AM BLOOD mthotrx-0.26

Discharge Labs
___ 05:14AM BLOOD WBC-5.7 RBC-4.08* Hgb-12.3* Hct-37.4* 
MCV-92 MCH-30.0 MCHC-32.8 RDW-13.4 Plt ___
___ 05:14AM BLOOD Neuts-80.6* Lymphs-17.6* Monos-0.8* 
Eos-1.0 Baso-0.1
___ 07:30AM BLOOD ___
___ 05:14AM BLOOD  WBC-5.7 Lymph-18 Abs ___ CD3%-93 
Abs CD3-949 CD4%-15 Abs CD4-157* CD8%-77 Abs CD8-790* 
CD4/CD8-0.2*
___ 05:14AM BLOOD Glucose-142* UreaN-11 Creat-0.9 Na-140 
K-3.3 Cl-103 HCO3-27 AnGap-13
___ 05:14AM BLOOD ALT-44* AST-26 LD(LDH)-187 AlkPhos-67 
TotBili-0.4
___ 06:08AM BLOOD Calcium-8.5 Phos-3.1# Mg-2.1
___ 05:14AM BLOOD mthotrx-0.04
 
Brief Hospital Course:
___ is a ___ man with HIV and hx of CNS 
lymphoma presenting for high-dose methotrexate infusion.

Active Issues
1. CNS Lymphoma:  Patient is currently on maintenance 
methotrextae every 2 months.  ___ presented to the hospital ahead 
of his scheduled appointment.  ___ was begun on NaHCO3 and a 
methotrexate diet until his urine was pH >8.  ___ tolerated the 
infusion well but had some diarrhea (addressed below).  His 
serum methotrexate levels were monitored at 24 hours and daily 
until 0.04 uM.  ___ claimed no neurologic symptoms with the 
treatment.

2. Diarrhea: Patient began to have diarrhea following the 
initiation of the treatment.  ___ claims this was normal.  A C. 
difficile sample was sent and pending at the time of discahrge. 
CD4 count was also send and was low at 157.  Patient was started 
on prophylactic bactrim prior to discharge and an appointment 
was setup with the physician assistant who oversees his HAART 
for the day following discharge. 

Chronic Issues
1. CAD:  ___ is s/p NSTEMI w/ PCI placed ___: patient follows 
with cardiolgoy while admitted. ___ was continued on his lipitor 
and plavix. Aspirin was held while admitted and resumed at 
discharge.

Transitional Issues
- please ensure patient knows schedule for next HD-MTX infusion
- please follow up with CD4 count given low count this 
admission, consider stool studies
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acyclovir 800 mg PO Q8H 
2. Aspirin 81 mg PO DAILY 
3. Clopidogrel 75 mg PO DAILY 
4. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
5. Lisinopril 5 mg PO DAILY 
6. Lopinavir-Ritonavir 2 TAB PO BID 
7. Metoprolol Succinate XL 25 mg PO DAILY 
8. Pantoprazole 40 mg PO Q24H 
9. Fish Oil (Omega 3) 1000 mg PO DAILY 
10. Atorvastatin 80 mg PO DAILY
 
Discharge Medications:
1. Acyclovir 800 mg PO Q8H 
2. Atorvastatin 80 mg PO DAILY 
3. Clopidogrel 75 mg PO DAILY 
4. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
5. Lisinopril 5 mg PO DAILY 
6. Lopinavir-Ritonavir 2 TAB PO BID 
7. Metoprolol Succinate XL 25 mg PO DAILY 
8. Pantoprazole 40 mg PO Q24H 
9. LOPERamide 2 mg PO QID:PRN diarrhea 
10. Aspirin 81 mg PO DAILY 
11. Fish Oil (Omega 3) 1000 mg PO DAILY 
12. Sulfameth/Trimethoprim DS 1 TAB PO 3X/WEEK (___) 
RX *sulfamethoxazole-trimethoprim 800 mg-160 mg 1 tablet(s) by 
mouth 3x/week Disp #*12 Tablet Refills:*0
 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Primary Diagnosis:
CNS Lymphoma

Secondary Diagnoses:
HIV
CAD s/p NSTEMI w/ PCI
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Dear Mr. ___,

It was a pleasure taking care of you at ___ 
___!

You were admitted for high-dose methotrexate maintenance 
therapy.  You received IV fluids and your methotrexate levels 
were monitored, which dropped appropriately.

Please come back on you scheduled date for your next maintenance 
chemotherapy.

Your ___ Team
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=14047385-DS-18 | hadm_id=22389941

 
Name:  ___     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: NEUROLOGY
 
Allergies: 
Dapsone / methotrexate
 
Attending: ___.
 
Chief Complaint:
HD Methotrexate treatment
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
___ is a ___ man with HIV on ART, CAD, h/o 
MI s/p stent placement ___, CNS lymphoma s/p 14 cycles MTX here 
for C15. Note that his last cycle was ___ of last year 
___.  He states today that he tried to come back from ___ 
___ and ___ Dr. ___ ___ but had to return to ___ 
___. Dr. ___ told him he could move to q6 month - 
qyearly MTX intervals. He saw him in ___ and they planned 
this admission. Otherwise he has no new symptoms. No headache or 
diplopia or urinary problems, no fevers or
nausea/vomiting/diarrhea.

REVIEW OF SYSTEMS:
GENERAL: No fever, chills, night sweats, recent weight changes.  
HEENT: No sores in the mouth, painful swallowing, intolerance to 
liquids or solids, sinus tenderness, rhinorrhea, or congestion.  
CARDS: No chest pain, chest pressure, exertional symptoms, or 
palpitations.  PULM: No cough, shortness of breath, hemoptysis, 
or wheezing.  GI: No nausea, vomiting, diarrhea, constipation or 
abdominal pain. No recent change in bowel habits, hematochezia, 
or melena.  GU: No dysuria or change in bladder habits.  MSK: No 
arthritis, arthralgias, myalgias, or bone pain.  DERM: Denies 
rashes, itching, or skin breakdown.  NEURO: No headache, visual 
changes, numbness/tingling, paresthesias, or focal neurologic 
symptoms.  PSYCH: No feelings of depression or anxiety. All 
other review of systems negative.
 
Past Medical History:
___ is a ___ left-handed man, with a
history of HIV on HAART, coronary artery disease, hypertension
and myocardial infarction that required a cardiac stent, who has
CNS lymphoma.  He had:
(1) stereotaxic biopsy of the mass by Dr. ___ on
___,
(2) an echocardiogram that was performed on ___ showing
apical hypokinesis but his ejection fraction remained at 55%,
(3) started high-dose methotrexate on ___ and had 5
induction cycles so far,
(4) started re-induction high-dose methtorexate on ___ and
had 3 cycles,
(5) started monthly maintenance high-dose methotrexate on
___ and had 4 cycles, and
(6) started every 2-month maintenance high-dose methotrexate on
___ and had 3 cycles.

His neurological problem began at the end of ___ when
he experienced imbalance and blurry vision.  Initially, his gait
imbalance was intermittent, mostly occuring after eating and
lasting for a couple of hours.  However, it progressed to a
constant fashion.  He also developed blurry vision and he had to
close one eye in order to see clearly.  On ___, his
imbalance was severe enough that his brother, ___, took him to ___.  He had a head
CT that showed a mass at the brainstem.  He was referred to see
Dr. ___ on ___ who admitted him to the
Neurosurgery Service.  A gadolinium-enhanced head MRI on 
___
showed a homogeneously enhancing mass at the lateral recess on
the right side of the fourth ventricle.  He then underwent a
stereotaxic biopsy of the mass by Dr. ___ on
___.  After biopsy he remains neurologically stable.  He
then started high-dose methotrexate on ___.

His cardiac history is significant for a myocardial infarction
with inferior ST elevation that occurred in ___.  
He
subsequently received a cardiac stent in the large obtuse
marginal branch.  He also had a chronically occluded LAD
collateralized from the right coronary artery.  An exercise
stress test in ___ showed a fixed moderate myocardial
perfusion defect in the anteroapical wall with no evidence of
reversible ischemia and echocardiogram.  His ejection fraction
was 55% with severe apical hypokinesis.  He had a repeat
echocardiogram on ___ that showed apical hypokinesis but 
his
ejection fraction remained at 55%. 

He is HIV positive from heterosexual contact.  He was on HAART
therapy from ___ to ___, and subsequently stopped from ___ to
___, and then resumed in ___.  His viral load is undetectable
when it was last checked at ___ in
___.  He sees Dr. ___ and ___ there.  He is now on Stribild and
Kaletra.

His past medical history is significant for coronary artery
disease, myocardial infarction, HIV disease, pancreatitis,
hypertension, hypercholesterolemia and gastric ulcer.  He also
had right-sided ophthalmic shingles as well as shingles in V3
distribution in ___.  He also underwent a cardiac stent
placement in ___.  
 
Social History:
___
Family History:
His parents are alive; his mother has pre-diabetes while his 
father has glaucoma and prostate cancer.  He has 6 brothers, one 
of the, has kidney problem.  He has 3 daughters and they are all 
healthy.
 
Physical Exam:
ADMISSION PHYSICAL EXAMINATION
VITAL SIGNS: 98.6 F, BP 97/62, HR 80, RR 16, and O2 Saturation 
97% in room air
General:  NAD
HEENT:  MMM, no OP lesions, no cervical, supraclavicular, or 
axillary adenopathy, no thyromegaly
CARDIOVASCUALR:  RR, NL S1S2 no S3S4 MRG
PULMONARY:  CTAB
GASTROINTESTINAL:  BS+, soft, NTND, no masses or 
hepatosplenomegaly
LIMBS:  No edema, clubbing, tremors, or asterixis; no inguinal 
adenopathy
SKIN:  No rashes or skin breakdown
NEUROLOGICAL EXAMINATION: Oriented x3. Cranial nerves II-XII are 
within normal
limits excluding visual acuity which was not assessed, no
nystagmus; strength is ___ of the proximal and distal upper and
lower extremities; reflexes are 2+ of the biceps, triceps,
patellar, and Achilles tendons, toes are down bilaterally; gait
is normal, coordination is intact.

DISCHARGE PHYSICAL EXAMINATION
VITAL SIGNS: 97.9 F, HR 72, BP 120/70, RR 18, and O2 saturation 
100 in room air
General:  NAD
HEENT:  MMM, no OP lesions, no cervical, supraclavicular, or
axillary adenopathy, no thyromegaly
CARDIOVASCULAR:  RR, NL S1S2 no S3S4 MRG
PULMONARY:  CTAB
GASTROINTESTINAL:  BS+, soft, NTND, no masses or 
hepatosplenomegaly
LIMBS:  No edema, clubbing, 
SKIN:  No rashes or skin breakdown
NEUROLOGICAL EXAMINATION: tremors, or asterixis; neuro-exam 
grossly intact
 
Pertinent Results:
ADMISSION LABS
___ 02:02PM BLOOD WBC-4.6 RBC-4.60 Hgb-14.0 Hct-42.1 MCV-92 
MCH-30.4 MCHC-33.3 RDW-13.1 RDWSD-43.8 Plt ___
___ 02:02PM BLOOD Neuts-64.0 ___ Monos-6.3 Eos-2.0 
Baso-0.4 Im ___ AbsNeut-2.95 AbsLymp-1.25 AbsMono-0.29 
AbsEos-0.09 AbsBaso-0.02
___ 02:02PM BLOOD ___ PTT-33.9 ___
___ 02:02PM BLOOD Glucose-134* UreaN-18 Creat-1.1 Na-136 
K-4.2 Cl-104 HCO3-23 AnGap-13
___ 02:02PM BLOOD ALT-34 AST-29 AlkPhos-56 TotBili-0.5
___ 02:02PM BLOOD Calcium-9.1 Phos-2.9 Mg-1.9

DISCHARGE LABS
___ 10:59PM BLOOD WBC-5.8 RBC-4.58* Hgb-13.8 Hct-41.7 
MCV-91 MCH-30.1 MCHC-33.1 RDW-13.2 RDWSD-44.1 Plt ___
___ 10:59PM BLOOD Neuts-82.7* Lymphs-13.8* Monos-2.8* 
Eos-0.0* Baso-0.2 NRBC-0.0 Im ___ AbsNeut-4.79# 
AbsLymp-0.80* AbsMono-0.16* AbsEos-0.00* AbsBaso-0.01
___ 10:59PM BLOOD Glucose-174* UreaN-14 Creat-1.2 Na-142 
K-3.4 Cl-100 HCO3-30 AnGap-15
___ 10:59PM BLOOD ALT-129* AST-52* LD(LDH)-177 AlkPhos-53 
TotBili-0.4
___ 10:59PM BLOOD Albumin-3.7 Calcium-8.8 Phos-2.6* Mg-2.2

PERTINENT LABS
___ 10:59PM BLOOD mthotrx-0.15
___ 10:47PM BLOOD mthotrx-3.5
 
Brief Hospital Course:
___ is a ___ man with HIV on ART, CAD, h/o 
MI s/p stent placement ___, CNS lymphoma s/p 14 cycles MTX here 
for C15 MTX. 

ACTIVE ISSUES
1. CNS lymphoma - admit for HD MTX on ___ D1. Patient 
tolerated treatment well.  Labs stable. He got bicarb/leucovorin 
per protocol.  Had recent brain MRI without recurrence of 
disease.  Patient's MTX level was 0.15 in 48 hours, hence to be 
discharged.

CHRONIC ISSUES
1. H/o HSV eruption - states he has discontinued his 
prophylactic
acyclovir. Will t/b with neuro onc team about this.
 
2. HIV - followed at ___, continue STRIBILD

3. Coronary Artery Disease: cont Plavix no acute cardiac 
symptoms

TRANSITIONAL ISSUES
1. Followup with Dr. ___ to be arranged in three months.
- will need followup MRI
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Clopidogrel 75 mg PO DAILY 
2. Metoprolol Succinate XL 25 mg PO DAILY 
3. Stribild (elvitegr-cobicist-emtric-tenof) ___ mg 
oral qd 
4. Aspirin 81 mg PO DAILY 
5. Atorvastatin 80 mg PO DAILY 
6. Fish Oil (Omega 3) 1000 mg PO DAILY 
7. Lisinopril 5 mg PO DAILY
 
Discharge Medications:
1. Clopidogrel 75 mg PO DAILY 
2. Metoprolol Succinate XL 25 mg PO DAILY 
3. Stribild (elvitegr-cobicist-emtric-tenof) ___ mg 
oral qd 
4. Aspirin 81 mg PO DAILY 
5. Atorvastatin 80 mg PO DAILY 
6. Fish Oil (Omega 3) 1000 mg PO DAILY 
7. Lisinopril 5 mg PO DAILY
 
Discharge Disposition:
Home
 
Discharge Diagnosis:
CNS lymphoma
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Dear Mr. ___, 

You were admitted to ___ for IV methotrexate treatment.  You 
tolerated the treatment well, and can now go home.  Please do 
not hesitate to call if you have any questions.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=14047385-DS-4 | hadm_id=22549408

 
Name:  ___     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: NEUROLOGY
 
Allergies: 
Dapsone
 
Attending: ___.
 
Chief Complaint:
High dose methotrexate
 
Major Surgical or Invasive Procedure:
None this hospitalization
 
History of Present Illness:
___ is a ___ ___ speaking male with HIV, 
recently diagnosed high-grade CNS B cell lymphoma (brain stem) 
s/p brain biopsy, temporary external ventricular drain (since 
removed), on high-dose MTX ___ and dexamethasone, recently 
admitted ___ with anal HSV2 infection. He was treated with 
treatment dose of acyclovir for 7 days and has continued 
acyclovir 200mg daily for prophylaxis. At discharge, his 
dexamethasone was tapered from 4mg BID to 4mg daily. The anal 
area has improved in pain and the rash is resolving. He returns 
today for scheduled high-dose MTX. He has no complaints this 
morning. He states that his last high-dose methotrexate was 
tolerated well. He did not experience any nausea, vomitting, 
diarrhea from the chemotherapy. He still complains of persistent 
double vision, which has been improving.
 
Past Medical History:
PAST ONCOLOGIC HISTORY:  
-- ___ - stereotaxic biopsy of the mass by Dr. ___ 
___  
-- ___ - started high-dose methotrexate  
-- ___ - C2D1 HD-MTX
CAD s/p BMS (___)
HIV on HAART (VL undetectable)
history of pancreatitis ___ HIV medication
Hypertension
Hyperlipidemia
Gastric ulcer
 
Social History:
___
Family History:
Family history is notable for father and brother with prostate 
cancer, and 
several paternal aunts with breast cancer and maternal uncles 
with diabetes.

 
Physical Exam:
============================
Admission
============================
Vital Signs: Temperature 97.7 F, blood pressure 110/80, pulse 
80, respiration 18 and oxygen saturation is 98% in room air.  
His measured weight is 184 lbs  
General: well-appearing, pleasant, no distress  
HEENT: well-healing scalp incision right occipital area, no 
tenderness, clear oral pharynx, no vesicular lesions, anicteric 
sclerae  
Neck: no adenopathy  
CV: RRR, normal S1, S2, no murmurs  
Lungs: lungs clear bilaterally  
Abdomen: soft, non-tender, non-distended, no organomegaly  
Perineum: healing vesicles, few open ulcers with clean bases  
Skin: full turgor  
Extremities: 2+ radial and DP pulses, no edema  

Neurological Examination: His mental status is intact.  Cranial 
nerves ___ are intact, no sensory or strength deficits, 
cerebellar function normal, ambulatory without assistance, A and 
O x 3, negative Brudzinsky and Kernig signs, right eye nystagmus 
on horizontal gaze  

==================================
Discharge
==================================
Vital Signs: Temperature is 98.7 F, blood pressure 110/68, pulse 
72, respiration 18 and oxygen saturation 99% in room air  
General: well-appearing, pleasant, no distress  
HEENT: clear oral pharynx, no vesicular lesions, anicteric 
sclerae  
Neck: no adenopathy, PERRL, EOMI  
CV: RRR, normal S1, S2, no murmurs  
Lungs: lungs clear bilaterally  
Abdomen: soft, non-tender, non-distended, no organomegaly  
Perineum: healing vesicles, few open ulcers with clean bases  
Skin: WWP, no rashes  
Extremities: 2+ radial and DP pulses, no edema

Neurological Examination: Mental status is intact. Cranial 
nerves ___ are intact, no sensory or strength deficits, 
cerebellar function normal, ambulatory without assistance, A and 
O x 3.
 
Pertinent Results:
===========================
Admission
===========================
___ 12:00PM BLOOD WBC-6.1 RBC-5.15 Hgb-16.1 Hct-48.0 MCV-93 
MCH-31.1 MCHC-33.5 RDW-13.3 Plt ___
___ 12:00PM BLOOD Glucose-307* UreaN-26* Creat-0.9 Na-129* 
K-5.7* Cl-94* HCO3-21* AnGap-20
___ 04:20PM BLOOD ALT-28 AST-8 LD(LDH)-171 AlkPhos-58 
TotBili-0.3
___ 12:00PM BLOOD Calcium-8.6 Phos-3.5 Mg-1.8
___ 04:37PM BLOOD Lactate-6.0*

===========================
Discharge
===========================
___ 05:20AM BLOOD WBC-3.6* RBC-4.51* Hgb-13.4* Hct-43.1 
MCV-95 MCH-29.6 MCHC-31.0 RDW-13.8 Plt ___
___ 05:20AM BLOOD Glucose-131* UreaN-23* Creat-0.9 Na-139 
K-3.7 Cl-95* HCO3-37* AnGap-11
___ 05:20AM BLOOD mthotrx-0.06

============================
Pertinent
============================
___ 04:37PM BLOOD Lactate-6.0*
___ 08:07AM BLOOD Lactate-3.5*
 
Brief Hospital Course:
___ is a ___ ___ speaking male with HIV, 
recently diagnosed high-grade CNS B cell lymphoma (brain stem) 
s/p brain biopsy, temporary external ventricular drain (since 
removed), on dexamethasone admit for high dose methotrexate.  

1. CNS Lymphoma: He presented for second induction dose of IV 
high-dose methtorexate. He started 24-hour urine collection for 
creatinine clearance the day before admission. He received his 
high-dose methotrexate. He tolerated it well. His urine was 
alkalinized. His IVF were increased to 200cc/hr. He was rescued 
with leucovorin. His dexamethasone was tapered to 2mg PO daily. 
He will return on ___ for the next round of high-dose 
methotrexate. His PPI and aspirin were held during his 
hospitalization.     

2. Anal HSV 2: He was on p.o acyclovir at 800 mg Q8H which he 
completed ___. His acyclovir prophylactic dose was changed 
to 400mg PO BID. 

3. Elevated Serum Lactate: This occurred during his hospital 
admission from ___ to ___. It remained elevated on 
admission to 6. The etiology was believed to be related to 
either his underlying lymphoma or ART therapy. He will follow up 
with his ___ PCP to determine if he needs to have his ART 
regimen changed.   

4. Hyponatremia: This is most likely SIADH given intracranial 
lymphoma. Has been chronic and stable but resolved during this 
hospitalization. 

5. HIV Disease: CD4 275, viral load undetectable in ___. Continued ART. ___ change per ___ PCP. 

6. Imbalance and Double Vision: This may be secondary to 
lymphoma. Remainder of neuro examine intact. He is placed on 
fall precautions.   

7. Coronary Artery Disease: He had a cardiac stent placed 
previously. He has sequela from his myocardial infarction in the 
past. But his repeat echocardiogram that was performed on 
___ reportedly showed apical hypokinesis but his ejection  
fraction remained at 55%. Continued lisinopril, metoprolol, 
pravastatin. Aspirin was briefly held during his MTX since it is 
acid. 

===========================
transitional issues
===========================
* Patient will return to ___ on ___
* Elevated lactate level
* He cannot travel outside the country until he achieves full 
remission
* Dexamethasone at 2mg PO daily
* MRI in 8 weeks
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Aspirin 81 mg PO DAILY 
2. Dexamethasone 4 mg PO DAILY 
3. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
4. Fish Oil (Omega 3) 1000 mg PO DAILY 
5. Lisinopril 5 mg PO DAILY 
6. Lopinavir-Ritonavir 2 TAB PO BID 
7. Metoprolol Succinate XL 25 mg PO DAILY 
8. Omeprazole 40 mg PO DAILY 
9. Pravastatin 40 mg PO DAILY 
10. Docusate Sodium 100 mg PO BID prn constipation 
11. Senna 1 TAB PO BID prn constipation 
12. Acyclovir 200 mg PO DAILY
 
Discharge Medications:
1. Acyclovir 400 mg PO Q12H 
RX *acyclovir 400 mg 1 tablet(s) by mouth twice a day Disp #*60 
Capsule Refills:*0
2. Docusate Sodium 100 mg PO BID prn constipation 
3. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
4. Lisinopril 5 mg PO DAILY 
5. Lopinavir-Ritonavir 2 TAB PO BID 
6. Metoprolol Succinate XL 25 mg PO DAILY 
7. Pravastatin 40 mg PO DAILY 
8. Senna 1 TAB PO BID prn constipation 
9. Aspirin 81 mg PO DAILY 
10. Fish Oil (Omega 3) 1000 mg PO DAILY 
11. Omeprazole 40 mg PO DAILY 
12. imaging
MRI Brain w&w/o contrast
ICD code: ___
diagnosis: CNS lymphoma
8 weeks from discharge - ___
13. Dexamethasone 2 mg PO DAILY 
RX *dexamethasone 2 mg 1 tablet(s) by mouth daily Disp #*30 
Tablet Refills:*0
 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY: 
1. CNS lymphoma

SECONDARY: 
2. Anal HSV infection
3. HIV
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Dear Mr. ___, 

It was a pleasure taking care of you at the ___ 
___. You came into the hospital for high 
dose methotrexate for the lymphoma in your brain. You tolerated 
this well. 

We increased your acyclovir to 400mg, two times daily. We 
decreased your dexamethasone to 2mg daily. 

You can not travel outside of the country until you have 
acheived a complete remision of your lymphoma. You will need a 
follow up MRI in 8 weeks. 

Come back to ___ for your next methotrexate on ___! 
We look forward to seeing you! 

Thank you for choosing ___. 
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=14047385-DS-11 | hadm_id=23050804

 
Name:  ___     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Dapsone
 
Attending: ___.
 
Chief Complaint:
elective admission for high dose methotrexate
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
___ primarily ___ speaking man with coronary artery disease 

s/p BMS to large OM branch in ___ for inferior STEMI, HIV on 
ART (CD4 275, viral load undetectable in ___, 
high-grade CNS B cell lymphoma (brain stem) s/p brain biopsy, on 

high-dose MTX (started ___, presenting 
for cycle 9 of high dose methotrexate. After cycle 4 he had an 
MRI which showed improvement in his disease but some areas of 
residual enhancement. He continued on 2 week intervals until 
cycle 7, at which point MRI improved so switched to monthly 
cycles.

On arrival to the floor today he feels well. had a good month in 

___ with his family. He has no abdominal 
pain, no nausea, no vomiting, no fevers. He has no headache. 
He has increased sensitivity of his R scalp, which has been an 
ongoing problem for many years, since he had shingles. he has no 
runny nose, 
fevers, or cough. He has some tingling in his left foot which is 

stable. His vision is about the same (some double vision but 
improved from before). He has some pain in his ankle and in the 
small joints of his hands that gets better with movement.

Of note, the patient was admitted on ___ with anal HSV2 
infection. He was treated with treatment dose acyclovir for 7 
days and continued acyclovir daily for prophylaxis. As an 
outpatient he was found to have breakthrough lesions on 
suppressive acyclovir and his PCP started him on treatment doses 

of valacyclovir 1g BID. He has subsequently been transitioned to 

higher dose acyclovir 800mg BID and has not had any breakthrough 

lesions.

REVIEW OF SYSTEMS:  
(+) Per HPI  
(-) Denies fever, chills, night sweats, recent weight loss or 
gain. Denies headache, rhinorrhea or congestion. Denies chest 
pain, chest pressure, or weakness. Denies nausea, vomiting, 
constipation, abdominal pain. Denies dysuria, or 
myalgias. Denies rashes or skin changes. All other ROS negative  


 
Past Medical History:
PAST ONCOLOGIC HISTORY:
-- ___ - stereotaxic biopsy of the mass by Dr. ___  
-- ___ - started high-dose methotrexate  
-- ___ - C2D1 HD-MTX
-- ___  - C3D1 HD-MTX
-- ___ - C4D1 HD-MTX
-- ___   - C5D1 HD-MTX
-- ___  - C6D1 HD-MTX
-- ___   - C7D1 HD-MTX
-- ___   - C8D1 HD-MTX
 
PAST MEDICAL HISTORY:
-CNS B-cell Lymphoma
-CAD s/p BMS to large OM branch in ___ - chronically occluded 
LAD collateralized from the right coronary artery
-HIV on ART 
-history of pancreatitis ___ HIV medication
-Hypertension
-Hyperlipidemia
-Gastric ulcer
-anal HSV
-R ophthalmic zoster
 
Social History:
___
Family History:
Family history is notable for father and brother with prostate 
cancer, and 
several paternal aunts with breast cancer and maternal uncles 
with diabetes.
 
Physical Exam:
Physical Exam:
VS: 98.9   129/80    77    18     98%RA
GEN: alert, oriented to name, place and situation. no acute
signs of distress.
HEENT: NCAT, Pupils equal and reactive, sclerae non-icteric,
MMM, OP clear no erythema.
Neck: Supple
Lymph nodes: No cervical, supraclavicular or axillary LAD.
CV: S1S2, reg rate and rhythm, no murmurs, rubs or gallops.
RESP: Good air movement bilaterally, no rhonchi or wheezing.
ABD: Soft, non-tender, non-distended, no hepatosplenomegaly
EXTR: No lower leg edema. tingling sensation L foot but no
sensory loss. no swelling over joints of hands or L ankle
DERM: No active rash
Neuro: muscle strength grossly full and symmetric in all major
muscle groups
PSYCH: Appropriate and calm. 
 
Pertinent Results:
==================================
              Labs
==================================
___ 12:30PM BLOOD WBC-6.4 RBC-4.55* Hgb-14.2 Hct-42.6 
MCV-94 MCH-31.3 MCHC-33.5 RDW-14.0 Plt ___
___ 06:30AM BLOOD WBC-4.2 RBC-4.53* Hgb-13.8* Hct-41.8 
MCV-92 MCH-30.5 MCHC-33.1 RDW-14.0 Plt ___
___ 12:30PM BLOOD Glucose-128* UreaN-11 Creat-1.0 Na-138 
K-4.1 Cl-104 HCO3-24 AnGap-14
___ 05:29AM BLOOD Glucose-125* UreaN-6 Creat-0.9 Na-135 
K-3.8 Cl-99 HCO3-29 AnGap-11
___ 12:30PM BLOOD ALT-18 AST-20 AlkPhos-71 TotBili-0.5
___ 05:29AM BLOOD ALT-28 AST-26 AlkPhos-75 TotBili-0.9
___ 12:30PM BLOOD Calcium-9.5 Phos-3.4 Mg-1.8
___ 05:55PM BLOOD mthotrx-6.2
___ 06:30AM BLOOD mthotrx-0.45
___ 05:29AM BLOOD mthotrx-0.07

==================================
            Radiology            
==================================
MRI brain ___ preliminary report
FINDINGS:
 
When compared to the most recent prior examination, there are 
new relatively
symmetric confluent areas of T2/FLAIR hyperintensities involving 
the deep and
periventricular white matter without associated enhancement or 
mass effect.
 
Again identified is inhomogeneous susceptibility status post 
biopsy in the
region of the fourth ventricle on the right likely related to 
chronic blood
products with associated adjacent parenchymal T2/FLAIR 
hyperintensity and
minimal residual enhancement. There is no evidence of residual 
mass or new
areas of abnormal enhancement. A right frontal catheter tract is 
again noted.
 
There is no acute intracranial hemorrhage. Diffusion weighting 
imaging does
not demonstrate evidence of acute infarct. Ventricles and extra 
axial spaces
are within normal limits. The major intracranial vessels exhibit 
the expected
signal void related to vascular flow.
 
The paranasal sinuses demonstrate scattered areas of mucosal 
thickening. There
is fluid signal in scattered mastoid air cells bilaterally. The 
sella turcica,
craniocervical junction, and orbits are unremarkable.
 
IMPRESSION:
 
 
1. New relatively symmetric confluent areas of T2/FLAIR deep and
periventricular bihemispheric white matter signal abnormality 
without
associated enhancement or mass effect. Findings may be related 
to HIV
encephalopathy. Other differential considerations would include 
drug/treatment
related changes, toxic/metabolic etiologies, infectious 
etiologies (such as
PML, SSPE).
2. Grossly stable minimal residual enhancement adjacent to the 
fourth
ventricle on the right with mild adjacent T2/FLAIR 
hyperintensity consistent
with postsurgical changes without evidence of a new lesion or 
new areas of
abnormal enhancement.
 
Brief Hospital Course:
___ male with HIV, CAD, CNS lymphoma here for cycle 9 high dose 

methotrexate treatment. MRI after cycle 4 showed residual 
disease, so he continued on 2 week intervals until cycle 7, at 
which point MRI improved so switched to monthly cycles. After 
urinary alkalinization, he received methotrexate 17200mg 
(8g/m2).  
This was followed by leucovorin rescue 24 hours later. His 
methotrexate level on ___ is 0.07. He was discharged 
home in good condition. He has been asked to report back to ___ 
___ in 4 weeks for the next cycle (#10).
He had an MRI after this cycle which shows some changes possibly 
HIV encephalopathy but no evidence of lymphoma recurrence. 
For his HSV, he has been on acyclovir 800mg BID and will be 
monitored for symptoms. He continued his metoprolol and 
lisinopril at 12.5mg and 2.5mg respectively with good control of 
blood 
pressure. On previous admissions his blood pressures have run 
slightly low but he has continued these medications without 
problem. During this admission he had continued double vision, 
which he has had since diagnosis. It has improved since original 
diagnosis and is now stable. He will see his ophthalmologist 
next month.   

# Dispo: 
[x] Discharge documentation reviewed, pt is stable for 
discharge.
[x] Time spent on discharge activity was greater than 30min.
[ ] Time spent on discharge activity was less than 30min.

# Active meds: See below.

____________________________________
___, MD, pager ___
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acyclovir 800 mg PO Q12H 
2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
3. Fish Oil (Omega 3) 1000 mg PO DAILY 
4. Lisinopril 2.5 mg PO DAILY 
5. Lopinavir-Ritonavir 2 TAB PO BID 
6. Metoprolol Succinate XL 12.5 mg PO DAILY 
7. Pravastatin 40 mg PO DAILY 
8. Aspirin 81 mg PO DAILY 
9. Omeprazole 40 mg PO DAILY 

 
Discharge Medications:
1. Acyclovir 800 mg PO Q12H 
2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
3. Fish Oil (Omega 3) 1000 mg PO DAILY 
4. Lisinopril 2.5 mg PO DAILY 
5. Lopinavir-Ritonavir 2 TAB PO BID 
6. Metoprolol Succinate XL 12.5 mg PO DAILY 
7. Pravastatin 40 mg PO DAILY 
8. Aspirin 81 mg PO DAILY 
9. Omeprazole 40 mg PO DAILY 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
CNS lymphoma
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Dear Mr. ___,
It was a pleasure taking care of you during your stay at ___ ___ ___. You were admitted for treatment of
your brain lymphoma with high dose methotrexate chemotherapy.
You tolerated the chemo very well with no complications. You
should return to 11 ___ in 1 month for your next treatment.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=14047385-DS-13 | hadm_id=23094208

 
Name:  ___     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Dapsone / methotrexate
 
Attending: ___
 
Chief Complaint:
elective admission for high dose methotrexate
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
___ primarily ___ speaking man with coronary artery disease 

s/p BMS to large OM branch in ___ for inferior STEMI, HIV on 
ART (CD4 275, viral load undetectable in ___, 
high-grade CNS B cell lymphoma (brain stem) s/p brain biopsy, on 

high-dose MTX (started ___, presenting 
for cycle 11 of high dose methotrexate. After cycle 4 he had an 
MRI which showed improvement in his disease but some areas of 
residual enhancement. He continued on 2 week intervals until 
cycle 7, at which point MRI improved so switched to monthly 
cycles.

On arrival to the floor today he feels well but says he has been 
having a lot of shoulder pain. initially intermittent, but in 
the last week or so pretty much constant. can't sleep on that 
side. no trauma he can recall. he had mentioned it on last 
admission but it was only mild and occasional at that time, now 
much worse. His double vision is stable. 

Of note, the patient was admitted on ___ with anal HSV2 
infection. He was treated with treatment dose acyclovir for 7 
days and continued acyclovir daily for prophylaxis. As an 
outpatient he was found to have breakthrough lesions on 
suppressive acyclovir and his PCP started him on treatment doses 

of valacyclovir 1g BID. He has subsequently been transitioned to 

higher dose acyclovir 800mg BID and has not had any breakthrough 

lesions.

REVIEW OF SYSTEMS:  
(+) Per HPI  
(-) Denies fever, chills, night sweats, recent weight loss or 
gain. Denies headache, rhinorrhea or congestion. Denies chest 
pain, chest pressure, or weakness. Denies nausea, vomiting, 
constipation, abdominal pain. Denies dysuria, or 
myalgias. Denies rashes or skin changes. All other ROS negative  

 
Past Medical History:
PAST ONCOLOGIC HISTORY:
-- ___ - stereotaxic biopsy of the mass by Dr. ___  
-- ___ - started high-dose methotrexate  
-- ___ - C2D1 HD-MTX
-- ___  - C3D1 HD-MTX
-- ___ - C4D1 HD-MTX
-- ___   - C5D1 HD-MTX
-- ___  - C6D1 HD-MTX
-- ___   - C7D1 HD-MTX
-- ___   - C8D1 HD-MTX
-- ___  - C9D1 HD-MTX
-- ___  - C10D1 HD-MTX
 
PAST MEDICAL HISTORY:
-CNS B-cell Lymphoma
-CAD s/p BMS to large OM branch in ___ - chronically occluded 
LAD collateralized from the right coronary artery
-HIV on ART 
-history of pancreatitis ___ HIV medication
-Hypertension
-Hyperlipidemia
-Gastric ulcer
-anal HSV
-R ophthalmic zoster
 
Social History:
___
Family History:
Family history is notable for father and brother with prostate 
cancer, and 
several paternal aunts with breast cancer and maternal uncles 
with diabetes.
 
Physical Exam:
Physical Exam:
VS: 97.9   108/68    65    18     99%RA 
GEN: alert, oriented to name, place and situation. no acute
signs of distress.
HEENT: NCAT, Pupils equal and reactive, sclerae non-icteric,
MMM, OP clear no erythema.
Neck: Supple
Lymph nodes: No cervical, supraclavicular or axillary LAD.
CV: S1S2, reg rate and rhythm, no murmurs, rubs or gallops.
RESP: Good air movement bilaterally, no rhonchi or wheezing.
ABD: Soft, non-tender, non-distended, no hepatosplenomegaly
EXTR: No lower leg edema. R deltoid firmness compared to L, no 
discrete mass, no skin changes
DERM: No active rash
Neuro: muscle strength grossly full and symmetric in all major
muscle groups 
.
DISCHARGE EXAM
VS: T= 97.5 HR= 106/69 (95/49-145/88) 55 18 100% RA 
GENERAL: WDWN in NAD. Oriented x3.  
HEENT: NCAT. Sclerae anicteric. PERRL, EOMI.  
NECK: Supple with no JVD.  
CARDIAC: RR, normal S1, S2. No m/r/g.  
LUNGS: No chest wall deformities, scoliosis or kyphosis. Resp 
were unlabored, no accessory muscle use. CTAB, no crackles, 
wheezes or rhonchi.  
ABDOMEN: Soft, NTND. No HSM or tenderness.  
EXTREMITIES: No c/c/e.  
SKIN: No stasis dermatitis, ulcers, scars, or xanthomas.  
NEURO: Alert, appropriately conversant, CNs2-12 intact, strength 
___ throughout, light touch sensation grossly intact throughout. 
 

 
Pertinent Results:
==================================
              Labs
==================================
___ 09:37AM BLOOD WBC-4.5 RBC-4.56* Hgb-13.9* Hct-41.3 
MCV-91 MCH-30.5 MCHC-33.7 RDW-14.0 Plt ___
___ 09:37AM BLOOD ___ PTT-34.4 ___
___ 09:37AM BLOOD Glucose-96 UreaN-15 Creat-0.8 Na-137 
K-3.9 Cl-103 HCO3-26 AnGap-12
___ 09:37AM BLOOD ALT-18 AST-17 AlkPhos-78 TotBili-0.4
___ 09:37AM BLOOD Calcium-9.4 Phos-3.6 Mg-1.8

DISCHARGE LABS 
___ 05:22AM BLOOD WBC-7.2# RBC-4.54* Hgb-13.6* Hct-41.8 
MCV-92 MCH-30.0 MCHC-32.5 RDW-13.8 Plt ___
___ 05:22AM BLOOD Glucose-134* UreaN-18 Creat-1.0 Na-138 
K-4.1 Cl-103 HCO3-26 AnGap-13

==================================
            Procedures
==================================
Port placement ___
*** UNAPPROVED (PRELIMINARY) REPORT ***
INDICATION: ___ year old man with CNS lymphoma
 
COMPARISON: CHEST X-RAY ___HEST ___
 
TECHNIQUE: OPERATORS: Dr. ___ (interventional 
radiology fellow) and Dr. ___ (interventional radiology 
attending) performed the procedure. The attending was present 
and supervising throughout the procedure.
 
ANESTHESIA: Moderate sedation was provided by administrating 
divided doses of 150mcg of fentanyl and 3 mg of midazolam 
throughout the total intra-service time of 45 minutes during 
which the patient's hemodynamic parameters were continuously 
monitored by an independent trained radiology nurse. 1% 
lidocaine was injected in the skin and subcutaneous tissues 
overlying the access site.
 
CONTRAST: 0 ml of Optiray contrast.
 
FLUOROSCOPY TIME AND DOSE: 1.3 min, approximately 15 mGy
 
PROCEDURE 1. Right internal jugular approach chest double lumen 
Port-a-cath placement
 
PROCEDURE DETAILS: Following the explanation of the risks, 
benefits and
alternatives to the procedure, written informed consent was 
obtained from the patient. The patient was then brought to the 
angiography suite and placed supine on the exam table. A 
pre-procedure time-out was performed per ___ protocol. The 
upper chest and right neck were prepped and draped in the usual 
sterile fashion.
 
Under continuous ultrasound guidance, the patent right internal 
jugular vein was compressible and accessed using a micropuncture 
needle. Permanent
ultrasound images were obtained before and after intravenous 
access, which
confirmed vein patency. Subsequently a Nitinol wire was passed 
into the right atrium using fluoroscopic guidance. The needle 
was exchanged for a
micropuncture sheath. The Nitinol wire was removed and a short 
___ wire was advanced to make appropriate measurements for 
catheter length. The ___ wire was then passed distally into 
the IVC.
 
Next, attention was turned towards creation of a subcutaneous 
pocket over the upper anterior chest wall. After instilling 
superficial and deeper local anesthesia using lidocaine mixed 
with epinephrine, a 2.5 cm transverse incision was made and a 
subcutaneous pocket was created by using blunt dissection. The 
double lumen port was then connected to the catheter. The 
catheter was tunneled from the subcutaneous pocket towards the 
venotomy site from where it was brought out using a tunneling 
device. The port was then connected to the catheter and checks 
were made for any leakage by accessing both diaphragms using a 
non-coring ___ needle. No leaks were found.
 
The port was then placed in the subcutaneous pocket and secured 
with ___
Prolene sutures on either side. The venotomy tract was dilated 
using the
introducer of the peel-away sheath supplied. Following this, the 
peel-away
sheath was placed over the ___ wire through which the port was 
threaded into the right side of the heart with the tip in the 
right atrium. The sheath was then peeled away.
 
The subcutaneous pocket was closed in layers with ___ 
interrupted and ___
subcuticular continuous Vicryl sutures. Steri-strips and a 
single Vicryl
suture was used to close the venotomy incision site. 
Steri-Strips were also applied over the sutures. Final spot 
fluoroscopic image demonstrating good alignment of the catheter 
and no kinking. The tip is in the right atrium.
 
Both lumens of the port were accessed using a non coring ___ 
needle and
could be aspirated and flushed easily. Sterile dressings were 
applied. The
patient tolerated the procedure well without immediate 
complication. The port was left accessed as requested.
 
FINDINGS:
 
Patent right internal jugular vein. Final fluoroscopic image 
showing port with catheter tip terminating in the right atrium.
 
IMPRESSION:
 
Successful placement of a double lumen chest Port-a-cath via the 
right
internal jugular venous approach. The tip of the catheter 
terminates in the right atrium. The catheter is accessed and 
ready for use.

CARDIAC CATHETERIZATION 
ESTIMATED blood loss: 5 cc
Hemodynamics (see above):
Coronary angiography:  right dominant
LMCA: 
LAD:  80% proximal, chronic 100% mid with distal vessel filling
via collaterals
LCX:  30% OM with patent stent
RCA:  100% mid with left to right collaterals to distal RCA
Interventional details After discussion with Oncology, decided 
to proceed with stenting. Change for JR4 guide, drug coated 
stent of occluded RCA with 3.5 by 34 Resolute.  Change for XB3.5 
guide and drug coated stent of
proximal LAD with 2.75 by 12 Resolute with good results. 
Angiomax used. 

Assessment & Recommendations
 1. ASA 81 mg daily indefinitely and plavix 75 mg daily for one
year.

IMAGING 
ECHO ___
The left atrium is mildly dilated. Left ventricular wall 
thicknesses and cavity size are normal. There is mild regional 
left ventricular systolic dysfunction with hypokinesis of the 
basal inferior and distal septal segments (LAD and RCA disease). 
The remaining segments contract normally (LVEF = 45%). There is 
no ventricular septal defect. Right ventricular chamber size and 
free wall motion are normal. The diameters of aorta at the 
sinus, ascending and arch levels are normal. The aortic valve 
leaflets (3) appear structurally normal with good leaflet 
excursion and no aortic stenosis or aortic regurgitation. The 
mitral valve appears structurally normal with trivial mitral 
regurgitation. There is no mitral valve prolapse. The pulmonary 
artery systolic pressure could not be determined. There is no 
pericardial effusion. 

IMPRESSION: Mild regional left ventricular systolic dysfunction, 
c/w multivessel CAD. 

Compared with the prior study (images reviewed) of ___, 
basal inferior hypokinesis is new. The other findings are 
similar.  

MRI Head ___
IMPRESSION:  
  
1. In comparison with the most recent examination, no 
significant changes are identified, relatively stable areas of 
high-signal intensity in the 
subcortical white matter and periventricular region detected on 
T2 and FLAIR sequences, probably related with HIV encephalopathy 
versus drug/treatment related changes. 
  
2. In the area of the fourth ventricle on the right, again 
postsurgical 
changes are re- demonstrated with minimal residual enhancement 
and 
susceptibility changes, likely consistent with residual blood 
products, no new lesions or new areas with abnormal enhancement 
are seen.) 

CT shoulder
IMPRESSION:  
  
1.  No definite shoulder mass identified. 
  
2.  Small focus of ___ opacities centrilobular 
nodularity in the right middle lobe, which could reflect a sign 
of early infection. Recommend clinical correlation. 
  
3. Mild degenerative changes at the right shoulder and 
acromioclavicular 
joints. 
  
4.  Air cysts in the lungs. This is nonspecific, but could be 
seen in the 
setting of Langerhans cell histiocytosis and 
lymphangiomyomatosis (unlikely in male patients), as well as 
other processes such as lymphocytic interstitial  pneumonia. 

 
Brief Hospital Course:
Assessment and Plan: ___ male with HIV, CAD, CNS lymphoma here 
for cycle 11 high dose methotrexate treatment course complicated 
by NSTEMI with subsequent DES to the RCA and ___ LAD. 

# NSTEMI- On ___ he experienced acute onset of chest discomfort 
with radiation down the left arm after walking around the 
nursingstation. His pain improved with sublingual nitroglycerin. 
His EKGduring chest pain showed sinus rhythm with a right bundle 
branchblock and new t-wave inversions in V2-V3 with ST 
depressions in V4-V5. He was also found to have elevated cardiac 
biomarkers with a troponin T that peaked at 0.19 and a CKMB that 
peaked at 13.
.
He underwent coronary angiography which demonstrated a 
rightdominant system with an 80% proximal LAD stenosis with 
chronic 100% mid-vessel occlusion with distal filling of the 
vessel viacollaterals. The circumflex had 30% lesion with a 
patent OM
stent. The RCA was 100% occluded in the mid-portion of the 
vessel with left to right collaterals. He had a 3.5x34mm 
Resolute drug eluting stent to the RCA and then had a 2.75x12mm 
Resolute drug eluting stent to the proximal LAD.
.
He had a post-procedure echocardiogram done which demonstrated 
an ejection fraction of 45% with hypokinesis of the basal 
inferior and distal septal segments. The right ventricle was 
normal and there was no significant valvular disease. He was 
continued on asa 81 mg and started on plavix 75 mg which he will 
need to continue for at least ___ year. His home pravastatin was 
changed to atorvastatin 80 mg and his home metoprolol succinate 
was increased to 25 mg daily. He will follow-up with Dr. ___. 

.
# port placement: as planned, port placement ___ for IV access. 
This will need to be flushed monthly. 
.
# R shoulder pain: tenderness in area of deltoid on R, vague 
firmness ? mass. normal CT shoulder
.
# CNS lymphoma: MRI after cycle 7 improved, switched to monthly 
methotrexate cycles. Repeat MRI on this hospitalization stable. 
He me cycle 4 of high-dose methotrexate, which he tolerated 
without complication. There was no evidence of vitreous lymphoma 
on neuroopthalmology exam ___. Patient will f/u with Dr. ___ 
to determine timing of his next course of methotrexate.
.
# HIV: Patient continued on home meds truvada and kaletra
.
# HSV: had been on valacyclovir 1g BID due to breakthrough 
lesions on suppressive dose acyclovir. spoke with his NP at 
___ and switched to acyclovir 800mg BID early ___. doing okay on this dose, no breakthrough lesions
.
# hypertension: Patient was continued on lisinopril.  His home 
metoprolol was increased as above.  There was no evidence of 
vitreous lymphoma on neuroopthalmology exam ___.
.
# Air cysts in the lungs- CT shoulder showed incidental findings 
of air cyst in her lungs. This was felt to be non specific in 
nature. No evidence of infection. Patient will f/u with 
oncology.
.
Transitional Issues
-Patient will follow-up with oncology and cardiology
- Oncology will call him regarding plan for the next 
chemotherapy cycle
- Patient was full code throughtout this admission
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acyclovir 800 mg PO Q12H 
2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
3. Fish Oil (Omega 3) 1000 mg PO DAILY 
4. Lisinopril 2.5 mg PO DAILY 
5. Lopinavir-Ritonavir 2 TAB PO BID 
6. Metoprolol Succinate XL 12.5 mg PO DAILY 
7. Pravastatin 40 mg PO DAILY 
8. Aspirin 81 mg PO DAILY 
9. Omeprazole 40 mg PO DAILY 

 
Discharge Medications:
1. Acyclovir 800 mg PO Q12H 
2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
3. Fish Oil (Omega 3) 1000 mg PO DAILY 
4. Lisinopril 2.5 mg PO DAILY 
5. Lopinavir-Ritonavir 2 TAB PO BID 
6. Metoprolol Succinate XL 25 mg PO DAILY 
RX *metoprolol succinate 25 mg 1 tablet(s) by mouth daily Disp 
#*30 Tablet Refills:*1
7. Aspirin 81 mg PO DAILY 
8. Atorvastatin 80 mg PO DAILY 
RX *atorvastatin 40 mg 2 tablet(s) by mouth daily Disp #*60 
Tablet Refills:*1
9. Clopidogrel 75 mg PO DAILY 
RX *clopidogrel 75 mg 1 tablet(s) by mouth daily Disp #*30 
Tablet Refills:*1
10. Pantoprazole 40 mg PO Q24H 
RX *pantoprazole 40 mg 1 tablet(s) by mouth daily Disp #*30 
Tablet Refills:*1

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
CNS lymphoma
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,
It was a pleasure taking care of you during your stay at ___. You were admitted for treatment of
your brain lymphoma with high dose methotrexate chemotherapy.
You tolerated the chemo very well. You did experience some chest 
pain and therefore required a cardiac catheterization. Stents 
were placed to open the arteries of your heart. You were started 
on new medications to help your heart. It is very important that 
you dont stop these medications unless instructed to do so by 
your cardiologist.  You also had a port-a-cath placed on this 
admission. You should keep it clean and dressed as instructed. 
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=14047385-DS-2 | hadm_id=24393930

 
Name:  ___     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: NEUROLOGY
 
Allergies: 
Dapsone
 
Attending: ___.
 
Chief Complaint:
Dizziness, diplopia, gait instability.
 
Major Surgical or Invasive Procedure:
___ Stereotactic brain biopsy
___ R frontal EVD 
 
History of Present Illness:
Mr. ___ is a ___ man with a history of HIV on HAART, 
CAD s/p BMS in ___, and recently found brainstem mass who 
presented to clinic with worsening dizziness, diplopia, gait 
instability, admitted to the inpatient service due to the acute 
rapid progression of his symptoms. He was in his usual state of 
health until 3 weeks ago when he began having dizziness and
imbalance. His symptoms worsened 1 week ago with diplopia, gait 
instability, and a posterior headache. He was recently seen at 
___, where brain imaging found a 2cm 
brainstem mass right of the fourth ventricle.

His cardiac history is significant for an inferior ST elevation 
MI in ___, for which he had got a BMS the large 
obtuse marginal branch.  At that time, he was also noted to have 
a chronically occluded LAD collateralized from the right 
coronary artery.  An exercise stress test in ___ 
showed
a fixed moderate myocardial perfusion defect in the anteroapical 
wall with no evidence of reversible ischemia and echocardiogram 
showed an EF of 55% with severe apical hypokinesis.  His HIV is 
well-controlled on Truvada and Kaletra with an undetectable VL.
 
Past Medical History:
CAD s/p BMS (___)
HIV on HAART (VL undetectable)
h/o pancreatitis ___ HIV medication
HTN
HLD
Gastric ulcer
 
Social History:
___
Family History:
It is notable for father and brother with prostate cancer, 
several paternal aunts with breast cancer and maternal uncles 
with diabetes.
 
Physical Exam:
___: WD/WN, comfortable, NAD.
HEENT: normocephalic, atraumatic
Neck: Supple.
Extremities: Warm and well-perfused.

Neurological Examination:
Mental status: Awake and alert, cooperative with exam, normal
affect.
Orientation: Oriented to person, place, and date.
Language: Speech fluent with good comprehension and repetition.
Naming intact. No dysarthria or paraphasic errors.

Cranial Nerves:
I: Not tested
II: Pupils equally round and reactive to light, 3 to 4
mm bilaterally. Visual fields are full to confrontation.
III, IV, VI: Extraocular movements full with nystagmus in all
directions.  Double vision worsens in left lateral gaze.
V, VII: Facial strength and sensation intact and symmetric.
VIII: Hearing intact to voice.
IX, X: Palatal elevation symmetrical.
XI: Sternocleidomastoid and trapezius normal bilaterally.
XII: Tongue midline without fasciculations.

Motor: Normal bulk and tone bilaterally.  Slightly Tremulous.
Strength full power ___ throughout. No pronator drift

Sensation: Intact to light touch bilaterally.

Coordination: normal on finger-nose-finger, rapid alternating
movements

UPON DISCHARGE:
Vital Signs: Temperature 98.0 F, Blood Pressure 114/68, Heart 
Rate 75, Respiratory Rate 16, and O2 saturation 97% in room air
___: well-appearing, NAD
HEENT: with suture site healing without signs of infection.
Cardiovascular: regular rate and rhythm. No murmurs. 
Respiration: CTAB, no wheezes.  
Abdomen: soft, NT, ND, no HSM. 
Extremities: no edema
Neurological Examination: His mental status is intact. CN II-XII 
intact, sensation/strength intact in all extremities.
 
Pertinent Results:
___ CTA ___
Fourth ventricle mass, better characterized on the subsequent 
MRI exam, but without significant vascularity of the mass.  No 
evidence for aneurysm or arteriovenous malformation.   

___ MR ___ w/without contrast
Relatively well-circumscribed slightly T2 hypointense fourth 
ventricular mass extending out to the foramen of Luschka.  
Differential would include ependymoma, choroid plexus papilloma, 
meningioma, lymphoma or oligodendroglioma. 

___ CT torso
1.  No evidence of primary malignancy within the chest.  No 
evidence of 
metastatic disease.
2.  Multiple low attenuation nodules throughout the thyroid 
gland.  Further assessment with thyroid ultrasound is 
recommended.   

___ CT ab/pelvis
1.  No evidence of primary malignancy or metastatic disease 
below the 
diaphragm.
2.  Two enhancing lesions within the liver that appear 
consistent with 
cavernous hemangiomas and are unchanged since ___.  

___ EKG
Normal sinus rhythm. Right bundle-branch block. Q waves in lead 
V2 consistent with possible prior anteroseptal myocardial 
infarction. No previous tracing available for comparison.  

___ MR ___ with contrast
___ well-circumscribed avid enhancing lesion in the area 
of 
the fourth ventricle on the right, with no evidence of 
hydrocephalus or new lesions.  The differential diagnosis is 
broad and includes ependymoma, meningioma, choroid plexus 
papilloma and the remote possibility of metastatic lesion cannot 
be completely ruled out. 

___ ___
Expected postoperative changes after right occipital approach 
stereotactic biopsy of a right fourth ventricular mass.  No 
significant mass effect.  No acute large territorial infarction. 


___ ___
1.  Interval placement of an external ventricular drain 
terminating in the ___ ventricle via a right frontal approach.  
Associated mild decrease in ventricle size.    
2.  Status post right occipital craniotomy and biopsy of a 
fourth ventricle lesion. Expected post procedural changes 
including pneumocephalus.  No complications including large 
hemorrhage noted. 

___ ___
IMPRESSION:
1. Slight increase in size of the ventricles compared to the 
prior study. 
Unchanged appearance of external ventricular drain terminating 
in the ___
ventricle via a right frontal approach.   
2.  Increased pneumocephalus in the anterior horn of the right 
lateral
ventricle.   
3.  Unchanged appearance of small subarachnoid hemorrhage along 
the course of the drain.   
ATTENDING NOTE: There is little change in ventricular size.  

___ MR spine
IMPRESSION:
No evidence of metastatic disease within the spine.  
There is a T2 hyperintense enhancing left retroperitoneal lesion 
measuring 15 x 16mm that may represent a fatty lymphnode of 
unknown significance.  Enlarged thyroid gland with multiple 
masses. Recommend followup thyroid ultrasound for further 
evaluation.  Bilateral L5 spondylolysis with grade 1 
anterolisthesis of L5 on S1. 

___
TTE
Conclusions:
The left atrium and right atrium are normal in cavity size. Left 
ventricular wall thicknesses and cavity size are normal. There 
is mild regional left ventricular systolic dysfunction with 
focal hypokinesis of the distal septum and mild dyskinesis of 
the apex. The remaining segments contract normally (LVEF = 50 
%). The estimated cardiac index is normal (>=2.5L/min/m2). No 
masses or thrombi are seen in the left ventricle. Transmitral 
and tissue Doppler imaging suggests normal diastolic function, 
and a normal left ventricular filling pressure (PCWP<12mmHg). 
Right ventricular chamber size and free wall motion are normal. 
The diameters of aorta at the sinus, ascending and arch levels 
are normal. The aortic valve leaflets (3) appear structurally 
normal with good leaflet excursion and no aortic stenosis or 
aortic regurgitation. The mitral valve appears structurally 
normal with trivial mitral regurgitation. There is no mitral 
valve prolapse. The pulmonary artery systolic pressure could not 
be determined. There is no pericardial effusion. 
IMPRESSION: Normal left ventricular cavity size with mild 
regional systolic dysfunction c/w CAD (distal LAD distribution). 

 
Brief Hospital Course:
___: Mr ___ is a ___ year old male who presented with 
dizziness, diplopia, gait instability, found to have 2cm right 
brainstem tumor and admitted to the Neurosurgical Service. Neuro 
onc / rad onc were consulted.  

___: CTA ___ with and without contrast was obtained and 
revealed no vascular abnormality.  An MRI of ___ revealed a 
right fourth ventricular mass.  Cardiology was consulted and 
determined patient is low risk for surgery, and recommended 
restarting ASA when able.  ID was consulted and recommneding 
contining current HIV regimen. 

___: CT abdomen/pelvis & CT chest and revealed no 
metastatic disease indicating tumor is likely a primary brain 
tumor. 

___: Meeting was held with Mr. ___, his family and an 
interpreter. The option for doing a brain biopsy here at ___ 
despite the patient being a non US resident with no insurance 
(and thus no benefits for post operative care) and the risks 
associated with surgery. Patient is scheduled to go to the OR 
tomorrow. Patient has elected to discuss his options with his 
family and let us know his final decision. 

___: The patient remained stable. His operative case was 
cancelled and rescheduled for tomorrow.

___: The patient went to the OR for a biopsy of his brain 
stem lesion.  A post operative scan showed an effaced fourth 
ventricle. The patient went back to the operating room for a 
placement of an external ventricular drain. He was extubated in 
the operating room and taken to the pacu for recovery. 

___:
The patient's urine culture came back positive for gram negative 
rods.  The patient remained on Vancomycin and Gentomycin. He had 
a repeat HCT which was stable and his EVD was raised to 25 above 
the tragus. The frozen pathology from the operating room showed 
high grade lymphoma and the patient was started on 
dexamethasone.  Cultures and cytology of his csf were sent off 
for analysis. 

On ___, the patient remained stable and his EVD output was 
minimal, his EVD was clamped at 1000 without issue. A CT ___ 
and CT spine were ordered for the next day.

On ___, ___ CT showed no enlargement of ventricles after 
clamping trial and EVD was removed. MRI of the c/t/l were 
completed and showed no evidence of drop mets. 

On ___, patient will have chemotherapy and was transferred 
to neuro-oncology. A cardiac echo and a 24 hr urine were ordered 
in preparation for chemotherapy. A repeat u/a was sent to 
re-evaluate for E. coli.

On ___, Repeat U/A found to be positive for infection. 
Patient was started on Augmentin per curbside rec of ID. Urine 
culture still pending. Echo results from yesterday consistent 
with coronary artery disease. Patient is to be transfer to 
Neuro-onc.  Pt received HD MTX that night.

___ to ___, MTX levels were monitored daily.  Pt was 
given Leucovorin and Na bicarb.  On day of discharge, MTX level 
was 0.04.  Pt was maintained on Dexamethasone, was weaned to 4mg 
BID on day of discharge. Pt did have asymptomatic bacteruria 
(urine cx showed E coli) and completed 4 days of Augmentin. For 
his HIV, pt was continued on home Lopinavir-Ritonavir and 
Truvada.  Pt will need follow up for the high grade squamous 
intraepithelial lesion (AIN II) as well as the thyroid nodule 
noted. Pt was continued on home antihypertensives, however, his 
aspirin was held in setting of
brain lesion.

Patient was full code. Patient was on heparin SC for DVT ppx.
 
Medications on Admission:
1.  Emtricitabine-tenofovir (Truvada) daily
2.  Lisinopril 5 mg daily
3.  Metoprolol succinate 25 mg daily
4.  Omeprazole 40 mg daily
5.  Pravastatin 40 mg daily
6.  Lopinavir-ritonavir (Kaletra) twice daily
7.  Aspirin 81 mg daily
8.  Fish oil daily
 
Discharge Medications:
1. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
2. Lisinopril 5 mg PO DAILY 
3. Lopinavir-Ritonavir 2 TAB PO BID 
4. Metoprolol Succinate XL 25 mg PO DAILY 
5. Omeprazole 40 mg PO DAILY 
6. Pravastatin 40 mg PO DAILY 
7. Dexamethasone 4 mg PO Q12H 
RX *dexamethasone 2 mg 2 tablet(s) by mouth twice a day Disp 
#*30 Tablet Refills:*0
8. Aspirin 81 mg PO DAILY 
9. Fish Oil (Omega 3) 1000 mg PO DAILY
 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Brainstem Tumor
Cerebral edema
HIV
UTI
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
You were admitted vision problems and gait imbalance.  You were 
found to have a brain tumor.  You underwent surgery and then had 
chemotherapy.  Your symptoms are now improving.  You also had a 
urinary tract infection which was treated with antibiotics.  You 
were then discharged home.  

You will return to the hospital on ___ for the next cycle 
of chemotherapy.

Have a friend/family member check your incision daily for 
signs of infection.
Exercise should be limited to walking; no lifting, straining, 
or excessive bending.
Increase your intake of fluids and fiber, as narcotic pain 
medicine can cause constipation. 
Unless directed by your doctor, do not take any 
anti-inflammatory medicines such as Motrin, Aspirin, Advil, and 
Ibuprofen etc.  
If you are being sent home on steroid medication, make sure 
you are taking a medication to protect your stomach (Prilosec, 
Protonix, or Pepcid), as these medications can cause stomach 
irritation.  Make sure to take your steroid medication with 
meals, or a glass of milk. 
Clearance to drive and return to work will be addressed at 
your post-operative office visit.
Make sure to continue to use your incentive spirometer while 
at home.

CALL YOUR SURGEON IMMEDIATELY IF YOU EXPERIENCE ANY OF THE 
FOLLOWING
New onset of tremors or seizures.
Any confusion or change in mental status. 
Any numbness, tingling, weakness in your extremities.
Pain or headache that is continually increasing, or not 
relieved by pain medication.
Any signs of infection at the wound site: increasing redness, 
increased swelling, increased tenderness, or drainage.
Fever greater than or equal to 101.5 F.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=14047385-DS-9 | hadm_id=24792779

 
Name:  ___     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Dapsone
 
Attending: ___.
 
Chief Complaint:
elective admission for high dose methotrexate
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
___ primarily ___ speaking man with coronary artery disease 

s/p BMS to large OM branch in ___ for inferior STEMI, HIV on 
ART (CD4 275, viral load undetectable in ___, 
high-grade CNS B cell lymphoma (brain stem) s/p brain biopsy, on 

high-dose MTX (started ___ and dexamethasone, presenting 
for cycle 7 of high dose methotrexate. After cycle 4 he had an 
MRI which showed improvement in his disease but some areas of 
residual enhancement. The plan was to continue on 2 week 
intervals until at least cycle 7 and then reassess. 

On arrival to the floor today he feels well. Reports that he had 
some ___ fried pork last night, after which he had 4 loose 
stools. He had one loose stool this morning. He has no abdominal 
pain, no nausea, no vomiting, no fevers. He has no headache. 
He has increased sensitivity of his R scalp, which has been an 
ongoing problem 
for many years, since he had shingles. he has no runny nose, 
fevers, or cough. He has some tingling in his left foot which is 
stable. His vision he thinks is better overall, but notes that 
he has double vision if he is looking up.

Of note, the patient was admitted on ___ with anal HSV2 
infection. He was treated with treatment dose acyclovir for 7 
days and continued acyclovir daily for prophylaxis. As an 
outpatient he was found to have breakthrough lesions on 
suppressive acyclovir and his PCP started him on treatment doses 
of valacyclovir 1g BID. He has subsequently been transitioned to 
higher dose acyclovir 800mg BID and has not had any breakthrough 
lesions.

REVIEW OF SYSTEMS:  
(+) Per HPI  
(-) Denies fever, chills, night sweats, recent weight loss or 
gain. Denies headache, rhinorrhea or congestion. Denies chest 
pain, chest pressure, or weakness. Denies nausea, vomiting, 
constipation, abdominal pain. Denies dysuria, arthralgias or 
myalgias. Denies rashes or skin changes. All other ROS negative  

 
Past Medical History:
PAST ONCOLOGIC HISTORY:
-- ___ - stereotaxic biopsy of the mass by Dr. ___  
-- ___ - started high-dose methotrexate  
-- ___ - C2D1 HD-MTX
-- ___  - C3D1 HD-MTX
-- ___ - C4D1 HD-MTX
-- ___   - C5D1 HD-MTX
-- ___  - C6D1 HD-MTX
 
PAST MEDICAL HISTORY:
-CNS B-cell Lymphoma
-CAD s/p BMS to large OM branch in ___ - chronically occluded 
LAD collateralized from the right coronary artery
-HIV on ART 
-history of pancreatitis ___ HIV medication
-Hypertension
-Hyperlipidemia
-Gastric ulcer
-anal HSV
-R ophthalmic zoster
 
Social History:
___
Family History:
Family history is notable for father and brother with prostate 
cancer, and 
several paternal aunts with breast cancer and maternal uncles 
with diabetes.
 
Physical Exam:
VS: 97.8   118/62     80     18     98%RA
GEN: alert, oriented to name, place and situation. no acute 
signs of distress.
HEENT: NCAT, Pupils equal and reactive, sclerae non-icteric, 
MMM, OP clear no erythema. frequent squinting of R eye
Neck: Supple
Lymph nodes: No cervical, supraclavicular or axillary LAD.
CV: S1S2, reg rate and rhythm, no murmurs, rubs or gallops.
RESP: Good air movement bilaterally, no rhonchi or wheezing.
ABD: Soft, non-tender, non-distended, no hepatosplenomegaly
EXTR: No lower leg edema. tingling sensation L foot but no 
sensory loss
DERM: No active rash
Neuro: muscle strength grossly full and symmetric in all major 
muscle groups
PSYCH: Appropriate and calm.
 
Pertinent Results:
==================================
              Labs
==================================
___ 10:50AM BLOOD WBC-5.0 RBC-3.65* Hgb-12.0* Hct-36.0* 
MCV-99* MCH-32.8* MCHC-33.2 RDW-16.7* Plt ___
___ 06:30AM BLOOD WBC-4.7 RBC-3.57* Hgb-11.2* Hct-34.9* 
MCV-98 MCH-31.5 MCHC-32.2 RDW-16.1* Plt ___
___ 06:10AM BLOOD WBC-4.7 RBC-3.75* Hgb-12.2* Hct-36.8* 
MCV-98 MCH-32.4* MCHC-33.1 RDW-16.3* Plt ___
___ 10:50AM BLOOD ___ PTT-34.2 ___
___ 10:50AM BLOOD Glucose-183* UreaN-17 Creat-0.9 Na-139 
K-3.7 Cl-104 HCO3-24 AnGap-15
___ 07:25AM BLOOD Glucose-100 UreaN-11 Creat-1.0 Na-142 
K-3.4 Cl-98 HCO3-40* AnGap-7*
___ 06:30AM BLOOD Glucose-126* UreaN-10 Creat-1.1 Na-138 
K-4.1 Cl-101 HCO3-30 AnGap-11
___ 06:10AM BLOOD Glucose-138* UreaN-10 Creat-0.9 Na-137 
K-4.1 Cl-102 HCO3-29 AnGap-10
___ 10:50AM BLOOD ALT-23 AST-17 AlkPhos-77 TotBili-0.4
___ 07:25AM BLOOD ALT-19 AST-19 AlkPhos-62 TotBili-0.8
___ 06:30AM BLOOD ALT-25 AST-22 AlkPhos-71 TotBili-0.7
___ 10:50AM BLOOD Albumin-3.9 Calcium-9.4 Phos-3.3 Mg-1.8
___ 07:25AM BLOOD Calcium-8.7 Phos-3.7 Mg-1.7
___ 06:30AM BLOOD mthotrx-0.68
___ 06:10AM BLOOD mthotrx-0.12

==================================
            Radiology            
==================================
MRI head ___
Final Report
STUDY:  MRI of the head with and without contrast.
 
CLINICAL INDICATION:  ___ man with history of CNS 
lymphoma, being
treated with high-dose of methotrexate with residual disease on 
last MRI,
followup examination.
 
COMPARISON:  Multiple prior MRI examinations, the most recent 
dated ___.
 
TECHNIQUE:  Pre-contrast axial and sagittal T1-weighted images 
were obtained,
axial FLAIR, axial T2, axial magnetic susceptibility and axial
diffusion-weighted images.  The T1-weighted sequences were 
repeated after the
administration of gadolinium contrast in axial T1, sagittal 
MP-RAGE and
multiplanar reconstructions were reviewed.
 
FINDINGS:  The patient is status post biopsy at the level of the 
fourth
ventricle on the right, again susceptibility artifacts are 
redemonstrated in
this region as well as mild high signal intensity on the 
corresponding axial
FLAIR (image #11, series #7), with no significant change since 
the prior
study, there is minimal residual enhancement in this area, 
apparently related
with post-surgical change with no evidence of residual mass or 
new areas with
abnormal enhancement.  There is no evidence of hydrocephalus or 
shifting of
the normally midline structures.  The supratentorial sulci and 
ventricles are
unremarkable with no evidence of diffusion abnormalities to 
indicate slow
diffusion.  Unchanged susceptibility artifact related with prior 
right frontal
external ventricular drain.  Major arterial vascular flow voids 
are present
and demonstrate normal distribution.  The orbits are 
unremarkable, the
paranasal sinuses again demonstrate a tiny mucus retention cyst 
on the left
maxillary sinus.
 
IMPRESSION:  Minimal residual enhancement adjacent to the fourth 
ventricle on
the right, with T2 and FLAIR hyperintensity, consistent with 
post-surgical
changes, stable since the prior examination, with no evidence of 
new lesions
or new areas of abnormal enhancement.  Long-term followup is 
advised to
demonstrate stability.

 
Brief Hospital Course:
___ male with HIV, CAD, CNS lymphoma here for cycle 7 high dose 

methotrexate treatment. MRI after cycle 4 showed residual 
disease, so plan was to increase dose to 8g/m2 and continue 
every 2 weeks until cycle 7, then reassess. After urinary 
alkalinization, he received methotrexate 16560mg (8g/m2) on ___ 
at 11pm.  
This was followed by leucovorin rescue 24 hours later. His 
methotrexate 
level on ___ is 0.12. He was continued on bicarbonate fluids 
and leucovorin for another 9 hours after that level and it is 
presumed his level is now less than 0.10. He will be discharged 
home in good condition. He had an MRI on this admission which 
showed post surgical changes and no evidence of residual 
disease. He will now be transitioned to monthly methotrexate 
cycles. He has been asked to report back to ___ on ___ 
for the next cycle (#8). 
For his HSV, he has been on acyclovir 800mg BID and will be 
monitored for symptoms. His blood pressure was slightly low 
while here but he continued his metoprolol and lisinopril at 
12.5mg and 2.5mg respectively with no symptoms of hypotension. 

# Dispo: 
[x] Discharge documentation reviewed, pt is stable for 
discharge.
[x] Time spent on discharge activity was greater than 30min.
[ ] Time spent on discharge activity was less than 30min.

# Active meds: See below.

____________________________________
___, MD, pager ___
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acyclovir 800 mg PO Q12H 
2. Dexamethasone 0.5 mg PO EVERY OTHER DAY 
3. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
4. Fish Oil (Omega 3) 1000 mg PO DAILY 
5. Lisinopril 2.5 mg PO DAILY 
6. Lopinavir-Ritonavir 2 TAB PO BID 
7. Metoprolol Succinate XL 12.5 mg PO DAILY 
8. Pravastatin 40 mg PO DAILY 
9. Aspirin 81 mg PO DAILY 
10. Omeprazole 40 mg PO DAILY 

 
Discharge Medications:
1. Acyclovir 800 mg PO Q12H 
2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
3. Fish Oil (Omega 3) 1000 mg PO DAILY 
4. Lisinopril 2.5 mg PO DAILY 
5. Lopinavir-Ritonavir 2 TAB PO BID 
6. Metoprolol Succinate XL 12.5 mg PO DAILY 
7. Pravastatin 40 mg PO DAILY 
8. Aspirin 81 mg PO DAILY 
9. Omeprazole 40 mg PO DAILY 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
CNS lymphoma
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Dear Mr. ___,
It was a pleasure taking care of you during your stay at ___ 
___. You were admitted for treatment of 
your brain lymphoma with high dose methotrexate chemotherapy. 
You tolerated the chemo very well with no complications. You 
should return to ___ in 1 month (___) for your next 
treatment.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=14047385-DS-12 | hadm_id=25170619

 
Name:  ___     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Dapsone / methotrexate
 
Attending: ___.
 
Chief Complaint:
elective admission for high dose methotrexate
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
___ primarily ___ speaking man with coronary artery disease 

s/p BMS to large OM branch in ___ for inferior STEMI, HIV on 
ART (CD4 275, viral load undetectable in ___, 
high-grade CNS B cell lymphoma (brain stem) s/p brain biopsy, on 

high-dose MTX (started ___, presenting 
for cycle 10 of high dose methotrexate. After cycle 4 he had an 
MRI which showed improvement in his disease but some areas of 
residual enhancement. He continued on 2 week intervals until 
cycle 7, at which point MRI improved so switched to monthly 
cycles.

On arrival to the floor today he feels well. came back from ___ 
___ ago. He has no abdominal pain, no nausea, no vomiting, 
no fevers. He has no headache. 
He has increased sensitivity of his R scalp, which has been an 
ongoing problem for many years, since he had shingles. he has no 

runny nose, fevers, or cough. He has some tingling in his left 
foot which is 
stable. His vision is about the same (some double vision but 
improved from before). He has some pain in his ankle and in the 
small joints of his hands that gets better with movement. He has 
developed some pain in his R shoulder also for the last few 
days. no trauma or exertion prior to pain starting

Of note, the patient was admitted on ___ with anal HSV2 
infection. He was treated with treatment dose acyclovir for 7 
days and continued acyclovir daily for prophylaxis. As an 
outpatient he was found to have breakthrough lesions on 
suppressive acyclovir and his PCP started him on treatment doses 

of valacyclovir 1g BID. He has subsequently been transitioned to 

higher dose acyclovir 800mg BID and has not had any breakthrough 

lesions.

REVIEW OF SYSTEMS:  
(+) Per HPI  
(-) Denies fever, chills, night sweats, recent weight loss or 
gain. Denies headache, rhinorrhea or congestion. Denies chest 
pain, chest pressure, or weakness. Denies nausea, vomiting, 
constipation, abdominal pain. Denies dysuria, or 
myalgias. Denies rashes or skin changes. All other ROS negative  


 
Past Medical History:
PAST ONCOLOGIC HISTORY:
-- ___ - stereotaxic biopsy of the mass by Dr. ___  
-- ___ - started high-dose methotrexate  
-- ___ - C2D1 HD-MTX
-- ___  - C3D1 HD-MTX
-- ___ - C4D1 HD-MTX
-- ___   - C5D1 HD-MTX
-- ___  - C6D1 HD-MTX
-- ___   - C7D1 HD-MTX
-- ___   - C8D1 HD-MTX
-- ___  - C9D1 HD-MTX
 
PAST MEDICAL HISTORY:
-CNS B-cell Lymphoma
-CAD s/p BMS to large OM branch in ___ - chronically occluded 
LAD collateralized from the right coronary artery
-HIV on ART 
-history of pancreatitis ___ HIV medication
-Hypertension
-Hyperlipidemia
-Gastric ulcer
-anal HSV
-R ophthalmic zoster
 
Social History:
___
Family History:
Family history is notable for father and brother with prostate 
cancer, and 
several paternal aunts with breast cancer and maternal uncles 
with diabetes.
 
Physical Exam:
VS: 98.0   120/64    56   18     100%RA
GEN: alert, oriented to name, place and situation. no acute
signs of distress.
HEENT: NCAT, Pupils equal and reactive, sclerae non-icteric,
MMM, OP clear no erythema.
Neck: Supple
Lymph nodes: No cervical, supraclavicular or axillary LAD.
CV: S1S2, reg rate and rhythm, no murmurs, rubs or gallops.
RESP: Good air movement bilaterally, no rhonchi or wheezing.
ABD: Soft, non-tender, non-distended, no hepatosplenomegaly
EXTR: No lower leg edema. tingling sensation L foot but no
sensory loss. no swelling over joints of hands. point tenderness 
on anterior aspect of R shoulder
DERM: No active rash
Neuro: muscle strength grossly full and symmetric in all major
muscle groups
PSYCH: Appropriate and calm. 
 
Pertinent Results:
==================================
              Labs
==================================
___ 12:50PM BLOOD WBC-5.8 RBC-4.44* Hgb-13.8* Hct-39.3* 
MCV-88 MCH-31.0 MCHC-35.1* RDW-14.2 Plt ___
___ 06:40AM BLOOD WBC-4.0 RBC-4.37* Hgb-13.7* Hct-39.4* 
MCV-90 MCH-31.3 MCHC-34.8 RDW-13.5 Plt ___
___ 12:50PM BLOOD Glucose-90 UreaN-15 Creat-0.9 Na-135 
K-4.2 Cl-104 HCO3-26 AnGap-9
___ 06:40AM BLOOD Glucose-113* UreaN-9 Creat-0.9 Na-141 
K-3.5 Cl-100 HCO3-33* AnGap-12
___ 12:50PM BLOOD ALT-13 AST-11 LD(LDH)-135 AlkPhos-73 
TotBili-0.3
___ 06:40AM BLOOD ALT-24 AST-16 AlkPhos-59 TotBili-0.5
___ 12:50PM BLOOD Albumin-4.2 Calcium-9.4 Phos-3.6 Mg-1.8
___ 05:40AM BLOOD mthotrx-0.43
___ 06:40AM BLOOD mthotrx-0.08
___ 05:40AM BLOOD ___

 
Brief Hospital Course:
___ male with HIV, CAD, CNS lymphoma here for cycle 10 high 
dose 
methotrexate treatment. MRI after cycle 4 showed residual 
disease, so he continued on 2 week intervals until cycle 7, at 
which point MRI improved so switched to monthly cycles. After 
urinary alkalinization, he received methotrexate 16960mg 
(8g/m2).  
This was followed by leucovorin rescue 24 hours later. His 
methotrexate level on ___ is 0.08. He was discharged 
home in good condition. He has been asked to report back to ___ 
___ on ___ for the next cycle (#11). He will come early 
and receive a port-a-cath that day. He will also see 
ophthalmology for a slit lamp exam that day. He has had stable 
double vision since diagnosis

For his HSV, he has been on acyclovir 800mg BID and will be 
monitored for symptoms. He continued his metoprolol and 
lisinopril at 12.5mg and 2.5mg respectively with good control of 

blood pressure. On previous admissions his blood pressures have 
run 
slightly low but he has continued these medications without 
problem. 

# Dispo: 
[x] Discharge documentation reviewed, pt is stable for 
discharge.
[x] Time spent on discharge activity was greater than 30min.
[ ] Time spent on discharge activity was less than 30min.

# Active meds: See below.

____________________________________
___, MD, pager ___
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acyclovir 800 mg PO Q12H 
2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
3. Fish Oil (Omega 3) 1000 mg PO DAILY 
4. Lisinopril 2.5 mg PO DAILY 
5. Lopinavir-Ritonavir 2 TAB PO BID 
6. Metoprolol Succinate XL 12.5 mg PO DAILY 
7. Pravastatin 40 mg PO DAILY 
8. Aspirin 81 mg PO DAILY 
9. Omeprazole 40 mg PO DAILY 

 
Discharge Medications:
1. Acyclovir 800 mg PO Q12H 
2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
3. Fish Oil (Omega 3) 1000 mg PO DAILY 
4. Lisinopril 2.5 mg PO DAILY 
5. Lopinavir-Ritonavir 2 TAB PO BID 
6. Metoprolol Succinate XL 12.5 mg PO DAILY 
7. Pravastatin 40 mg PO DAILY 
8. Aspirin 81 mg PO DAILY 
9. Omeprazole 40 mg PO DAILY 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
CNS lymphoma
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Dear Mr. ___,
It was a pleasure taking care of you during your stay at ___. You were admitted for treatment of
your brain lymphoma with high dose methotrexate chemotherapy.
You tolerated the chemo very well with no complications. You
should return to ___ on ___ for your next treatment.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=14047385-DS-7 | hadm_id=26244682

 
Name:  ___     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Dapsone
 
Attending: ___.
 
Chief Complaint:
elective admission for high dose methotrexate
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
___ primarily ___ speaking man with coronary artery disease 

s/p BMS to large OM branch in ___ for inferior STEMI, HIV on 
ART (CD4 275, viral load undetectable in ___, recently 

diagnosed high-grade CNS B cell lymphoma (brain stem) s/p brain 
biopsy, on high-dose MTX (started ___ and dexamethasone, 
presenting for cycle 5 of high dose methotrexate. After the last 
cycle he had an MRI which showed improvement in his disease but 
some areas of residual enhancement. The plan was to continue on 
2 week intervals for at least 3 more cycles. 

Of note, the patient was admitted on ___ with anal HSV2 
infection. He was treated with treatment dose acyclovir for 7 
days and continued acyclovir daily for prophylaxis. As an 
outpatient he was found to have breakthrough lesions on 
suppressive acyclovir and his PCP started him on treatment doses 
of valacyclovir 1g BID. 

Today, he reports feeling well. He just got back from the 
___. He felt well there but after return has 
developed a very mild cough and some shortness of breath for the 
last 2 days. He denies any n/v/f/c. no sore throat or runny 
nose. He has no skin rash, including herpetic lesions. He has 
increased sensitivity of his R scalp, which has been present 
since surgery. He has some tingling in his left foot which is 
stable. His vision is stable. 

REVIEW OF SYSTEMS:  
(+) Per HPI  
(-) Denies fever, chills, night sweats, recent weight loss or 
gain. Denies headache, rhinorrhea or congestion. Denies chest 
pain, chest 
pressure, or weakness. Denies nausea, vomiting, diarrhea, 
constipation, abdominal pain. Denies dysuria, arthralgias or 
myalgias. Denies rashes or skin changes. All other ROS negative  

 
Past Medical History:
PAST ONCOLOGIC HISTORY:
-- ___ - stereotaxic biopsy of the mass by Dr. ___  
-- ___ - started high-dose methotrexate  
-- ___ - C2D1 HD-MTX
-- ___  - C3D1 HD-MTX
-- ___ - C4D1 HD-MTX

PAST MEDICAL HISTORY:
-CNS B-cell Lymphoma
-CAD s/p BMS to large OM branch in ___ - chronically occluded 
LAD collateralized from the right coronary artery
-HIV on ART 
-history of pancreatitis ___ HIV medication
-Hypertension
-Hyperlipidemia
-Gastric ulcer
 
Social History:
___
Family History:
Family history is notable for father and brother with prostate 
cancer, and 
several paternal aunts with breast cancer and maternal uncles 
with diabetes.
 
Physical Exam:
VS: 98.5   100/70   70   18    97%RA
GEN: alert, oriented to name, place and situation. no acute 
signs of distress.
HEENT: NCAT, Pupils equal and reactive, sclerae non-icteric, 
MMM.
Neck: Supple
Lymph nodes: No cervical, supraclavicular or axillary LAD.
CV: S1S2, reg rate and rhythm, no murmurs, rubs or gallops.
RESP: Good air movement bilaterally, no rhonchi or wheezing.
ABD: Soft, non-tender, non-distended, no hepatosplenomegaly
EXTR: No lower leg edema. tingling sensation L foot but no 
sensory loss
DERM: No active rash
Neuro: muscle strength grossly full and symmetric in all major 
muscle groups
PSYCH: Appropriate and calm.
 
Pertinent Results:
==================================
              Labs
==================================
___ 01:00PM BLOOD WBC-7.0# RBC-3.90* Hgb-12.3* Hct-37.5* 
MCV-96 MCH-31.5 MCHC-32.8 RDW-20.2* Plt ___
___ 06:35AM BLOOD WBC-3.7* RBC-3.89* Hgb-12.2* Hct-37.7* 
MCV-97 MCH-31.2 MCHC-32.3 RDW-19.1* Plt ___
___ 01:00PM BLOOD Glucose-118* UreaN-22* Creat-0.8 Na-136 
K-4.0 Cl-101 HCO3-24 AnGap-15
___ 01:00PM BLOOD Glucose-118* UreaN-22* Creat-0.8 Na-136 
K-4.0 Cl-101 HCO3-24 AnGap-15
___ 06:35AM BLOOD Glucose-108* UreaN-13 Creat-0.9 Na-140 
K-4.5 Cl-98 HCO3-33* AnGap-14
___ 01:00PM BLOOD ALT-25 AST-19 AlkPhos-70 TotBili-0.7
___ 06:35AM BLOOD ALT-55* AST-30 AlkPhos-66 TotBili-0.9
___ 01:00PM BLOOD Albumin-3.8 Calcium-9.3 Phos-5.0*# Mg-1.9
___ 06:35AM BLOOD Calcium-9.1 Phos-3.4 Mg-1.9
___ 06:25AM BLOOD mthotrx-1.3
___ 06:35AM BLOOD mthotrx-0.05

==================================
            Radiology            
==================================

MRI head ___
FINDINGS:
 
There has been interval removal of a right frontal external 
ventricular drain
with some areas of blooming susceptibility along the tract 
likely related to
residual blood products. The patient is status post biopsy of a 
___
ventricular mass through a right suboccipital approach with 
associated mild T1
intrinsic hyperintensity and blooming susceptibility within the 
right aspect
of the ___ ventricle likely related to residual blood products. 
The
previously noted enhancing mass within the ___ ventricle is no 
longer
identified; there is some mild residual enhancement and adjacent 

parenchymal
high T2/FLAIR hyperintensity.
 
There is no evidence of acute intracranial infarct or 
hemorrhage. There are
nonspecific small scattered T2/FLAIR high signal foci throughout 

the brain.
Gray white matter differentiation is otherwise maintained. 
Ventricles and
extra axial spaces are also otherwise within normal limits for 
age. The major
intracranial vessels exhibit the expected signal void related to 

vascular
flow.
 
The paranasal sinuses demonstrate scattered areas of mucosal 
thickening.
Fluid signal and inflammatory changes are noted within scattered 

right greater
than left mastoid air cells. The sella turcica, craniocervical 
junction, and
orbits are unremarkable.
 
IMPRESSION:
 
Previously identified enhancing ___ ventricular mass is no 
longer present;
however, there is some mild residual enhancement and adjacent 
parenchymal high
T2/FLAIR hyperintensity abbout the right aspect of the ___ 
ventricle. 

 
Brief Hospital Course:
___ male with HIV, CAD, CNS lymphoma here for cycle 5 high dose 

methotrexate treatment. MRI after cycle 4 showed residual 
disease, so after urinary alkalinization, he received increased 
dose 8g/m2 = 16320mg on ___. This was 
followed by leucovorin rescue 24 hours later. His methotrexate 
level on ___ is 0.05 and he will be discharged home in good 
condition. He will continue on biweekly 
methotrexate for 2 more cycles and has been asked to report back 
to ___ on 
___ for the next cycle (#6). after cycle 7 he will have another 
MRI to assess response.
For his HSV, he was switched to acyclovir 800mg BID and will be 
monitored for symptoms. His blood pressure was slightly low 
while here and his metoprolol and lisinopril were reduced by 
half to 12.5mg and 2.5mg respectively. 

# Dispo: 
[x] Discharge documentation reviewed, pt is stable for 
discharge.
[x] Time spent on discharge activity was greater than 30min.
[ ] Time spent on discharge activity was less than 30min.

# Active meds: See below.

____________________________________
___, MD, pager ___
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
2. Fish Oil (Omega 3) 1000 mg PO DAILY 
3. Lisinopril 5 mg PO DAILY 
4. Lopinavir-Ritonavir 2 TAB PO BID 
5. Metoprolol Succinate XL 25 mg PO DAILY 
6. Pravastatin 40 mg PO DAILY 
7. ValACYclovir 1000 mg PO Q12H 
8. Aspirin 81 mg PO DAILY 
9. Omeprazole 40 mg PO DAILY 
10. Dexamethasone 1 mg PO DAILY 

 
Discharge Medications:
1. Dexamethasone 0.5 mg PO DAILY 
RX *dexamethasone 0.5 mg 1 tablet(s) by mouth once a day Disp 
#*30 Tablet Refills:*0
2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
3. Fish Oil (Omega 3) 1000 mg PO DAILY 
4. Lisinopril 2.5 mg PO DAILY 
5. Lopinavir-Ritonavir 2 TAB PO BID 
6. Metoprolol Succinate XL 12.5 mg PO DAILY 
7. Pravastatin 40 mg PO DAILY 
8. Acyclovir 800 mg PO Q12H 
RX *acyclovir 800 mg 1 tablet(s) by mouth twice a day Disp #*60 
Capsule Refills:*1
9. Aspirin 81 mg PO DAILY 
10. Omeprazole 40 mg PO DAILY 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
CNS lymphoma
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Dear Mr. ___,
It was a pleasure taking care of you during your stay at ___ 
___ ___ ___. You were admitted for treatment of 
your brain lymphoma with high dose methotrexate chemotherapy. 
You tolerated the chemo very well with no complications. You 
should return to 11 ___ in 2 weeks for your next treatment.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=14047385-DS-20 | hadm_id=26459383

 
Name:  ___     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Dapsone / methotrexate
 
Attending: ___
 
Chief Complaint:
Routine Chemotherapy
 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
History obtained via review of OMR and in-person ___
interpreter. 

___ with HIV on HAART and CNS lymphoma on maintenance HD-MTX
(last dose ___ who presents for admission for routine
chemotherapy.

His most recent HD-MTX was over a year ago on ___. The
therapy was well tolerated. His admission was complicated by a
UTI treated with cipro in addition to folliculitis. 

He has been followed by Dr. ___ orthopedics for his known
bilateral osteonecrosis of both hips. His treatment plan 
includes
observation without surgical intervention. In addition he has
been seen by Dr. ___ his ___ sarcoma. He has had
resolution of his lesion and has no visceral involvement on
imaging. His treatment plan includes yearly observation. 

His Port was also removed on ___. 

The patient had an episode of back itching a few days ago. He
went to ___ where he was evaluated and told to have a drug
reaction due to his lisinopril which he has stopped taking. He 
is
unsure if this is due to his lisinopril as he had a similar
sensation after eating spicy meat. He has no throat swelling or
difficulty breathing. 

He feels well and is without complaints. He has no fevers or
chills. No chest pain, dyspnea or palpitations. No abd pain. No
n/v/d. No dysuria. 

ROS: 10 point review of systems discussed with patient and
negative unless noted above

 
Past Medical History:
PAST ONCOLOGIC HISTORY:
His neurological problem began at the end of ___ when
he experienced imbalance and blurry vision.  Initially, his gait
imbalance was intermittent, mostly occuring after eating and
lasting for a couple of hours.  However, it progressed to a
constant fashion.  He also developed blurry vision and he had to
close one eye in order to see clearly.  On ___, his
imbalance was severe enough that his brother, ___, took him to ___.  He had a head
CT that showed a mass at the brainstem.  He was referred to see
Dr. ___ on ___ who admitted him to the
Neurosurgery Service.  A gadolinium-enhanced head MRI on 
___
showed a homogeneously enhancing mass at the lateral recess on
the right side of the fourth ventricle.  He then underwent a
stereotaxic biopsy of the mass by Dr. ___ on
___.  After biopsy he remains neurologically stable.  He
then started high-dose methotrexate on ___.
(1) stereotaxic biopsy of the mass by Dr. ___ on
___,
(2) an echocardiogram that was performed on ___ showing
apical hypokinesis but his ejection fraction remained at 55%,
(3) started high-dose methotrexate on ___ and had 5
induction cycles so far,
(4) started re-induction high-dose methtorexate on ___ and
had 3 cycles,
(5) started monthly maintenance high-dose methotrexate on
___ and had 4 cycles,
(6) started every 2-month maintenance high-dose methotrexate on
___ and had 3 cycles,
(7) gadolinium-enhanced head MRI from ___ showed no 
evidence
of active disease, 
(8) started every 3-month maintenance high-dose methotrexate on
___ and had 1 cycle,
(9) saw dermatology for penile lesion on ___ and biopsy
showed Kaposi sarcoma, and
(10) gadolinium-enhanced head MRI from ___ showed no
evidence of active disease.
(11) ___ HD-MTX 8g/m2 (planned)

 
PAST MEDICAL HISTORY: 
- HIV on HAART
- Kaposi sarcoma - solitary penile lesion, ___
- CNS lymphoma as above
- Right-sided opthalmic/V3 shingles
- Bilateral femoral head avascular necrosis 
- Thyroid nodule
- CAD/MI - Stent placed ___ NSTEMI ___ during HD-MTX
admission, DES to RCA and LAD
- Pancreatitis
- HTN
- HLD
- Hx of gastric ulcer
 
Social History:
___
Family History:
His parents are alive; his mother has pre-diabetes while his 
father has glaucoma and prostate cancer.  He has 6 brothers, one 

of the, has kidney problem.  He has 3 daughters and they are all 

healthy.    
 
Physical Exam:
ADMISSION
___ 1342 Temp: 98.5 PO BP: 114/73 HR: 68 RR: 18 O2 sat: 95% 

   
GENERAL:  NAD
HEENT:  Sclerae anicteric. PERRL. Moist mucous membranes, no 
oral
lesions
NECK:  Supple
LUNGS:  No increased WOB, CTAB. No wheezing, rhonchi or crackles
HEART:  RRR no MRG
ABD:  NTND No HSM, normal bowel sounds
EXT:  Warm, no edema 
SKIN:  blanching erythema on back
NEURO:  CN II-XII grossly intact. Strength ___ UE and ___ b/l
ACCESS:  PIV x2 L hand

DISCHARGE
24 HR Data (last updated ___ @ 831)
    Temp: 98.6 (Tm 98.6), BP: 108/69 (108-110/66-69), HR: 61
(59-61), RR: 18, O2 sat: 99% (99-100), O2 delivery: RA
Fluid Balance (last updated ___ @ 832)
  Last 8 hours  Total cumulative 700ml
    IN: Total 1700ml, PO Amt 120ml, IV Amt Infused 1580ml
    OUT:  Total 1000ml, Urine Amt 1000ml
  Last 24 hours  Total cumulative -653ml
    IN: Total 4522ml, PO Amt 120ml, IV Amt Infused 4402ml
    OUT:  Total 5175ml, Urine Amt 5175ml

GENERAL:  NAD
HEENT:  Sclerae anicteric. PERRL. Moist mucous membranes, no 
oral
lesions
NECK:  Supple
LUNGS:  No increased WOB, CTAB. No wheezing, rhonchi or crackles
HEART:  RRR no MRG
ABD:  NTND No HSM, normal bowel sounds
EXT:  Warm, no edema 
SKIN:  blanching erythema on back
NEURO:  CN II-XII grossly intact. Strength ___ UE and ___ b/l
ACCESS:  PIV x2 L hand
 
Pertinent Results:
ADMISSION
___ 02:09PM BLOOD WBC-10.9* RBC-5.02 Hgb-15.4 Hct-44.7 
MCV-89 MCH-30.7 MCHC-34.5 RDW-12.1 RDWSD-39.1 Plt ___
___ 02:09PM BLOOD Glucose-172* UreaN-20 Creat-1.0 Na-135 
K-4.5 Cl-100 HCO3-23 AnGap-12
___ 02:09PM BLOOD ALT-32 AST-22 AlkPhos-62 TotBili-0.2
___ 02:09PM BLOOD Albumin-4.1 Calcium-9.4 Phos-2.2* Mg-2.3

PERTINENT
___ 01:30AM BLOOD ALT-272* AST-174* AlkPhos-47 TotBili-0.4
___ 01:10AM BLOOD mthotrx-1.4*
___ 01:30AM BLOOD mthotrx-0.12

DISCHARGE
___ 01:30AM BLOOD WBC-4.5 RBC-4.49* Hgb-13.6* Hct-39.6* 
MCV-88 MCH-30.3 MCHC-34.3 RDW-12.3 RDWSD-39.6 Plt ___
___ 01:30AM BLOOD Glucose-205* UreaN-12 Creat-0.9 Na-142 
K-3.8 Cl-101 HCO3-28 AnGap-13
___ 01:30AM BLOOD ALT-272* AST-174* AlkPhos-47 TotBili-0.4
___ 01:30AM BLOOD Calcium-8.5 Phos-3.3 Mg-2.0

MICRO
None

IMAGING
None

___ 06:45AM BLOOD WBC-4.9 RBC-4.47* Hgb-13.5* Hct-40.7 
MCV-91 MCH-30.2 MCHC-33.2 RDW-12.1 RDWSD-40.7 Plt ___
___ 06:45AM BLOOD ALT-302* AST-133* AlkPhos-39* TotBili-0.6
___ 12:40AM BLOOD mthotrx-0.06
___ 09:19AM BLOOD mthotrx-0.11
___ 01:30AM BLOOD mthotrx-0.12
___ 01:10AM BLOOD mthotrx-1.4*
 
Brief Hospital Course:
___ with HIV on ART and CNS lymphoma on maintenance HD-MTX 
presents for planned chemotherapy.

# CNS Lymphoma:  Patient was admitted for maintenance HD-MTX. 
Recent MRI obtained 4 days prior to admission showed no signs of 
recurrent lymphoma. He was started on HD-MTX protocol per OMS 
order set. He received Benadryl pre-medication. His urine was 
alkalinized with sodium bicarbonate per protocol and he received 
leucovorin rescue per protocol. He MTX was <0.1 at time of 
discharge. His course was complicated by transaminitis which was 
seen on prior admissions. He will return in ___ year for repeat 
admission for HD-MTX. He will have a clinic visit with Dr. ___ 
___ MRI scheduled prior to admission on ___
 
# Transaminitis: Likely due to MTX. No abd pain. Has occurred in
past. Patient instructed to follow up with PCP to ensure 
resolution upon discharge

# Hyperglycemia:
Likely due to D5W from HCO3 gtt. Improved

# Hypophosphatemia:
- repleted

# HIV: Well controlled, followed at ___ home Stribild

# ___ sarcoma: Single isolated lesion, now resolved. No 
evidence of visceral involvement.

# CAD: Takes single agent ASA at home. Will hold in setting of
MTX. Used Plavix in house for antiplatelet effect while holding 
ASA. Continued on home metoprolol. Will restart aspirin and 
statin upon discharge.

# HTN: Con't home metoprolol. Patient was recently evaluated in 
the ED for concern of drug rash that was attributed to 
lisinopril. This was held while in house and discontinued as he 
had not been taking it. 

# HLD: Home statin was held while on MTX. Will resume at 
discharge

TRANSITIONAL ISSUES
[]f/u with PCP to recheck LFTs
[]will return for HD-MTX in ___ year ___

billing: >30 min spent coordinating care for discharge
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Metoprolol Succinate XL 25 mg PO DAILY 
2. Stribild (elvitegr-cobicist-emtric-tenof) ___ mg 
oral qd 
3. Aspirin 81 mg PO DAILY 
4. Centrum Silver Ultra Mens (multivit-min-FA-lycopen-lutein) 
___ mcg oral DAILY 
5. Cyanocobalamin 1000 mcg PO DAILY 
6. Fish Oil (Omega 3) 1000 mg PO DAILY 
7. Pantoprazole 40 mg PO Q24H 
8. Pravastatin 80 mg PO QPM 
9. Vitamin D 1000 UNIT PO DAILY 

 
Discharge Medications:
1.  Aspirin 81 mg PO DAILY  
2.  Centrum Silver Ultra Mens (multivit-min-FA-lycopen-lutein) 
___ mcg oral DAILY  
3.  Cyanocobalamin 1000 mcg PO DAILY  
4.  Fish Oil (Omega 3) 1000 mg PO DAILY  
5.  Metoprolol Succinate XL 25 mg PO DAILY  
6.  Pantoprazole 40 mg PO Q24H  
7.  Pravastatin 80 mg PO QPM  
8.  Stribild (elvitegr-cobicist-emtric-tenof) ___ mg 
oral qd  
9.  Vitamin D 1000 UNIT PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
CNS Lymphoma

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

It was a pleasure taking care of you at ___ 
___. You were admitted for your scheduled HD-MTX 
chemotherapy. You tolerated the infusion well. Your next 
chemotherapy is scheduled for one year ___.

You should hear from Dr. ___ office in the next few days to 
schedule this. If you do not hear from them, please call Dr. 
___ office at ___ to help schedule this.

In addition, your liver numbers were slightly elevated due to 
the chemotherapy. Please make a follow up appointment with your 
PCP to have them rechecked to ensure they are going down in 1 
week. 

We wish you the best!

Your ___ Care team
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=14047385-DS-10 | hadm_id=26594213

 
Name:  ___     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Dapsone
 
Attending: ___.
 
Chief Complaint:
elective admission for high dose methotrexate for CNS lymphoma
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
___ primarily ___ speaking man with coronary artery disease 

s/p BMS to large OM branch in ___ for inferior STEMI, HIV on 
ART (CD4 275, viral load undetectable in ___, 
high-grade CNS B cell lymphoma (brain stem) s/p brain biopsy, on 

high-dose MTX (started ___ and dexamethasone, presenting 
for cycle 8 of high dose methotrexate. After cycle 4 he had an 
MRI which showed improvement in his disease but some areas of 
residual enhancement. He continued on 2 week intervals until 
cycle 7, at which point MRI improved so switched to monthly 
cycles.

On arrival to the floor today he feels well. had a good month in 
___ with his family. He has no abdominal 
pain, no nausea, no vomiting, no fevers. He has no headache. 
He has increased sensitivity of his R scalp, which has been an 
ongoing problem 
for many years, since he had shingles. he has no runny nose, 
fevers, or cough. He has some tingling in his left foot which is 

stable. His vision he thinks is better overall.

Of note, the patient was admitted on ___ with anal HSV2 
infection. He was treated with treatment dose acyclovir for 7 
days and continued acyclovir daily for prophylaxis. As an 
outpatient he was found to have breakthrough lesions on 
suppressive acyclovir and his PCP started him on treatment doses 

of valacyclovir 1g BID. He has subsequently been transitioned to 

higher dose acyclovir 800mg BID and has not had any breakthrough 

lesions.

REVIEW OF SYSTEMS:  
(+) Per HPI  
(-) Denies fever, chills, night sweats, recent weight loss or 
gain. Denies headache, rhinorrhea or congestion. Denies chest 
pain, chest pressure, or weakness. Denies nausea, vomiting, 
constipation, abdominal pain. Denies dysuria, arthralgias or 
myalgias. Denies rashes or skin changes. All other ROS negative  

 
Past Medical History:
PAST ONCOLOGIC HISTORY:
-- ___ - stereotaxic biopsy of the mass by Dr. ___  
-- ___ - started high-dose methotrexate  
-- ___ - C2D1 HD-MTX
-- ___  - C3D1 HD-MTX
-- ___ - C4D1 HD-MTX
-- ___   - C5D1 HD-MTX
-- ___  - C6D1 HD-MTX
 
PAST MEDICAL HISTORY:
-CNS B-cell Lymphoma
-CAD s/p BMS to large OM branch in ___ - chronically occluded 
LAD collateralized from the right coronary artery
-HIV on ART 
-history of pancreatitis ___ HIV medication
-Hypertension
-Hyperlipidemia
-Gastric ulcer
-anal HSV
-R ophthalmic zoster
 
Social History:
___
Family History:
Family history is notable for father and brother with prostate 
cancer, and 
several paternal aunts with breast cancer and maternal uncles 
with diabetes.
 
Physical Exam:
VS: 98.2    120/70    82    16     98%RA
GEN: alert, oriented to name, place and situation. no acute
signs of distress.
HEENT: NCAT, Pupils equal and reactive, sclerae non-icteric,
MMM, OP clear no erythema. frequent squinting of R eye
Neck: Supple
Lymph nodes: No cervical, supraclavicular or axillary LAD.
CV: S1S2, reg rate and rhythm, no murmurs, rubs or gallops.
RESP: Good air movement bilaterally, no rhonchi or wheezing.
ABD: Soft, non-tender, non-distended, no hepatosplenomegaly
EXTR: No lower leg edema. tingling sensation L foot but no
sensory loss
DERM: No active rash
Neuro: muscle strength grossly full and symmetric in all major
muscle groups
PSYCH: Appropriate and calm. 
 
Pertinent Results:
==================================
              Labs
==================================
___ 11:40AM BLOOD WBC-6.2 RBC-4.22* Hgb-13.3* Hct-40.2 
MCV-95 MCH-31.4 MCHC-33.0 RDW-14.3 Plt ___
___ 06:45AM BLOOD WBC-5.7 RBC-4.17* Hgb-13.3* Hct-39.5* 
MCV-95 MCH-31.8 MCHC-33.5 RDW-14.4 Plt ___
___ 11:40AM BLOOD ___ PTT-29.7 ___
___ 11:40AM BLOOD Glucose-124* UreaN-18 Creat-1.0 Na-137 
K-4.0 Cl-103 HCO3-23 AnGap-15
___ 06:40AM BLOOD Glucose-95 UreaN-14 Creat-1.0 Na-138 
K-3.6 Cl-97 HCO3-33* AnGap-12
___ 06:45AM BLOOD Glucose-109* UreaN-6 Creat-0.9 Na-140 
K-3.5 Cl-99 HCO3-34* AnGap-11
___ 11:40AM BLOOD ALT-16 AST-23 LD(LDH)-277* AlkPhos-79 
TotBili-0.4
___ 06:40AM BLOOD ALT-21 AST-24 AlkPhos-69 TotBili-0.6
___ 06:45AM BLOOD ALT-31 AST-31 AlkPhos-81 TotBili-0.5
___ 11:40AM BLOOD Albumin-4.3 Calcium-9.8 Phos-3.6 Mg-1.8
___:50PM BLOOD mthotrx-2.0
___ 06:45AM BLOOD mthotrx-0.30
___ 06:20PM BLOOD mthotrx-0.09

==================================
            Radiology            
==================================
MRI brain ___
IMPRESSION:  Minimal residual enhancement adjacent to the fourth 
ventricle on
the right, with T2 and FLAIR hyperintensity, consistent with 
post-surgical
changes, stable since the prior examination, with no evidence of 
new lesions
or new areas of abnormal enhancement.  Long-term followup is 
advised to
demonstrate stability.

 
Brief Hospital Course:
___ male with HIV, CAD, CNS lymphoma here for cycle 8 high dose 

methotrexate treatment. MRI after cycle 4 showed residual 
disease, so he continued on 2 week intervals until cycle 7, at 
which point MRI improved so switched to monthly cycles. After 
urinary 
alkalinization, he received methotrexate 16640mg (8g/m2).  
This was followed by leucovorin rescue 24 hours later. His 
methotrexate level on ___ is 0.09. He was discharged 
home in good condition. He has been asked to report back to ___ 
___ in 5 weeks 
for the next cycle (#9). He wants to spend an extra week in ___ 
___ daughter's birthday. 
For his HSV, he has been on acyclovir 800mg BID and will be 
monitored for symptoms. He continued his metoprolol and 
lisinopril at 
12.5mg and 2.5mg respectively with good control of blood 
pressure. On previous admissions his blood pressures have run 
slightly low but he has continued these medications without 
problem. During this admission he had continued double vision, 
which he has had since diagnosis. Overall he thinks it is much 
better, but maybe a little worse in the last month, though he is 
not sure. He will follow up with his eye doctor this week.  

# Dispo: 
[x] Discharge documentation reviewed, pt is stable for 
discharge.
[x] Time spent on discharge activity was greater than 30min.
[ ] Time spent on discharge activity was less than 30min.

# Active meds: See below.

____________________________________
___, MD, pager ___
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acyclovir 800 mg PO Q12H 
2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
3. Fish Oil (Omega 3) 1000 mg PO DAILY 
4. Lisinopril 2.5 mg PO DAILY 
5. Lopinavir-Ritonavir 2 TAB PO BID 
6. Metoprolol Succinate XL 12.5 mg PO DAILY 
7. Pravastatin 40 mg PO DAILY 
8. Aspirin 81 mg PO DAILY 
9. Omeprazole 40 mg PO DAILY 

 
Discharge Medications:
1. Acyclovir 800 mg PO Q12H 
2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
3. Fish Oil (Omega 3) 1000 mg PO DAILY 
4. Lisinopril 2.5 mg PO DAILY 
5. Lopinavir-Ritonavir 2 TAB PO BID 
6. Metoprolol Succinate XL 12.5 mg PO DAILY 
7. Pravastatin 40 mg PO DAILY 
8. Aspirin 81 mg PO DAILY 
9. Omeprazole 40 mg PO DAILY 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
CNS lymphoma

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,
It was a pleasure taking care of you during your stay at ___. You were admitted for treatment of
your brain lymphoma with high dose methotrexate chemotherapy.
You tolerated the chemo very well with no complications. You
should return to ___ in 1 month for your next treatment.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=14047385-DS-14 | hadm_id=27220518

 
Name:  ___     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: NEUROLOGY
 
Allergies: 
Dapsone / methotrexate
 
Attending: ___.
 
Chief Complaint:
Fever and redness of portacath site
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
___ is a ___ man with HIV and CNS lymphoma 
receiving MTX (last cycle ___ s/p portacath insertion ___ 
by ___ and recent NSTEMI while admitted for methotrexate therapy 
presents with pain, redness and warmth at the portacath site. He 
was seen by a doctor in the ___ almost two weeks 
ago and is now on day 5 of clindamycin and day 7 of levoflox 
(prescribed a ___t that time). He notes he had 
fevers and chills prior to presenting to the provider in the ___ 
___ after a day of antibiotics symptoms are improving and 
he has had no further fevers. There is some residual erythema 
and tenderness at the port site but he feels it is dramatically 
improved. He presented to the ED today for further evaluation of 
this issue. Regarding his HIV, last CD4 count in our system was 
___ and was 275. 

ED course:
- Triage   12:58:  Temperature 97.6 F, pulse 87, blood pressure 
118/70, respiration 18 and oxygen saturation is 99% in room air 
On examination, Portacath site noted to be red, swollen and 
tender with extrusion of internal suture.  
- labs: Lactate: 1.2. 
chem 138/3.5; 106/24: ___ <86. 
CBC: 7.6 (64% PMNS) > 38.2 <314. INR 1.1
- interventions: ED resident spoke with Dr. ___ advised 
admission for likely portacath removal. Received clindamycin 
300mg po once and levoflox 500mg po once.

On the floor, patient is comfortable and well-appearing. He 
denies pain at the port site. He denies feeling flushed or 
chills.

REVIEW OF SYSTEMS:
GENERAL: No night sweats, recent weight changes.
HEENT: No sores in the mouth, painful swallowing, intolerance to 
liquids or solids, sinus tenderness, rhinorrhea, or congestion.
CARDS: No chest pain, chest pressure, exertional symptoms, or
palpitations.
PULM: No cough, shortness of breath, hemoptysis, or wheezing.
GI: No nausea, vomiting, constipation or abdominal pain. No 
hematochezia or melena. He does note he has had some diarrhea 
since starting the antibiotics.
GU: No dysuria or change in bladder habits.
MSK: No arthritis, arthralgias, myalgias, or bone pain.
DERM: Denies rashes, itching, or skin breakdown.
NEURO: No headache, visual changes, numbness/tingling, 
paresthesias, or focal neurologic symptoms.
PSYCH: No feelings of depression or anxiety. All other review of 
systems negative.
 
Past Medical History:
PAST ONCOLOGIC HISTORY:
-- ___ - stereotaxic biopsy of the mass by Dr. ___  
-- ___ - started high-dose methotrexate  
-- ___ - C2D1 HD-MTX
-- ___  - C3D1 HD-MTX
-- ___ - C4D1 HD-MTX
-- ___   - C5D1 HD-MTX
-- ___  - C6D1 HD-MTX
-- ___   - C7D1 HD-MTX
-- ___   - C8D1 HD-MTX
-- ___  - C9D1 HD-MTX
-- ___  - C10D1 HD-MTX
-- ___   - C11D1 HD-MTX
 
PAST MEDICAL HISTORY:
-coronary artery disease s/p PCI in ___ and ___
-NSTEMI ___
-HIV
-pancreatitis (possibly from dapsone)
-hypertension,
-hypercholesterolemia
-gastric ulcer
-h/o right-sided ophthalmic shingles as well as shingles in V3
distribution in ___.  
 
Social History:
___
Family History:
Mother - diabetes
Father - glaucoma, prostate cancer
 
Physical Exam:
EXAMINATION ON ADMISSION:
===============================
VITAL SIGNS: Temperature 97.9 F, blood pressure 112/78, pulse 
80, respiration 18 and oxygen saturation 99% in room air
GENERAL:  NAD
HEENT:  MMM, no OP lesions, no cervical, supraclavicular, or 
axillary adenopathy, no thyromegaly
CARDIOVASCULAR:  RR, NL S1S2 no S3S4 MRG
CHEST: mild erythema over the portacath insertion site, but the 
venous access port closer to the neck has an open area of skin 
breakdown and erythema however neither area is painful on 
palpation
PULMONARY:  CTAB
ABDOMEN:  BS+, soft, NTND, no masses or hepatosplenomegaly
LIMBS:  No edema, clubbing, tremors, or asterixis
SKIN:  No rashes

NEUROLOGICAL EXAMINATION:  Cranial nerves II-XII are within 
normal limits excluding visual acuity which was not assessed, no 
nystagmus; strength is ___ of the proximal and distal upper and 
lower extremities; Coordination is intact, no tremor or 
asterixis

EXAMINATION ON DISCHARGE:
================================
VITAL SIGNS: Temperature 98.0 F, blood pressure 108/70, pulse 
81, respiration 18 and oxygen saturation 100% in room air
VITAL SIGNS Range: Tmax=98  BP (108-112/66-78)  HR (65-81)
GENERAL: in no acute distress, pleasant mood
CHEST: mild erythema over the portacath insertion site, no pus 
seen
CARDIOVASCULAR: normal S1/S2, no m/r/g
LUNGS: CTAB
ABDOMEN: soft, BS+, nontender, nondistended
LIMBS:  No edema, clubbing, tremors, or asterixis
SKIN:  No rashes

NEUROLOGICAL EXAMINATION:  No change.  Cranial nerves II-XII are 
within normal limits excluding visual acuity which was not 
assessed, no nystagmus; strength is ___ of the proximal and 
distal upper and lower extremities; Coordination is intact, no 
tremor or asterixis
 
Pertinent Results:
PERTINENT LABS:
=================
___ 08:00AM BLOOD WBC-5.9 RBC-4.12* Hgb-12.6* Hct-38.0* 
MCV-92 MCH-30.6 MCHC-33.2 RDW-13.8 Plt ___
___ 08:00AM BLOOD Glucose-163* UreaN-12 Creat-0.9 Na-140 
K-4.2 Cl-108 HCO3-25 AnGap-11
___ 08:00AM BLOOD Calcium-9.2 Phos-2.4* Mg-1.9

CARDIOLOGY:
=================
ECG (___): Sinus rhythm. Right bundle-branch block. Compared 
to the previous tracing of ___ the rate has increased. The 
Q-T interval has shortened. Otherwise, no diagnostic interim 
change.

MICROBIOLOGY:
=================
- Stool culture (___): 
     - C. difficile DNA amplification assay: negative
     - FECAL CULTURE: NO SALMONELLA OR SHIGELLA FOUND. 
     - CAMPYLOBACTER CULTURE: NO CAMPYLOBACTER FOUND. 
- Blood culture x 2 (___): PENDING
 
Brief Hospital Course:
___ is a ___ man with HIV and CNS lymphoma 
(last treated with MTX ___ presents to ___ 13 days after 
experiencing pain, redness, and warmth at ___ site. His 
last CD4 was 275 in ___. 

(1) Port Infection: 
Patient began experiencing pain/redness/warmth at ___ site 
on ___ while in the ___ - he was seen by a 
doctor there, and then started on clindamycin and levofloxacin. 
Although symptoms had dramatically improved (only residual 
erythema/tenderness left), he presented to ___ ___ to 
receive further evaluation. Upon admission, blood cultures were 
sent (still pending) and he was evaluated by IV nurse and 
medical staff, who found no purulence or evidence of surrounding 
infection/collection at either port site or at location of more 
cranial stitch. The stitch was trimmed down. No evidence on labs 
of infection (afebrile, no HR/BP abnormalities, no 
leukocytosis). He was discharged on the same clindamycin and 
levofloxacin regimen, to be completed on ___.

(2) Antibiotic Associated Diarrhea: 
Patient reported experiencing multiple bouts of loose/liquid 
diarrhea since initiation of antibiotics. He was afebrile, and 
his vital signs/labs showed no evidence of c.diff infection. The 
stool culture, fecal culture, and c. diff assay returned 
negative on ___. The patient's diarrhea is presumed to be 
associated with antibiotic use, and may be treated with 
loperamide in follow-up.

TRANSITIONAL CARE ISSUES:
=====================
- follow-up with Dr. ___ to be scheduled
- manage diarrhea (likely antibiotic-related) with loperamide
- follow-up pending blood cultures
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Clindamycin 600 mg PO Q6H 
2. Levofloxacin 500 mg PO Q24H 
3. Lopinavir-Ritonavir 2 TAB PO BID 
4. Acyclovir 800 mg PO Q8H 
5. Aspirin 81 mg PO DAILY 
6. Lisinopril 5 mg PO DAILY 
7. Metoprolol Succinate XL 12.5 mg PO DAILY 
8. Pantoprazole 40 mg PO Q24H 
9. Atorvastatin 80 mg PO DAILY 
10. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
11. Clopidogrel 75 mg PO DAILY 

 
Discharge Medications:
1. Acyclovir 800 mg PO Q8H 
2. Aspirin 81 mg PO DAILY 
3. Atorvastatin 80 mg PO DAILY 
4. Clopidogrel 75 mg PO DAILY 
5. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
6. Lisinopril 5 mg PO DAILY 
7. Lopinavir-Ritonavir 2 TAB PO BID 
8. Metoprolol Succinate XL 12.5 mg PO DAILY 
9. Pantoprazole 40 mg PO Q24H 
10. Clindamycin 450 mg PO Q6H 
RX *clindamycin HCl 150 mg 3 capsule(s) by mouth every six (6) 
hours Disp #*60 Capsule Refills:*0
11. Levofloxacin 500 mg PO Q24H 
RX *levofloxacin 500 mg 1 tablet(s) by mouth daily Disp #*5 
Tablet Refills:*0
 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Right chest cellulitis associated with port:  Improved
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Dear Mr. ___,

It was a pleasure participating in your care while you were 
inpatient at ___. You were admitted for consideration of port 
removal as you recently had an infection. Your port was 
evaluated, and does not require removal. You will finish your 
antibiotics as scheduled tomorrow (levofloxacin and 
clindamycin). 

You will have a follow-up scheduled with Dr. ___ week. You 
will be contacted with this appointment. Please do not hesitate 
to call his office if you develop fevers, chills, nausea, 
vomiting, diarrhea or other concerning symptoms.

We wish you the best, 
Your ___ team!
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=14047385-DS-8 | hadm_id=27402680

 
Name:  ___     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Dapsone
 
Attending: ___.
 
Chief Complaint:
elective admission for high dose methotrexate
 
Major Surgical or Invasive Procedure:
none

 
History of Present Illness:
___ primarily ___ speaking man with coronary artery disease 

s/p BMS to large OM branch in ___ for inferior STEMI, HIV on 
ART (CD4 275, viral load undetectable in ___, 
high-grade CNS B cell lymphoma (brain stem) s/p brain biopsy, on 
high-dose MTX (started ___ and dexamethasone, presenting 
for cycle 6 of high dose methotrexate. After cycle 4 he had an 
MRI which showed improvement in his disease but some areas of 
residual enhancement. The plan was to continue on 2 week 
intervals until at least cycle 7. 

Of note, the patient was admitted on ___ with anal HSV2 
infection. He was treated with treatment dose acyclovir for 7 
days and continued acyclovir daily for prophylaxis. As an 
outpatient he was found to have breakthrough lesions on 
suppressive acyclovir and his PCP started him on treatment doses 

of valacyclovir 1g BID. 

Today, he reports feeling okay but has had a headache since noon 
yesterday. He rates it ___ but has not taken tylenol or 
ibuprofen, because it is not that bad yet. He has increased 
sensitivity of his R scalp, which has been an ongoing problem 
for many years, since he had shingles. He has a bit of a sore 
throat with some slight pain when swallowing. This started 2 
days ago. he has no runny nose, fevers, or cough. He has no skin 
rash, including herpetic lesions.  He has some tingling in his 
left foot which is stable. His vision he thinks is better 
overall, but says he did have to use his reading glasses on 
___. 

REVIEW OF SYSTEMS:  
(+) Per HPI  
(-) Denies fever, chills, night sweats, recent weight loss or 
gain. Denies headache, rhinorrhea or congestion. Denies chest 
pain, chest 
pressure, or weakness. Denies nausea, vomiting, diarrhea, 
constipation, abdominal pain. Denies dysuria, arthralgias or 
myalgias. Denies rashes or skin changes. All other ROS negative  

 
Past Medical History:
PAST ONCOLOGIC HISTORY:
-- ___ - stereotaxic biopsy of the mass by Dr. ___  
-- ___ - started high-dose methotrexate  
-- ___ - C2D1 HD-MTX
-- ___  - C3D1 HD-MTX
-- ___ - C4D1 HD-MTX
-- ___   - C5D1 HD-MTX
 
PAST MEDICAL HISTORY:
-CNS B-cell Lymphoma
-CAD s/p BMS to large OM branch in ___ - chronically occluded 
LAD collateralized from the right coronary artery
-HIV on ART 
-history of pancreatitis ___ HIV medication
-Hypertension
-Hyperlipidemia
-Gastric ulcer
-anal HSV
-R ophthalmic zoster
 
Social History:
___
Family History:
Family history is notable for father and brother with prostate 
cancer, and 
several paternal aunts with breast cancer and maternal uncles 
with diabetes.
 
Physical Exam:
VS: 98   118/72    84   18    99%RA
GEN: alert, oriented to name, place and situation. no acute 
signs of distress.
HEENT: NCAT, Pupils equal and reactive, sclerae non-icteric, 
MMM, OP clear no erythema
Neck: Supple
Lymph nodes: No cervical, supraclavicular or axillary LAD.
CV: S1S2, reg rate and rhythm, no murmurs, rubs or gallops.
RESP: Good air movement bilaterally, no rhonchi or wheezing.
ABD: Soft, non-tender, non-distended, no hepatosplenomegaly
EXTR: No lower leg edema. tingling sensation L foot but no 
sensory loss
DERM: No active rash
Neuro: muscle strength grossly full and symmetric in all major 
muscle groups
PSYCH: Appropriate and calm.
 
Pertinent Results:
==================================
              Labs
==================================
___ 10:27AM BLOOD WBC-6.3# RBC-3.59* Hgb-11.4* Hct-35.2* 
MCV-98 MCH-31.7 MCHC-32.3 RDW-19.0* Plt ___
___ 07:30AM BLOOD WBC-4.8 RBC-3.30* Hgb-10.4* Hct-32.2* 
MCV-98 MCH-31.4 MCHC-32.2 RDW-18.8* Plt ___
___ 06:00AM BLOOD WBC-4.1 RBC-4.04* Hgb-12.6* Hct-39.7* 
MCV-98 MCH-31.2 MCHC-31.8 RDW-18.1* Plt ___
___ 10:27AM BLOOD Glucose-124* UreaN-14 Creat-0.9 Na-135 
K-3.7 Cl-100 HCO3-26 AnGap-13
___ 07:30AM BLOOD Glucose-98 UreaN-12 Creat-0.9 Na-135 
K-3.8 Cl-97 HCO3-33* AnGap-9
___ 06:00AM BLOOD Glucose-156* UreaN-9 Creat-0.8 Na-137 
K-4.2 Cl-96 HCO3-31 AnGap-14
___ 10:27AM BLOOD ALT-23 AST-17 LD(LDH)-239 AlkPhos-74 
TotBili-0.9
___ 07:30AM BLOOD ALT-24 AST-19 AlkPhos-72 TotBili-0.7
___ 06:00AM BLOOD ALT-37 AST-30 AlkPhos-83 TotBili-0.7
___ 10:27AM BLOOD Calcium-8.7 Phos-4.0 Mg-1.6
___ 05:10PM BLOOD mthotrx-1.6
___ 06:00AM BLOOD mthotrx-0.25
___ 05:35PM BLOOD mthotrx-0.09

==================================
            Radiology            
==================================

MRI head ___
FINDINGS:
 
There has been interval removal of a right frontal external 
ventricular drain
with some areas of blooming susceptibility along the tract 
likely related to
residual blood products. The patient is status post biopsy of a 
___
ventricular mass through a right suboccipital approach with 
associated mild T1
intrinsic hyperintensity and blooming susceptibility within the 
right aspect
of the ___ ventricle likely related to residual blood products. 
The
previously noted enhancing mass within the ___ ventricle is no 
longer
identified; there is some mild residual enhancement and adjacent 


parenchymal
high T2/FLAIR hyperintensity.
 
There is no evidence of acute intracranial infarct or 
hemorrhage. There are
nonspecific small scattered T2/FLAIR high signal foci throughout 


the brain.
Gray white matter differentiation is otherwise maintained. 
Ventricles and
extra axial spaces are also otherwise within normal limits for 
age. The major
intracranial vessels exhibit the expected signal void related to 


vascular
flow.
 
The paranasal sinuses demonstrate scattered areas of mucosal 
thickening.
Fluid signal and inflammatory changes are noted within scattered 


right greater
than left mastoid air cells. The sella turcica, craniocervical 
junction, and
orbits are unremarkable.
 
IMPRESSION:
 
Previously identified enhancing ___ ventricular mass is no 
longer present;
however, there is some mild residual enhancement and adjacent 
parenchymal high
T2/FLAIR hyperintensity abbout the right aspect of the ___ 
ventricle. 

 
Brief Hospital Course:
___ male with HIV, CAD, CNS lymphoma here for cycle 6 high dose 
methotrexate treatment. MRI after cycle 4 showed residual 
disease, so plan was to increase dose to 8g/m2 and continue 
every 2 weeks until cycle 7, then reassess. After urinary 
alkalinization, he received 16560mg methotrexate on ___.  
This was 
followed by leucovorin rescue 24 hours later. His methotrexate 
level on ___ is 0.09 and he will be discharged home in good 
condition. He will continue on biweekly methotrexate for 1 more 
cycle and has been asked to report back to ___ on ___ for 
the next cycle (#7). after cycle 7 he will have another MRI to 
assess response.
For his HSV, he has been on acyclovir 800mg BID and will be 
monitored for symptoms. His blood pressure was slightly low 
while here but he continued his metoprolol and lisinopril at 
12.5mg and 2.5mg respectively with no symptoms of hypotension. 

# Dispo: 
[x] Discharge documentation reviewed, pt is stable for 
discharge.
[x] Time spent on discharge activity was greater than 30min.
[ ] Time spent on discharge activity was less than 30min.

# Active meds: See below.

____________________________________
___, MD, pager ___

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Dexamethasone 0.5 mg PO DAILY 
2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
3. Fish Oil (Omega 3) 1000 mg PO DAILY 
4. Lisinopril 2.5 mg PO DAILY 
5. Lopinavir-Ritonavir 2 TAB PO BID 
6. Metoprolol Succinate XL 12.5 mg PO DAILY 
7. Pravastatin 40 mg PO DAILY 
8. Acyclovir 800 mg PO Q12H 
9. Aspirin 81 mg PO DAILY 
10. Omeprazole 40 mg PO DAILY 

 
Discharge Medications:
1. Acyclovir 800 mg PO Q12H 
2. Dexamethasone 0.5 mg PO EVERY OTHER DAY 
3. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
4. Fish Oil (Omega 3) 1000 mg PO DAILY 
5. Lisinopril 2.5 mg PO DAILY 
6. Lopinavir-Ritonavir 2 TAB PO BID 
7. Metoprolol Succinate XL 12.5 mg PO DAILY 
8. Pravastatin 40 mg PO DAILY 
9. Aspirin 81 mg PO DAILY 
10. Omeprazole 40 mg PO DAILY 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
CNS lymphoma

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,
It was a pleasure taking care of you during your stay at ___ 
___. You were admitted for treatment of 
your brain lymphoma with high dose methotrexate chemotherapy. 
You tolerated the chemo very well with no complications. You 
should return to 11 ___ in 2 weeks for your next treatment.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=14047385-DS-6 | hadm_id=27550223

 
Name:  ___     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Dapsone
 
Attending: ___.
 
Chief Complaint:
elective admission for high dose methotrexate
 
Major Surgical or Invasive Procedure:
none
 
History of Present Illness:
___ primarily ___ speaking man with coronary artery disease 
s/p BMS to large OM branch in ___ for inferior STEMI, HIV on 
ART (CD4 275, viral load undetectable in ___, recently 
diagnosed high-grade CNS B cell lymphoma (brain stem) s/p brain 
biopsy, on high-dose MTX (started 
___ and dexamethasone, presenting for cycle 4 of high dose 

methotrexate.

Of note, the patient was admitted on ___ with anal HSV2 
infection. He was treated with treatment dose acyclovir for 7 
days and continued acyclovir daily for prophylaxis. As an 
outpatient his PCP was concerned about breakthrough on 
suppressive acyclovir and started him on treatment doses of 
valacyclovir 1g BID. 

Today he feels well but says last week he had several sleepless 
nights. tried trazadone but made him dizzy. tried AMbien, didn't 
work. He had a terrible headache so went to ___ for 
evaluation and had a head CT which showed post surgical changes 
but no other concerning findings. He subsequently slept well and 
the headache improved. His vision is improving but not back to 
normal. He has stable gait imbalance. He denies any new 
neurologic symptoms. 

REVIEW OF SYSTEMS:  
(+) Per HPI  
(-) Denies fever, chills, night sweats, recent weight loss or 
gain. Denies headache, rhinorrhea or congestion. Denies cough, 
shortness of breath, or wheezing. Denies chest pain, chest 
pressure, or weakness. Denies nausea, vomiting, diarrhea, 
constipation, abdominal pain. Denies dysuria, arthralgias or 
myalgias. Denies rashes or skin changes. All other ROS negative  

 
Past Medical History:
PAST ONCOLOGIC HISTORY:
-- ___ - stereotaxic biopsy of the mass by Dr. ___  
-- ___ - started high-dose methotrexate  
-- ___ - C2D1 HD-MTX
-- ___  - C3D1 HD-MTX

PAST MEDICAL HISTORY:
-CNS B-cell Lymphoma
-CAD s/p BMS to large OM branch in ___ - chronically occluded 
LAD collateralized from the right coronary artery
-HIV on ART 
-history of pancreatitis ___ HIV medication
-Hypertension
-Hyperlipidemia
-Gastric ulcer
 
Social History:
___
Family History:
Family history is notable for father and brother with prostate 
cancer, and 
several paternal aunts with breast cancer and maternal uncles 
with diabetes.
 
Physical Exam:
Physical Examination:
VS: 98.5   112/69    79   18    98%RA
GEN: Alert, oriented to name, place and situation. no acute 
signs of distress.
HEENT: NCAT, Pupils equal and reactive, sclerae non-icteric, 
MMM.
Neck: Supple
Lymph nodes: No cervical, supraclavicular or axillary LAD.
CV: S1S2, reg rate and rhythm, no murmurs, rubs or gallops.
RESP: Good air movement bilaterally, no rhonchi or wheezing.
ABD: Soft, non-tender, non-distended, no hepatosplenomegaly
EXTR: No lower leg edema. tingling sensation L foot but no 
sensory loss
DERM: No active rash
Neuro: muscle strength grossly full and symmetric in all major 
muscle groups
PSYCH: Appropriate and calm.

 
Pertinent Results:
==================================
              Labs
==================================
___ 12:11PM BLOOD WBC-4.6# RBC-4.07* Hgb-12.5* Hct-36.6* 
MCV-90 MCH-30.8 MCHC-34.2 RDW-18.1* Plt ___
___ 05:30AM BLOOD WBC-2.6* RBC-3.81* Hgb-11.5* Hct-35.9* 
MCV-94 MCH-30.2 MCHC-32.1 RDW-18.6* Plt ___
___ 12:11PM BLOOD ___ PTT-26.7 ___
___ 12:11PM BLOOD Glucose-134* UreaN-19 Creat-0.7 Na-135 
K-4.4 Cl-100 HCO3-26 AnGap-13
___ 05:30AM BLOOD Glucose-117* UreaN-17 Creat-0.7 Na-138 
K-4.2 Cl-99 HCO3-31 AnGap-12
___ 12:11PM BLOOD ALT-33 AST-20 LD(LDH)-302* AlkPhos-77 
TotBili-0.6
___ 05:30AM BLOOD ALT-32 AST-18 AlkPhos-67 TotBili-0.8
___ 12:11PM BLOOD Albumin-4.1 Calcium-8.9 Phos-3.7 Mg-2.0
___ 05:05AM BLOOD Calcium-8.5 Phos-3.3 Mg-1.9
___ 05:05AM BLOOD mthotrx-0.29
___ 05:30AM BLOOD mthotrx-0.08

==================================
            Radiology            
==================================

MRI head ___ prelim report
FINDINGS:
 
There has been interval removal of a right frontal external 
ventricular drain
with some areas of blooming susceptibility along the tract 
likely related to
residual blood products. The patient is status post biopsy of a 
___
ventricular mass through a right suboccipital approach with 
associated mild T1
intrinsic hyperintensity and blooming susceptibility within the 
right aspect
of the ___ ventricle likely related to residual blood products. 
The
previously noted enhancing mass within the ___ ventricle is no 
longer
identified; there is some mild residual enhancement and adjacent 
parenchymal
high T2/FLAIR hyperintensity.
 
There is no evidence of acute intracranial infarct or 
hemorrhage. There are
nonspecific small scattered T2/FLAIR high signal foci throughout 
the brain.
Gray white matter differentiation is otherwise maintained. 
Ventricles and
extra axial spaces are also otherwise within normal limits for 
age. The major
intracranial vessels exhibit the expected signal void related to 
vascular
flow.
 
The paranasal sinuses demonstrate scattered areas of mucosal 
thickening.
Fluid signal and inflammatory changes are noted within scattered 
right greater
than left mastoid air cells. The sella turcica, craniocervical 
junction, and
orbits are unremarkable.
 
IMPRESSION:
 
Previously identified enhancing ___ ventricular mass is no 
longer present;
however, there is some mild residual enhancement and adjacent 
parenchymal high
T2/FLAIR hyperintensity abbout the right aspect of the ___ 
ventricle. 
 
Brief Hospital Course:
___ male with HIV, CAD, CNS lymphoma here for cycle 4 high dose 
methotrexate treatment. After urinary alkalinization, he 
received 6g/m2 = 12240mg of methotrexate on ___. This was 
followed by leucovorin rescue 24 hours later. His methotrexate 
level on ___ is 0.08 and he will be discharged home in good 
condition. He had an MRI while here which showed good response 
but one area of residual disease. He will continue on biweekly 
methotrexate and has been asked to report back to ___ on 
___ for the next cycle. 
For his HIV, HSV, CAD, and hypertension he was continued on his 
home meds as detailed below. 

# Dispo: 
[x] Discharge documentation reviewed, pt is stable for 
discharge.
[x] Time spent on discharge activity was greater than 30min.
[ ] Time spent on discharge activity was less than 30min.

# Active meds: See below.

____________________________________
___, MD, pager ___
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acyclovir 400 mg PO Q12H 
2. Dexamethasone 1 mg PO DAILY 
3. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
4. Fish Oil (Omega 3) 1000 mg PO DAILY 
5. Lisinopril 2.5 mg PO DAILY 
6. Lopinavir-Ritonavir 2 TAB PO BID 
7. Pravastatin 40 mg PO DAILY 
8. Aspirin 81 mg PO DAILY 
9. Omeprazole 40 mg PO DAILY 
10. Metoprolol Succinate XL 12.5 mg PO DAILY 
11. ValACYclovir 1000 mg PO Q12H 

 
Discharge Medications:
1. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
2. Fish Oil (Omega 3) 1000 mg PO DAILY 
3. Lisinopril 5 mg PO DAILY 
4. Lopinavir-Ritonavir 2 TAB PO BID 
5. Metoprolol Succinate XL 25 mg PO DAILY 
6. Pravastatin 40 mg PO DAILY 
7. ValACYclovir 1000 mg PO Q12H 
8. Aspirin 81 mg PO DAILY 
9. Omeprazole 40 mg PO DAILY 
10. Dexamethasone 1 mg PO DAILY 

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
CNS lymphoma
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Dear Mr. ___,
It was a pleasure taking care of you during your stay at ___ 
___. You were admitted for treatment of 
your brain lymphoma with high dose methotrexate chemotherapy. 
You tolerated the chemo very well with no complications. You 
should return to ___ in 2 weeks for your next treatment.
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=14047385-DS-19 | hadm_id=28096192

 
Name:  ___     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: MEDICINE
 
Allergies: 
Dapsone / methotrexate
 
Attending: ___.
 
Chief Complaint:
Admission for HD MTX

 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
___ is a ___ year old man with HIV on HAART and CNS
lymphoma on maintenance HD-MTX who is admitted for planned
chemotherapy.

Patient's most recent HD-MTX was over a year ago on ___. He
has been planning q12 month cycles. Of note, in the interim he
was noted to have Kaposi's sarcoma lesion on his penis. Staging
scans showed no visceral involvement, and lesion has since
resolved. He was seen by Dr. ___. 

CT scan was notable for femoral head avascular necrosis and
thyroid nodules. He has undergone MRI of pelvis/hip x2 and FNA 
of
thyroid x2 for further evaluation with no specific findings to
date

He otherwise feels well. He denies fevers or chills. He gets
intermittent headaches a few times a month. No visual changes. 
No
recent cold symptoms. No cough, shortness of breath or chest
pain. No N/V/D. No dysuria. No new leg pain or swelling. He does
note a small pustule behind his right ear and a few scattered
over his chest and back. No fevers, no erythema or tenderness, 
no
fluctuant masses. Also notes intermittent right hip pain over 
the
last few months. No other complaints.

REVIEW OF SYSTEMS: 
A complete 10-point review of systems was performed and was
negative unless otherwise noted in the HPI.
 
Past Medical History:
PAST ONCOLOGIC HISTORY:
His neurological problem began at the end of ___ when
he experienced imbalance and blurry vision.  Initially, his gait
imbalance was intermittent, mostly occuring after eating and
lasting for a couple of hours.  However, it progressed to a
constant fashion.  He also developed blurry vision and he had to
close one eye in order to see clearly.  On ___, his
imbalance was severe enough that his brother, ___, took him to ___.  He had a head
CT that showed a mass at the brainstem.  He was referred to see
Dr. ___ on ___ who admitted him to the
Neurosurgery Service.  A gadolinium-enhanced head MRI on 
___
showed a homogeneously enhancing mass at the lateral recess on
the right side of the fourth ventricle.  He then underwent a
stereotaxic biopsy of the mass by Dr. ___ on
___.  After biopsy he remains neurologically stable.  He
then started high-dose methotrexate on ___.
(1) stereotaxic biopsy of the mass by Dr. ___ on
___,
(2) an echocardiogram that was performed on ___ showing
apical hypokinesis but his ejection fraction remained at 55%,
(3) started high-dose methotrexate on ___ and had 5
induction cycles so far,
(4) started re-induction high-dose methtorexate on ___ and
had 3 cycles,
(5) started monthly maintenance high-dose methotrexate on
___ and had 4 cycles,
(6) started every 2-month maintenance high-dose methotrexate on
___ and had 3 cycles,
(7) gadolinium-enhanced head MRI from ___ showed no 
evidence
of active disease, 
(8) started every 3-month maintenance high-dose methotrexate on
___ and had 1 cycle,
(9) saw dermatology for penile lesion on ___ and biopsy
showed Kaposi sarcoma, and
(10) gadolinium-enhanced head MRI from ___ showed no
evidence of active disease.
(11) ___ HD-MTX 8g/m2 (planned)

 
PAST MEDICAL HISTORY: 
- HIV on HAART
- Kaposi sarcoma - solitary penile lesion, ___
- CNS lymphoma as above
- Right-sided opthalmic/V3 shingles
- Bilateral femoral head avascular necrosis 
- Thyroid nodule
- CAD/MI - Stent placed ___ NSTEMI ___ during HD-MTX
admission, DES to RCA and LAD
- Pancreatitis
- HTN
- HLD
- Hx of gastric ulcer
 
Social History:
___
Family History:
His parents are alive; his mother has pre-diabetes while his 
father has glaucoma and prostate cancer.  He has 6 brothers, one 

of the, has kidney problem.  He has 3 daughters and they are all 

healthy.    
 
Physical Exam:
ADMISSION PHYSICAL EXAM:  
VS: T 98.3 HR 74 BP 123/76 RR  SAT  96% O2 on RA
GENERAL: Pleasant, lying in bed comfortably
EYES: Anicteric sclerea, PERLL, EOMI; 
ENT: Oropharynx clear without lesion, JVD not elevated 
CARDIOVASCULAR: Regular rate and rhythm, no murmurs, rubs, or
gallops; 2+ radial pulses
RESPIRATORY: Appears in no respiratory distress, clear to
auscultation bilaterally, no crackles, wheezes, or rhonchi
GASTROINTESTINAL: Normal bowel sounds; nondistended; soft,
nontender without rebound or guarding; no hepatomegaly, no
splenomegaly
MUSKULOSKELATAL: Warm, well perfused extremities without lower
extremity edema; Normal bulk 
NEURO: Alert, oriented, CN II-XII intact, motor and sensory
function grossly intact
SKIN: 1mm pustule behind right ear without surrounding erythema,
drainage, or fluctuance. Similar scattered lesions associated
with hair folliciles over chest and back. 
LYMPHATIC: No cervical, supraclavicular, submandibular
lymphadenopathy. No significant ecchymoses

DISCHARGE PHYSICAL EXAM:  
VS: T 97.8 BP 118/73 HR 54 RR 20 O2 97%RA
GENERAL: Pleasant, sitting up in chair comfortably
EYES: Anicteric sclerea, PERLL, EOMI; 
ENT: Oropharynx clear without lesion, JVD not elevated 
CARDIOVASCULAR: Regular rate and rhythm, no murmurs, rubs, or
gallops; 2+ radial pulses
RESPIRATORY: Appears in no respiratory distress, clear to
auscultation bilaterally, no crackles, wheezes, or rhonchi
GASTROINTESTINAL: Normal bowel sounds; nondistended; soft,
nontender without rebound or guarding; no hepatomegaly, no
splenomegaly
MUSKULOSKELATAL: Warm, well perfused extremities without lower
extremity edema; Normal bulk 
NEURO: Alert, oriented, motor and sensory function grossly 
intact
SKIN: 1mm nodule behind right ear without surrounding erythema,
drainage, or fluctuance. 
 
Pertinent Results:
ADMISSION LABS:
===============

___ 11:33AM BLOOD WBC-4.4 RBC-5.10 Hgb-15.5 Hct-45.8 MCV-90 
MCH-30.4 MCHC-33.8 RDW-12.4 RDWSD-40.7 Plt ___
___ 11:33AM BLOOD ___ PTT-30.4 ___
___ 11:33AM BLOOD Glucose-95 UreaN-20 Creat-1.0 Na-138 
K-4.1 Cl-104 HCO3-22 AnGap-16
___ 11:33AM BLOOD ALT-35 AST-27 LD(LDH)-179 AlkPhos-55 
TotBili-0.4
___ 11:33AM BLOOD Albumin-4.2 Calcium-9.3 Phos-3.4 Mg-1.9

DISCHARGE LABS:
===============

___ 04:49AM BLOOD WBC-6.0 RBC-4.88 Hgb-14.8 Hct-43.5 MCV-89 
MCH-30.3 MCHC-34.0 RDW-12.5 RDWSD-41.0 Plt ___
___ 04:49AM BLOOD Glucose-166* UreaN-11 Creat-0.9 Na-138 
K-3.6 Cl-101 HCO3-25 AnGap-16
___ 04:49AM BLOOD ALT-152* AST-58* LD(LDH)-191 AlkPhos-52 
TotBili-0.4
___ 04:49AM BLOOD Calcium-8.6 Phos-2.7 Mg-2.2

MTX TREND:
==========

___ 11:35PM BLOOD mthotrx-2.7
___ 11:09PM BLOOD mthotrx-0.18
___ 05:43PM BLOOD mthotrx-0.07

URINE:
======

___ 11:27AM URINE Color-Yellow Appear-Clear Sp ___
___ 11:27AM URINE Blood-NEG Nitrite-NEG Protein-TR 
Glucose-NEG Ketone-NEG Bilirub-NEG Urobiln-4* pH-8.0 Leuks-MOD

MICRO:
======
___ CULTURE (Final ___:    < 10,000 CFU/mL.L
 
Brief Hospital Course:
PRINCIPLE REASON FOR ADMISSION:
___ is a ___ year old man with HIV on HAART and CNS 
lymphoma on maintenance HD-MTX who is admitted for planned 
chemotherapy.

# CNS lymphoma: Most recent imaging shows no evidence of
recurrence. Per patient request has been placed on q12 month
schedule, although this cycle was delayed due to scheduling and
concurrent medical issues. Urine was alkalinzed with IV and po 
sodium bicarbonate per protocol. He tolerated infusion of 8g/m2 
on ___ with some
mild pruritis, which has been pretty consistent per patients
prior episodes. Leucovorin rescue per protocol and monitored MTX 
level q24 hours until <0.1. Tolerated treatment well without 
signficant side effects aside from mild transaminitis which 
persisted on discharge. He should have this monitored to ensure 
normalization of his LFT's. He will follow up in 12 months for 
his next HD-MTX with clinic visit with Dr. ___ and 
repeat MRI.

# POC: Medial lumen of POC malfuncitoning. Needs stripping. 
Emailed IV access team to alert them for outpatient management.

# Dysuria: Developed single episode of dysuria day prior to 
discharge. UA did have white cells and bacteria. We empirically 
treated with cipro 500 bid x10 days (through ___. Urine 
culture with <10K CFU. He should follow up with his primary care 
doctor to ensure resolution of his dysuria/pyuria.

# Folliculitis: Scattered simple folliculitis on admission exam. 
Could consider mollascum given HIV status, but  lesions appear 
to be more c/w simple folliculitis. No signs of systemic 
infection or even surrounding cellulitis or deeper skin 
infection. Stable.

# HIV: Well controlled, followed at ___. Continued home 
Stribild.

# Kaposi's sarcoma - Single isolated lesion, now resolved prior 
to admission. No evidence of visceral involvement.

# CAD: Takes single agent ASA at home. We held ASA in the 
setting of MTX and substituted plavix instead. We resumed ASA on 
discharge. We also held his statin. We continued metoprolol. 

# HTN: Continued home metoprolol and lisinopril 

# Thyroid nodules: Followed as outpatient. Cytology negative; 
final path pending. Plan for outpatient follow up as previously 
planned

# GERD
# Hx of gastric ulcer: Held home pantoprazole in setting of MTX. 
Substituted ranitidine

# Billing: >30 minutes spent coordinating and executing this 
discharge plan

TRANSITIONAL ISSUES:
====================
- Complete Cipro on ___ am
- Repeat UA after completing antibioitics
- ___ needs to set up stripping of his medial lumen of port
- ___ in one year with Dr. ___ in clinic and with MRI

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Metoprolol Succinate XL 25 mg PO DAILY 
2. Stribild (elvitegr-cobicist-emtric-tenof) ___ mg 
oral qd 
3. Aspirin 81 mg PO DAILY 
4. Atorvastatin 80 mg PO DAILY 
5. Fish Oil (Omega 3) 1000 mg PO DAILY 
6. Lisinopril 5 mg PO DAILY 
7. Pantoprazole 40 mg PO Q24H 
8. Pravastatin 80 mg PO QPM 
9. Vitamin D 1000 UNIT PO DAILY 
10. Cyanocobalamin 1000 mcg PO DAILY 
11. Centrum Silver Ultra Mens (multivit-min-FA-lycopen-lutein) 
___ mcg oral DAILY 

 
Discharge Medications:
1.  Ciprofloxacin HCl 500 mg PO Q12H Duration: 10 Days 
RX *ciprofloxacin HCl 500 mg 1 tablet(s) by mouth twice a day 
Disp #*9 Tablet Refills:*0 
2.  Aspirin 81 mg PO DAILY  
3.  Atorvastatin 80 mg PO DAILY  
4.  Centrum Silver Ultra Mens (multivit-min-FA-lycopen-lutein) 
___ mcg oral DAILY  
5.  Cyanocobalamin 1000 mcg PO DAILY  
6.  Fish Oil (Omega 3) 1000 mg PO DAILY  
7.  Lisinopril 5 mg PO DAILY  
8.  Metoprolol Succinate XL 25 mg PO DAILY  
9.  Pantoprazole 40 mg PO Q24H  
10.  Pravastatin 80 mg PO QPM  
11.  Stribild (elvitegr-cobicist-emtric-tenof) ___ 
mg oral qd  
12.  Vitamin D 1000 UNIT PO DAILY  

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
# CNS Lymphoma
# Urinary tract infection

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Mr. ___,

It was a pleasure taking care of you at ___ 
___. You were admitted for your scheduled HD-MTX 
chemotherapy. You tolerated the infusion well. You did have some 
pain with urination, and we started you on an antibiotic. Please 
take this twice a day throughout the morning of ___. You will 
also need to follow up with the interventional radiology 
department to fix your port. You should hear from them in the 
next few days to schedule this. If you do not hear from them, 
please call Dr. ___ office at ___ to help schedule 
this. Your next HD-MTX is tentatively scheduled for one year on 
___. You will follow up with Dr. ___ in clinic and with 
an MRI before this visit. It has been a pleasure taking care of 
you.

Sincerely, 
Your ___ Care Team
 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=14047385-DS-21 | hadm_id=29559033

 
Name:  ___     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: SURGERY
 
Allergies: 
Dapsone / methotrexate
 
Attending: ___.
 
Chief Complaint:
multinodular goiter causing dysphagia
 
Major Surgical or Invasive Procedure:
total thyroidectomy
 
History of Present Illness:
This patient presented with a large multinodular toxic goiter.

 
Past Medical History:
- HIV on HAART (viral load undetectable)
- CAD
- HTN
- MI s/p stent placement x 3 (___)
- CNS lymphoma (dx ___, on chemotherapy, no neuro deficits)

 
Social History:
___
Family History:
His parents are alive; his mother has pre-diabetes while his 
father has glaucoma and prostate cancer.  He has 6 brothers, one 

of the, has kidney problem.  He has 3 daughters and they are all 

healthy.    
 
Physical Exam:
Gen: NAD, AOx3
HEENT: neck incision clean/dry/intact, without evidence of 
hematoma, steri strips in place
Chest: no labored breathing
Ext: warm, well perfused
Neuro: Sensation grossly intact, moving all extremities equally

 
Pertinent Results:
___ 09:11AM BLOOD Calcium-9.2

 
Brief Hospital Course:
Mr. ___ presented to ___ holding at ___ on ___ 
for a total thyroidectomy, for multinodular goiter causing 
dysphagia. He tolerated the procedure well without complications 
(Please see operative note for further details). After an 
uneventful stay in the PACU, the patient was transferred to the 
floor for further post-operative management.

Neuro: Patient takes tramadol at home at baseline. In the 
hospital, pain was well controlled on Tylenol. 
CV: The patient remained stable from a cardiovascular 
standpoint; vital signs were routinely monitored.
Pulm: The patient remained stable from a pulmonary standpoint; 
oxygen saturation was routinely monitored. Had good pulmonary 
toileting, as early ambulation and incentive spirometry were 
encouraged throughout hospitalization.
GI: The patient was started on a regular diet post operatively, 
which and tolerated well. Patient's intake and output were 
closely monitored.
GU: At time of discharge, the patient was voiding without 
difficulty.
ID: Patient has a history of HIV on HAART. His medications were 
continued while in the hospital. 
Endocrine:POD #1 Calcium level 9.2. 
Wound: surgical site without evidence of hematoma or infection.
On POD#1, the patient was discharged to home. At discharge, he 
was tolerating a regular diet, passing flatus, voiding, and 
ambulating independently. He will follow-up in the clinic with 
Dr. ___ in 4 weeks. This information was communicated to 
the patient directly prior to discharge.

 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever 
2. Lisinopril 5 mg PO DAILY 
3. Fish Oil (Omega 3) 1000 mg PO TID 
4. Metoprolol Succinate XL 25 mg PO DAILY 
5. Ranitidine 150 mg PO DAILY 
6. Elvitegravir/Cobicistat/Emtricitabine/Tenofov ___ 
mg Other DAILY 
7. Pravastatin 80 mg PO QPM 
8. Acyclovir 800 mg PO BID 
9. TraMADol 50 mg PO Q8H:PRN Pain - Moderate 
10. Ibuprofen 600 mg PO Q6H:PRN Pain - Mild 
11. Pantoprazole 40 mg PO DAILY 
12. Aspirin 81 mg PO DAILY 
13. Cyanocobalamin 1000 mcg PO DAILY 
14. Vitamin D 1000 UNIT PO DAILY 

 
Discharge Medications:
1.  Levothyroxine Sodium 150 mcg PO DAILY 
RX *levothyroxine 150 mcg 1 tablet(s) by mouth once a day Disp 
#*30 Tablet Refills:*3 
2.  Acetaminophen 650 mg PO Q6H:PRN Pain - Mild/Fever  
3.  Acyclovir 800 mg PO BID  
4.  Aspirin 81 mg PO DAILY  
5.  Cyanocobalamin 1000 mcg PO DAILY  
6.  Ibuprofen 600 mg PO Q6H:PRN Pain - Mild  
7.  Lisinopril 5 mg PO DAILY  
8.  Metoprolol Succinate XL 25 mg PO DAILY  
9.  Pantoprazole 40 mg PO DAILY  
10.  Pravastatin 80 mg PO QPM  
11.  Ranitidine 150 mg PO DAILY  
12.  Stribild 1 tab Other DAILY  
13.  Stribild ___ mg Other DAILY  
14.  TraMADol 50 mg PO Q8H:PRN Pain - Moderate  
15.  Vitamin D 1000 UNIT PO DAILY  
16. HELD- Fish Oil (Omega 3) 1000 mg PO TID  This medication was 
held. Do not restart Fish Oil (Omega 3) until follow-up 
appointment.

 
Discharge Disposition:
Home
 
Discharge Diagnosis:
Toxic multinodular goiter (partial substernal).

 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Mr. ___,
You were admitted to the inpatient general surgery unit after 
your total thyroidectomy. You have adequate pain control and 
have tolerated a regular diet and may return home to continue 
your recovery. 
You will be discharged home on thyroid hormone replacement and 
calcium supplement, please take as prescribed. Monitor for 
symptoms of low Calcium such as numbness or tingling around 
mouth/fingertips or muscle cramps in your legs. If you 
experience any of these symptoms please call Dr. ___ 
___ for advice or if you have severe symptoms go to the 
emergency room. 
Please resume all regular home medications, unless specifically 
advised not to take a particular medication and take any new 
medications as prescribed. You may take acetaminophen 
(Tylenol)and or ibuprofen(Motrin). Please get plenty of rest, 
continue to walk several times per day, and drink adequate 
amounts of fluids. 
Please call your surgeon or go to the emergency department if 
you have increased pain, swelling, redness, or drainage from the 
incision site. You may shower and wash incisions with a mild 
soap and warm water. Avoid swimming and baths until cleared by 
your surgeon. Gently pat the area dry. You have a neck incision 
with steri-strips in place, do not remove, they will fall off on 
their own.
Best Wishes,
Your ___ Care Team

 
Followup Instructions:
___


-----
===== DISCHARGE NOTE =====
note_id=14047385-DS-5 | hadm_id=29955200

 
Name:  ___     Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   M
 
Service: NEUROLOGY
 
Allergies: 
Dapsone
 
Attending: ___.
 
Chief Complaint:
Scheduled cycle 3 high-dose methotrexate
 
Major Surgical or Invasive Procedure:
None
 
History of Present Illness:
Primary Oncologist: ___  
Primary Care Physician: ___ MD  
 
CC: Cycle 3 high dose methotrexate 
 
HPI:  
___ is a ___ ___ speaking man with 
coronary artery disease s/p BMS to large OM branch in ___ for 
inferior STEMI, HIV on ART (CD4 275, viral load undetectable in 
___, recently diagnosed high-grade CNS B cell lymphoma 
(brain stem) s/p brain biopsy, on high-dose MTX (started 
___ and dexamethasone, presenting for cycle 3 of high dose 
methotrexate.

The patient was admitted from ___ for cycle 2 of 
high dose methotrexate. He tolerated the treatment well. When 
the patient was admitted he was noted to be hyponatremic to 129; 
this corrected with control of serum glucose and administration 
of IVFs. He was also noted to have a serum lactate of 6, which 
trended down to 3. This was attributed potentially to his ART.

Of note, the patient was admitted on ___ with anal HSV2 
infection. He was treated with treatment dose acyclovir for 7 
days and continued acyclovir daily for prophylaxis.

Today the patient feels well, his only symptom is occasional 
mild double vision, which is longstanding and has been improving 
with chemo. VS: temperature 97.7 F, blood pressure 114/70, pulse 
93, respiration 20 and oxygen saturation 96% in room air. He 
tolerated the past two cycles of methotrexate well with no 
symptoms.    

Review of Systems:  
(+) Per HPI  
(-) Denies fever, chills, night sweats, recent weight loss or 
gain. Denies blurry vision, diplopia, loss of vision, 
photophobia. Denies headache, sinus tenderness, rhinorrhea or 
congestion. Denies chest pain or tightness, palpitations, lower 
extremity edema. Denies cough, shortness of breath, or wheezes. 
Denies nausea, vomiting, diarrhea, constipation, abdominal pain, 
melena, hematemesis, hematochezia. Denies dysuria, stool or 
urine incontinence. Denies arthralgias or myalgias. Denies 
rashes or skin breakdown. No numbness/tingling in extremities. 
All other systems negative.
 
Past Medical History:
PAST ONCOLOGIC HISTORY:
-- ___ - stereotaxic biopsy of the mass by Dr. ___  
-- ___ - started high-dose methotrexate  
-- ___ - C2D1 HD-MTX

PAST MEDICAL HISTORY:
-CNS B-cell Lymphoma
-CAD s/p BMS to large OM branch in ___ - chronically occluded 
LAD collateralized from the right coronary artery
-HIV on ART 
-history of pancreatitis ___ HIV medication
-Hypertension
-Hyperlipidemia
-Gastric ulcer
 
Social History:
___
Family History:
Family history is notable for father and brother with prostate 
cancer, and 
several paternal aunts with breast cancer and maternal uncles 
with diabetes.
 
Physical Exam:
ADMISSION PHYSICAL EXAMINATION:  
Vital Signs: Temperature 97.7 F, blood pressure 114/70, pulse 
93, respiration 20 and oxygen saturation 96% in room air
General: Alert, oriented, comfortable, Cushingoid appearance
HEENT: EOMI without nystagmus; pupils round, equal, nonreactive; 
Mucous membranes moist, oropharynx clear without 
erythema/exudate  
Neck: Supple, without lymphadenopathy  
Cardiovascular:  RRR, S1 S2, no MRG
Lungs: CTAB with some bibasilar crackles
Abdomen: +BS, soft, nontender, not distended
Extremities:   Warm, well-perfused, no edema, DP pulses 2+ b/l

Neurological Examination: Alert, oriented, good historian, 
occasional double vision but EOMI, ___ strength in UE and ___ 
bilaterally, sensation to light touch intact. 

DISCHARGE PHYSICAL EXAMINATION:  
Vital Signs: Temperature 98.1/98.1 F, blood pressure 110/70, 
pulse 73, respiration 18 and oxygen saturation 100% in room air
I/O 8hours: 1.6L/2.6L pH 8
General: Alert, oriented, comfortable, Cushingoid appearance
HEENT: EOMI without nystagmus; pupils round, equal, nonreactive; 
Mucous membranes moist, oropharynx clear without 
erythema/exudate  
Neck: Supple, without lymphadenopathy  
Cardiovascular:  RRR, S1 S2, no MRG
Lungs: CTAB with some bibasilar crackles
Abdomen: +BS, soft, nontender, not distended
Extremities: Warm, well-perfused, no edema, DP pulses 2+ b/l

Neurological Examination: Alert, oriented, good historian, 
occasional double vision but EOMI, ___ strength in UE and ___ 
bilaterally, sensation to light touch intact, Gait intact.
 
Pertinent Results:
ADMISSION LABS:
---------------
___ 12:55PM BLOOD WBC-4.5 RBC-4.25* Hgb-13.2* Hct-39.8* 
MCV-94 MCH-31.1 MCHC-33.1 RDW-14.7 Plt ___
___ 12:55PM BLOOD Neuts-48* Bands-8* ___ Monos-4 
Eos-0 Baso-0 ___ Metas-8* Myelos-8* NRBC-1*

PERTINENT LABS:
---------------
___ 06:00PM BLOOD mthotrx-1.7
___ 06:00PM BLOOD mthotrx-0.12
___ 06:20AM BLOOD mthotrx-0.05
___ 07:00AM BLOOD %HbA1c-6.3* eAG-134*

DISCHARGE LABS:
---------------
___ 06:20AM BLOOD WBC-2.5* RBC-4.43* Hgb-13.4* Hct-42.0 
MCV-95 MCH-30.3 MCHC-31.9 RDW-15.0 Plt ___
___ 06:20AM BLOOD Neuts-64.3 ___ Monos-1.2* Eos-1.2 
Baso-0.6
___ 06:20AM BLOOD Glucose-204* UreaN-16 Creat-0.8 Na-134 
K-4.2 Cl-92* HCO3-36* AnGap-10
___ 06:20AM BLOOD ALT-78* AST-34 LD(LDH)-235 AlkPhos-63 
TotBili-0.6
___ 06:20AM BLOOD Calcium-8.7 Phos-3.0 Mg-1.9
___ 09:23AM BLOOD Lactate-2.3*
 
Brief Hospital Course:
___ is a ___ man with HIV, recently 
diagnosed high-grade CNS B cell lymphoma (brain stem), on 
dexamethasone admitted for cycle 3 of high dose methotrexate.  

1. CNS Lymphoma:  He presented for his third induction dose of 
high-dose methtorexate. He started 24-hour urine collection for 
creatinine clearance the day before admission. He received his 
high-dose methotrexate. He tolerated it well. His urine was 
alkalinized. His IVF were increased to 200cc/hr. He was rescued 
with leucovorin. His dexamethasone was tapered to 1mg PO daily. 
He will return on ___ for the next round of high-dose 
methotrexate. His PPI and aspirin were held during his 
hospitalization and restarted on discharge.     

2. Anal HSV 2:  He was continued on home prophylactic acyclovir. 


3. HIV:  CD4 275, viral load undetectable in ___. 
Continued ART. ___ change per ___ PCP. Elevated lactate level 
noted last admission now improved to 2.3. 

4. Imbalance and Double Vision:  This may be secondary to 
lymphoma. Remainder of neuro examine intact. This admission, the 
patient had very stable gait and he notes his double vision to 
be improved from prior.

5. Coronary Artery Disease:  He is s/p 2 bare metal stents ___: 
Continued on lisinopril, metoprolol, pravastatin. However, 
lisinopril and metoprolol doses were cut in half as patient had 
mild symptomatic orthostasis. Aspirin was held while inpatient 
since it is an acid but restarted on discharge.

===========================
Transitional Issues
===========================
1. CNS Lymphoma:  Admitted for cycle 3 of HD MTX. Tolerated 
chemo well and MTX level on the morning of discharge was 0.05. 
Dexamethasone was tapered to 1mg daily. Will come back ___ 
for next high dose methotrexate infusion.

2. CAD s/p Stents ___:  Aspirin was held while inpatient due to 
methotrexate infusion. It will be restarted on discharge. We 
also decreased lisinopril from 5 to 2.5mg daily and toprol XL 
from 25 to 12.5mg daily because the patient had mild symptomatic 
orthostasis.

3. Elevated Lactate:  This was noted on prior admission, and now 
improved to 2.3. 

4. CODE: Full

5. EMERGENCY CONTACT: Family contact:  His wife is ___ 
___ at cell:
___ and his brother is ___ at cell: 
___.
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acyclovir 400 mg PO Q12H 
2. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
3. Lisinopril 5 mg PO DAILY 
4. Lopinavir-Ritonavir 2 TAB PO BID 
5. Metoprolol Succinate XL 25 mg PO DAILY 
6. Pravastatin 40 mg PO DAILY 
7. Aspirin 81 mg PO DAILY 
8. Fish Oil (Omega 3) 1000 mg PO DAILY 
9. Omeprazole 40 mg PO DAILY 
10. Dexamethasone 2 mg PO DAILY
 
Discharge Medications:
1. Acyclovir 400 mg PO Q12H 
2. Dexamethasone 1 mg PO DAILY 
RX *dexamethasone 1 mg 1 tablet(s) by mouth daily Disp #*30 
Tablet Refills:*0
3. Emtricitabine-Tenofovir (Truvada) 1 TAB PO DAILY 
4. Fish Oil (Omega 3) 1000 mg PO DAILY 
5. Lisinopril 2.5 mg PO DAILY 
RX *lisinopril 2.5 mg 1 tablet(s) by mouth daily Disp #*30 
Tablet Refills:*0
6. Lopinavir-Ritonavir 2 TAB PO BID 
7. Pravastatin 40 mg PO DAILY 
8. Aspirin 81 mg PO DAILY 
9. Omeprazole 40 mg PO DAILY 
10. Metoprolol Succinate XL 12.5 mg PO DAILY 
RX *metoprolol succinate 25 mg half tablet extended release 24 
hr(s) by mouth daily Disp #*30 Tablet Refills:*0
 
Discharge Disposition:
Home
 
Discharge Diagnosis:
PRIMARY DIAGNOSIS:
CNS lymphoma
SECONDARY DIAGNOSES:
HIV
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.
 
Discharge Instructions:
Dear Mr. ___,

It was a pleasure to take care of you at ___ 
___. You were admitted for the administratin of high 
dose methotrexate for your CNS lymphoma. You tolerated the 
medication well, without major adverse effects. We decreased 
your dose of dexamethasone to 1 mg daily.

We also decreased the dose of your heart medications (Metoprolol 
and Lisinopril) because you were feeling lightheaded and your 
blood pressure were low to normal. Please continue to discuss 
with your PCP if you should continue on this lower dose of heart 
medications.

Please take your medications as prescribed and follow up with 
the appointments listed below.
 
Followup Instructions:
___
